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ABSTRACT
Effect o f  Relaxation on Neuro-Immune Responses of 
Persons Undergoing Chemotherapy
Chemotherapy can be considered both a physiologic and a psychological stressor. Anxiety, 
nausea, emesis, and immunosuppression are commonly associated with chemotherapy, and may 
adversely affect the outcome or the process of treatment. Chemotherapy-related anxiety can 
exacerbate negative side-effects. Some psychological stressors, such as anxiety, can result in 
down-regulation of certain immune functions. Studies have demonstrated that behavioral 
interventions, such as specific relaxation strategies, can modify stress-related immune modulation. 
These behavioral interventions have also been shown to decrease the degree of nausea and 
vomiting associated with chemotherapy. The purpose of this study was to examine whether a 
relaxation intervention would result in decreased anxiety, decreased nausea and vomiting, and 
decreased immune modulation in persons undergoing chemotherapy for breast cancer.
A baseline neuro-immune assessment, including immune function tests, state and trait anxiety, and 
serum catecholamines, was performed on 12 women diagnosed with breast cancer and slated to 
undergo four cycles o f Adriamycin/Cytoxan (AC) chemotherapy. Subjects were assigned to an 
experimental or a control group. The control group underwent chemotherapy according to the 
prescribed AC regimen. The experimental group underwent the same chemotherapy and a 
relaxation intervention. The neuro-immune assessment was repeated just before subjects received 
the third and fourth chemotherapy infusions, with the addition o f assessment of nausea and 
emesis.
Study findings revealed that state anxiety was significantly lower at measure two for the 
experimental group (t = 3.20, p -  0.02). No significant difference in anticipatory nausea and 
vomiting was found between groups. Evaluation of immune function tests was inconclusive.
These findings suggest that a relaxation intervention may lower anxiety in individuals who are 
undergoing chemotherapy. Future research efforts should continue to explore whether relaxation 
interventions can modify the degree of side effects associated with chemotherapy, and potentially 
improve the quality of life for persons requiring the treatment.
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Chapter I 
Introduction
The immune system is an important protective mechanism against infection and some 
types o f cancer. Studies of the immune system have revealed that physiological and/or 
psychological stress can modify immune function, in some situations resulting in 
immunosuppression. Although the association is not yet clear, alterations in immune function 
indicating immunosuppression are hypothesized to result in impaired host defense mechanisms.
Chemotherapy, a common treatment for cancer, is accompanied by side effects, such as 
immunosuppression and nausea and vomiting, that may affect the outcome of the therapy and 
patient compliance with the treatment regimen. Persons undergoing chemotherapy are not only 
stressed physiologically as a direct effect o f the cytotoxic drugs, but also psychologically due to 
the diagnosis of cancer and anticipated side effects. Because o f  both physical and psychological 
side effects, chemotherapy may be considered a severe stressor (Razavi et al., 1993; Walker et al., 
1999).
Because stress can down-regulate the immune system, it has been hypothesized that 
interventions that decrease the stress response may modulate the effects o f stress. Behavioral 
strategies to promote relaxation have been studied and, in many cases, have shown promising 
results in lessening the degree o f down-regulation in immune functions seen in persons subjected 
to stress, as compared with controls.
Purpose
The purpose of this pilot study was to examine the effect o f  a nursing relaxation 
intervention involving slow stroke back massage and progressive muscle relaxation on the neuro-
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-immune Status 2
immune response of chemotherapy recipients. Specifically, the study was designed to determine 
the effect of a nursing relaxation intervention on the extent o f anxiety, immunosuppression, and 
anticipatory nausea and vomiting in chemotherapy recipients.
The study purpose was accomplished by using a prospective repeated measures design 
with an intervention and a control group. Baseline neuro-immune information was obtained on 
persons slated to undergo chemotherapy. A control group underwent routine chemotherapy with 
four cycles of Adriamycin and Cytoxan. An experimental group also underwent routine 
chemotherapy with four cycles of Adriamycin and Cytoxan, but in addition were exposed to a 
nursing relaxation intervention. After two cycles of chemotherapy had been completed, and just 
prior to the third dose, all subjects underwent a repeated neuro-immune assessment and 
assessment of chemotherapy-associated nausea and vomiting. All subjects were assessed again 
just prior to the fourth and final cycle o f chemotherapy. Differences between the baseline and 
repeated measurements were evaluated, as were differences between the experimental and control 
groups.
Background and Significance 
Recent research has demonstrated a predictable neuro-immune response to stress, 
resulting in depression of certain components of the immune system (Benschop et al., 1993; 
Blalock, 1994; Kropiunigg, 1993; Schedlowski et al., 1993). Responses to stress vary, depending 
on the nature of the stressor (Ader, Felten, & Cohen, 1990), and can be summarized as follows: 
once sensory recognition o f a stressor occurs, the body responds by central nervous system 
stimulation of the hypothalamus, inducing secretion of corticotropin-releasing hormone (CRH).
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CRH triggers release o f corticotropin from the pituitary gland, which in turn stimulates the 
adrenal gland to produce glucocorticoids that maintain a feedback property o f inhibiting CRH and 
corticotropin release. Glucocorticoids also can modulate immune function and metabolism 
(Blalock, 1994). Until recently, researchers have held a common understanding that while 
interplay between the neuroendocrine and psychological systems existed, the immune system 
functioned independently. Increasing evidence now supports a bidirectional modulation between 
immune and neuro-endocrine systems (Bellinger, Madden, Felten, & Felten, 1994; Blalock, 1989). 
A meta-analysis o f stress and immunity in humans has shown substantial evidence for a correlation 
between stress and immune system modulation and cellular decreases (Herbert & Cohen, 1993a).
Studies o f the immunological effects of stress have demonstrated a propensity for the 
development of conditioned responses (Ader & Cohen, 1991; Ader et al., 1990). Ader and Cohen 
(1975) found that following illness-induced taste aversion conditioning using a saccharine drink 
paired with an immunosuppressant, rats exposed to saccharine drink alone demonstrated 
immunosuppression. Subsequent animal studies corroborated the fact that a conditioned stimulus 
can induce immunosuppression (Bovbjerg, Cohen, & Ader, 1987; Kelley, Dantzer, Mormede, 
Salmon, & Aynaud, 1985; Kusnecov, Husband, & King, 1990; Lysle, Cunnick, Fowler, & Rabin, 
1988; Roudebush & Bryant, 1991). Human investigations have indicated that some individuals 
undergoing chemotherapy develop anticipatory immunosuppression (Bovbjerg et al., 1990; 
Fredrikson, Furst, Lekander, Rotstein, & Blomgren, 1993). While anticipatory 
immunosuppression has received little study to date, another induced effect, anticipatory nausea 
and vomiting (ANY) has been widely reported in the literature and may serve as a model for study
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of conditioned immunosuppression. An estimated 25-65% of patients undergoing chemotherapy 
experience ANV as a conditioned response to chemotherapy (Andrykowski, 1990; Andrykowski 
et al.,1988; Andrykowski & Redd, 1987; Burish & Carey, 1986; Morrow, 1992; Nicholas & 
Hollandsworth, 1986). Anxiety has been found to be associated with ANV (Jacobsen, Bovbjerg, 
& Redd, 1993; Jacobsen & Redd, 1988; Lev, 1992). Studies involving a number of behavioral 
interventions have been reported to alleviate both anticipatory and treatment-induced nausea and 
vomiting. Behavioral interventions that have been found effective in diminishing anxiety, nausea, 
and vomiting associated with chemotherapy include progressive muscle relaxation training 
(PMRT) (Cotanch & Strom, 1987), PMRT and guided imagery (Burish, Carey, Krozely, &
Greco, 1987), systematic desensitization (Morrow & Morrell, 1982; Morrow et al., 1992), 
cognitive distraction and relaxation training (Vasterling, Jenkins, Tope, & Burish, 1993), hypnosis 
(Jacobsen & Redd, 1988), relaxation training and guided imagery (Lyles, Burish, Krozely, & 
Oldham, 1982), and relaxation using combined slow-stroke massage and guided imagery (Scott, 
Donahue, Mastrovito, & Hakes, 1986).
Immunosuppression is a common side effect of chemotherapy and may occur as a direct 
result o f drug cytotoxicity (Fallowfield, 1992). In addition, anxiety is a common emotion 
experienced by cancer patients (Jacobson et al., 1993; Lev, 1992; Walker et al., 1999). Research 
indicates a correlation between anxiety level and incidence of ANV (Morrow, 1992) and between 
anxiety and anticipatory immunosuppression (Fredrikson et al., 1993).
Although many studies have identified the occurrence of immunosuppression, few studies 
have focused on interventions to modify stress-related neuro-immune changes (Sabbioni, 1993).
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Many behavioral interventions have been implemented and studied to help cancer patients deal 
with psychological reactions to cancer, but behavioral interventions as a means to modulate the 
immune system have received little study (Fawzy, Fawzy, & Hyun, 1994; Schedlowski, Twews, & 
Schmoll, 1994).
Certain interventions in healthy hosts without a specific identified stressor have been 
studied. Green and Green (1987), assessing the effects of relaxation on the immune system, found 
that subjects undergoing a relaxation response, massage, or visualization exhibited higher salivary 
immunoglobulin A (IgA) levels than did a control group in which touch alone was used. Groer et 
al. (1994) studied the effects of nursing back-rub on well, older subjects and found that salivary 
IgA levels increased for the experimental group.
Studies o f the effects o f mirthful laughter on the immune and neuroendocrine systems 
indicated an association between laughter and an increase in natural killer (NK) cell activity (Berk, 
Tan, Napier, & Eby, 1989), an increase in spontaneous lymphocyte blastogenesis (Berk et al., 
1988), and a decrease in stress-associated hormones (Berk, Tan, Fry, et al., 1989). Dillon, 
Minchoff and Baker (1985-86) found that salivary IgA concentrations increased significantly in 
subjects after they had viewed a humorous videotape, but not after viewing a didactic videotape.
Other studies have involved persons with an identified stressor. For example, a pilot study 
assessing relaxation training and immunological status o f persons suffering bereavement 
suggested that relaxation training resulted in a promising psycho-immunological trend, with 
further study indicated (Houldin, McCorkle, & Lowery, 1993). The authors did not describe the 
the trend noted. Kiecolt-Glaser et al. (1986) assessed intervention techniques with healthy
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subjects anticipating a stressor, measuring the effect o f relaxation practice on cellular immunity in 
medical students undergoing final course examinations. While all subjects showed decreases in 
immunological response prior to the examination in comparison with the baseline, those who 
practiced the relaxation techniques had less decrease in helper/inducer cell percentages than did 
the controls, leading the researchers to suggest that intervention may be a factor in enhancing 
immunity during stressful events.
Literature review has revealed that while there are studies addressing anticipatory neuro- 
immune response before a stressor and neuro-immune responses following a stressor, there are 
few studies addressing whether intervention can modify the neuro-immune response. Prior to 
1999 no study was found addressing the whole continuum, including assessment o f neuro-immune 
status prior to onset o f  a stressor, with intervention to modify stress-associated response and 
assessment afterward to see if immune modification occurred as a result o f the intervention.
There is a need for research regarding how specific stress characteristics may affect immune 
status. Research is also needed on the effectiveness of interventions to modify stress responses. If 
stressors that modify the immune system and result in immunosuppression are identified, then 
interventions could be planned to modify an anticipated negative stress response and prevent 
immunosuppression from occurring, or, potentially, to enhance immune function. No studies have been 
reported on the effects of bio-behavioral interventions in modifying the degree of anxiety and 
immunosuppression associated with chemotherapy, a known psycho-biological stressor.
Persons undergoing chemotherapy need to be studied prospectively to assess whether an 
intervention could enhance or protect their immune status. A decade ago, Kiecolt-Glaser & Glaser
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(1988) recognized a need for prospective studies on the immunological effects o f stress, but a 
review of literature published since then revealed that prospective studies, especially dealing with 
interventions, are not common. Relaxation strategies are a common part o f nursing intervention; 
research on the efficacy of these interventions on the neuro-immune system could add greatly to 
the discipline, justifying the use of specific interventions in client care.
Conceptual Framework 
The conceptual framework used for this study was the “Stress-Coping-Adaptation” (SCA) 
framework described by Monsen, Floyd, and Brookman (1992). The authors described the SCA 
process as “... the synthesis of the separate concepts o f stress, coping, and adaptation into an 
interacting triad encompassing the reciprocal and continuous interrelationship o f  person/ 
environment in health states” (pp. 27-28). “The conceptualization of SCA succinctly expresses the 
person/environment health-related transaction and accounts for phenomena o f concern in the 
development of science in nursing” (p. 28). In this model, the authors use Selye and Lazarus’s 
concept of stress as a psychophysiological response of arousal in response to demands that are 
perceived as stressful in person/environment transactions. Stress has both a cognitive and a 
physiological component. Those stresses perceived as undesirable can result in health changes, 
and conversely, changes in health state can result in stress. Coping, considered from the context 
of Folkman and Lazarus, is how the individual manages perceived stressful demands of the 
person/environment relationship. A significant part o f this model is the concept that nursing 
actions are seen as facilitating coping efforts through supportive or interventive care. Adaptation 
is considered the consequence of efforts to cope with the stress experience. It involves use of
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behaviors or cognitive measures to neutralize the stress experience and reestablish integrity of 
function” (p. 28). Effective adaptation requires a balance between stress and coping. If this 
balance is not achieved adaptation is not optimal, and the stress response continues.
For the purpose of this research, the SCA framework is conceptualized as the model 
displayed in Figure 1. Within the SCA conceptual framework stress is psychophysiological 
arousal that arises as a result of person or environmental transactions perceived as stressful by the 
individual. Coping is how the individual manages the perceived stress and involves both cognitive
STRESS






coping, which if 







to deal with stressor
Figure 1. Study model of Stress-Coping-Adaptation (SCA) conceptual framework.
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and behavioral measures. Adaptation is the consequence of coping with the perceived stress. If 
coping has been effective the adaptation will result in reduced anxiety and enhanced well-being.
In this study stress was defined as a perceived negative experience, specifically that of 
chemotherapy with its associated physiological and psychological side effects, that resulted in a 
psycho-physiological response. Coping was the individual's response to deal with the perceived 
stress. A nursing relaxation intervention was incorporated to assist coping. The resulting 
adaptation was studied with physiologic assessment of neuro-immune functions, physiologic and 
psychological assessment o f  anxiety, and self-report of nausea and/or relaxation intervention.
Inclusion of the relaxation intervention into the proposed SCA conceptual model, with 
possible resulting altered stress response, is depicted in Figure 2. The stressor was chemotherapy, 
with the associated stress o f  the diagnosis o f cancer and knowledge o f potential side effects from 
therapy. The relaxation intervention targeted different parts o f the model. The massage, given just 
before chemotherapy, was an attempt to diminish conditioned responses such as 
immunosuppression and anxiety associated with the chemotherapy administration, and to induce a 
relaxation response instead. Daily progressive muscle relaxation (PMR) practice was intended to 
enhance the coping response once the stressor had occurred and help the coping result in optimal 
adaptation. It was expected that positive adaptation would result in lower stress levels and a 
positive modulation in immune parameters in the intervention group versus the control group. 
Coping was viewed as a process to accomplish adaptation and was not the focus of this study.
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ADAPTATION
Consequence of 
coping, which if 
effective will result in 
reduced anrrietyand 
enhanced well-being
Figure 2. Study SCA conceptual framework, with relaxation intervention.
Research Hypotheses 
The following research hypotheses were studied:
1. Relaxation intervention, in the form of slow-stroke back massage and progressive 
muscle relaxation, would reduce the degree of anxiety in clients receiving 
chemotherapy, as compared to those who did not experience the relaxation 
intervention.
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2. Relaxation intervention, in the form o f slow-stroke back massage and progressive 
muscle relaxation, would reduce the degree of anticipatory nausea and vomiting 
(ANV) in clients receiving chemotherapy, as compared to those who did not 
experience the relaxation intervention.
3. Relaxation intervention, in the form o f slow-stroke back massage and progressive 
muscle relaxation, would reduce the degree of immunosuppression in clients 
receiving chemotherapy, as compared to those who did not experience the relaxation 
intervention.
Because of the lack of information on bio-behavioral intervention and chemotherapy, 
additional goals of this pilot study were to expand on the available information on the effect of 
Adriamycin/Cytoxan (AC) chemotherapy on the immune system and to develop a plan for a 
further intervention study of persons undergoing chemotherapy.
Definition of Maior Variables and Concepts
Dependent Variables:
Three dependent variables, related to persons undergoing chemotherapy, were included: 
anxiety, immunosuppression, and anticipatory nausea and vomiting.
Anxiety variables included state anxiety, which was defined as the anxiety level at the 
tested moment, and trait anxiety, referring to the subject's baseline level o f  anxiety. These were 
assessed using Spielberger's (1983) State Trait Anxiety Inventory (STAI-Y). Physiologic 
indicators of increased anxiety included blood pressure and heart rate, and the serum
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catecholamines epinephrine and norepinephrine, which have the potential for modulating the 
immune system (Ader, Cohen, & Felten, 1995; Fredrikson et al., 1993).
Immunosuppression was defined as specified immune levels that show a significant drop 
from baseline level or lower than expected normal ranges based on standardized laboratory 
values. This was assessed by blood or serum analysis o f Total Complement, Serum 
Immunoglobulin, Flow Cytometry Phenotyping of CD45-F/CD12-PE lymphocyte purity, CD3+ 
T-Lymphocytes (percent and absolute numbers), CD20+ B-Lymphocytes (percent and absolute 
numbers), CD3+25+IL-2 Activated T Lymphocytes (percent and absolute numbers), CD3- 
CD16+56+ NK Cells (percent and absolute numbers), Mitogen Stimulation Assay with PHA, 
Natural Killer Cell Assay (Effectors, Target Cells, 40:1, 20:1,10:1,5:1 and Lytic units), and 
Cytokines IL-2, IL-4, IL-6, IL-10, IL-12, and INFy.
Anticipatory nausea and vomiting (ANV) was defined as the nausea or vomiting that 
occurred before or during chemotherapy in anticipation o f the treatment (Burish & Carey, 1986; 
Morrow, 1992). ANV was assessed using the Morrow Assessment of Nausea and Emesis 
(MANE) instrument.
Independent Variable
The independent variable was the relaxation intervention planned to elicit a relaxation 
response in subjects. The relaxation intervention consisted of a 10-minute slow-stroke back 
massage just before administration of chemotherapy and daily practice o f progressive muscle 
relaxation. For this study, researcher interaction was considered a part o f  the relaxation 
intervention because the researcher administered the massage and spent time with the
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experimental subjects during unavoidable waiting periods and blood specimen draws. In addition, 
the researcher’s voice was on the guided progressive muscle relaxation tape.
Attribute Variables
Selected attribute variables were recorded for each subject, including birth date, cancer 
diagnosis (including extent, cellular type, and intervention), any medical problems, and associated 
medications. Cardiovascular assessment, including heart rate and blood pressure, was recorded on 
experimental subjects during the relaxation intervention. These were to be obtained from clinic 
records for all subjects during administration of chemotherapy, but were not consistently 
recorded.
Assumptions
The research was based on the following assumptions: (1) patients undergoing 
chemotherapy would be able to distinguish between the often subjective sensations o f nausea and 
anxiety when self-reporting on the STAI-Y and the MANE; (2) laboratory tests would provide 
accurate measurement of immune function and serum catecholamine levels; (3) specimens would 
be handled and reported accurately by the laboratories; (4) if immunological changes occurred, 
they would be measurable; (5) clinic equipment used and maintained according to protocol would 
assess cardiovascular parameters o f heart rate and blood pressure accurately; (6) outpatient clinic 
staff would cooperate with the study and consistently observe clinic procedures; (7) relaxation 
strategies would actually result in relaxation; and (8) experimental subjects would practice the 
relaxation exercises as requested.
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Chapter II 
Critical Review of Relevant Literature 
A brief introduction and overview of psychoneuroimmunology (PNI), showing linkages 
between stress and the immune system will be provided as a background to the immunological 
studies that will be reviewed. This will be followed by animal and human PNI studies o f the 
immune system, with a focus on conditioned changes. Based on the hypothesis by Green & Green 
(1987) that if  stress contributes to immunosuppression, relaxation may enhance the immune 
system, studies reflecting interventions to modify immune responses are reviewed. Finally, the 
phenomenon of conditioned anticipatory nausea and vomiting is reviewed.
Psvchoneuroimmunologv: Linkage Between Stress and the Immune System 
Human response to stress has been extensively studied and reported in the health-related 
literature. Responses to stress vary, depending on the nature of the stressor (Ader et al., 1990). 
According to Weizman and Bessler (1999), “The correlation between stress and immunity is not 
linear, and both increases and decreases in immunocompetence can occur following exposure to 
different stressors” (p. 9).
The body’s response to stress can be summarized as follows: once there is sensory 
recognition o f a stressor, the body responds by central nervous system stimulation o f the 
hypothalamus, causing secretion o f corticotropin-releasing hormone (CRH). CRH stimulates 
release of corticotropin from the pituitary, which in turn stimulates the adrenal gland to produce 
glucocorticoids. Glucocorticoids not only have a feedback property o f inhibiting CRH and 
corticotropin release, but also can modify immune function and metabolism (Blalock, 1994).
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There is also a direct bidirectional connection between the central nervous system (CNS) and the 
immune system through innervation o f lymphoid tissues. These nerve fibers connect at 
neuroeffector junctions with lymphocytes and macrophages. Neurotransmitters, released from the 
nerve fibers, can diffuse to act at distant sites and also can act on immune cells such as 
lymphocytes, granulocytes, and monocytes that have neurotransmitter receptors, and cytokines 
released by immune cells can influence CNS activity (Ader et al., 1995).
Recent research has demonstrated evidence for interaction between the immune system 
and the neuroendocrine system, with the immune system capable of regulating neuroendocrine 
function and vice versa (Ader et al., 1995; Bellinger et al., 1994; Blalock, 1989). This has given 
rise to research in the field of psychoneuroimmunology, which studies the mind-body interaction 
from a holistic paradigm or, as defined by Nguyen (1991), as the " ... field of research that 
investigates how the central nervous system (CNS) and the immune system may interact to 
influence health" (p. 1). The focus of this study is on the neuro-immune response to a 
chemotherapy stressor that involves both physiologic and psychological stress for the recipient.
Review of relevant literature revealed that there is much written about the effects o f stress 
in general on the emotional and physical health of individuals. Adler (1994) suggested that 
persons undergoing stress may experience increased susceptibility to disease, including 
cardiovascular and infectious diseases and complications during pregnancy. Rice (1992) and 
Sparacino (1982) associated adverse emotional and mental health with stressful situations. 
Benschop et al. (1993, p. 1825), reporting on the relationship of psychobiological factors and 
immune functions, stated that"... inadequate coping with life stress, as reflected by high levels of
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self-reported symptoms, affects immune function." Some interesting animal research raises a 
question of what effect stress has on cancer metastasis and response to treatment. Mice with Lewis 
lung tumors were found to have significant increase in tumor metastasis when stressed, as compared 
with non-stressed mice (Giraldi, Perissin, Zorzet, & Rapozzi, 1992). Later research by members 
o f this team found that stress negated the antitumor effect o f cyclophosphamide in treated mice 
with Lewis lung tumor, in comparison with non-stressed mice (Zorzet, Perissin, Rapozzi, & 
Giraldi, 1998). While the mechanism o f the relationship between health and stress-induced 
immunosuppression may not be clear, there is sufficient information to suggest that there is a 
negative association.
The endocrine system responds to stress with a variety of stress hormones (Blalock, 1994; 
Frankenhauser, 1971; Henry, 1987; Kim, 1987; Lundberg, 1976; Siconolfi, 1994), with the 
response to perceived stress occurring quickly. Epinephrine and norepinephrine are secreted 
within 2 to 3 minutes of perception of a stressor, and the effects of sympathetic stimulation are 
maintained for 1 to 2 hours (Robinson, 1990). Catecholamines have an effect on the immune 
system. The CNS and the immune system are linked both directly through neurological 
innervation of immune system tissues, and indirectly through soluble neuro-endocrine or 
biochemical products (Ader et al., 1995; Zeller, McCaine, & Swanson, 1996).
Research on the effects o f stress on the immune system has indicated that there is a neuro- 
immune response to stress, resulting in a depression of certain aspects of the immune system 
(Ader & Cohen, 1993; Benschop et al., 1993; Kropiunigg, 1993; Schedlowski et al., 1993;
Walker, Johnson, Whiting, Heys, & Ermin, 1993). Stress, social disruption, and depression are
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associated with activation of the hypothalamic-pituitary-adrenocortical (HP AC) axis, with 
resulting secretion of catecholamines and other substances. Increase in catecholamines has been 
associated with reduction in peripheral lymphocyte numbers, reduced phytohemagglutinin (PHA) 
response, and suppression of natural killer (NK) cell activity (Khansari, Murgo, & Faith, 1990; 
Kiecolt-Glaser, Cacioppo, Malarkey, & Glaser, 1992; O'Leary & Miller, 1991; Schedlowski et al., 
1993). There is evidence to support the correlation of increased stress hormones with depression 
of certain aspects of the immune system (Ader et al., 1995; Ader & Cohen, 1991; Ader et al., 
1990; Cupps & Fauci, 1982; Landmann et al., 1984; Linn, Linn, & Jensen, 1981; Zeller et al.,
1996 ). A meta-analysis of stress and immunity in humans has shown substantial evidence for an 
inverse correlation of stress with immune function and cellular decreases (Herbert & Cohen, 
1993a).
According to Kiecolt-Glaser et al. (1992), immune system changes that follow short-term 
stress mimic changes that occur following injection of epinephrine and seem to "...reflect transient 
alterations in lymphocyte migration from lymphoid organs and peripheral blood mediated through 
adrenergic receptors on lymphocytes or via the sympathetic innervation o f lymphoid organs" (p. 
680). These changes include increased NK cell percentage, decreased blastogenic response to 
mitogens, and decreased CD4 cell percentages, while monocytes and total T cells remain 
unchanged. Benschop et al. (1993) also reported that NK cells are sensitive to changes under 
stressful situations, although a study by the authors could not show an association between stress­
ful situations and decreased NK cell activity. First-time parachutists, undergoing what can be 
considered the acute psychological stressor o f a first jump, were assessed for sympathetic adrenal
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hormones and immune changes prior to, during (with use of a small portable pump attached to an 
intravenous catheter), and following the jump. As expected, adrenalin and noradrenaline levels 
increased during and immediately following the jump. There was an increase in NK cell activity 
and an increase in lymphocyte subsets immediately following the jump. However, an hour later 
there was a significant decrease below starting values. This study indicated that short-term 
psychological stress resulted in increased secretion of sympathetic adrenal hormones and in 
changes in NK cell activity and numbers, supporting the theory o f nervous and immune systems 
interacting during stress (Schedlowski et al., 1993). One may also conclude that the time interval 
after the stress may be important when assessing certain immune functions.
Stress Related Immune System Changes in the Animal Model 
Studies on the immunologic effects of stress have shown that these effects can be 
conditioned (Ader & Cohen, 1991; Ader et al., 1990). An early study by Ader and Cohen (1975) 
found that following illness-induced taste aversion conditioning, using a saccharine drink paired 
with an immunosuppressant, rats exposed to the saccharine drink demonstrated immuno­
suppression. Subsequent animal studies have also demonstrated that a conditioned stimulus can 
result in immunosuppression (Bovbjerg et al., 1987; Kelley et al., 1985; Kusnecov et al., 1990; 
Lysle et al., 1988; Roudebush & Bryant, 1991). A review of selected studies follows.
Based on the idea that behavioral conditioning may result in immunosuppression, Ader 
and Cohen (1975) performed a study in which rats were conditioned by pairing a saccharine drink 
with cyclophosphamide injection. Non-conditioned animals were given water with saccharine 
and injected with cyclophosphamide, while the control animals were given plain water and
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distilled water injection. Animals given the saccharine and cyclophosphamide injections developed 
an aversion to the saccharine solution. Immune study revealed significant immunosuppression in 
animals that were previously conditioned and were given saccharine prior to or following antigen 
administration.
Grochowicz et al. (1991) used the same technique of taste aversion conditioning, 
combining oral saccharine and injection of cyclosporin ten and six days prior to heart allograft in 
rats. The conditioned rats were given saccharine alone one day before and three days after heart 
transplantation. The conditioned animals had significantly prolonged heart graft survival as 
compared to conditioned control groups, indicating that immunosuppression occurred as a 
conditioned response.
Roudebush and Bryant (1991) used the conditioning technique o f pairing saccharine with 
cyclophosphamide injection to study a delayed type hypersensitivity response in mice.
Experimental animals were first conditioned, and all animals sensitized with 5% picryl chloride 
(PCL). On the third day, 50pL of PCL were applied to a hind footpad of all the mice. Conditioned 
animals were also given saccharine as drinking solution. Conditioned mice demonstrated 
significantly less delayed hypersensitivity type paw swelling than did unconditioned mice. Another 
interesting finding was that when all mice were sacrificed and studied, no significant differences in 
serum corticosterone levels were found in nonconditioned or in conditioned groups of mice, 
showing that the conditioned immunosuppression that occurred was not associated with increased 
glucocorticoid levels.
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Physical stressors such as electric shock have also been found to be immunosuppressive in 
rats (Lysle et al., 1988). Laudenslager, Ryan, Drugan, Hyson, and Maier (1983) found that rats 
who were exposed to inescapable shock demonstrated suppression of mitogen-stimulated 
lymphocyte proliferation (with phytohemagglutinin and concanavalin A), as compared to rats 
exposed to escapable shock. The authors concluded that not only did shock affect the immune 
response, but also that the aspect of controllability was important in immune system modulation.
Lysle et al. (1988), building on the theory that stresses such as electric shock can be 
immunosuppressive, studied whether a non-aversive stimulus of a psychological nature that had 
been associated with shock could also affect immune function. Rats were placed into groups that 
were conditioned with shock plus sound, shock plus light, or shock alone, and a control group 
that received handling and transporting but no shock. Results indicated that when the conditioned 
rats were exposed to the stimulus, they developed suppressed lymphocyte reactivity to mitogens, 
indicating immunosuppression. These results support the theory of occurrence of conditioned 
immunosuppression, and also that a psychological stressor can result in conditioned 
immunosuppression.
While most studies focused on conditioned immunosuppression, Bovbjerg et al. (1987) studied 
immune enhancement in a study o f behavioral conditioning involving mice. Mice were first conditioned 
using saccharine and cyclophosphamide. They were subsequently given saccharine drink on three days 
following sensitization, and then injected with a low dose of cyclophosphamide. When then challenged 
with sheep red blood cells (SRBC), the mice initially demonstrated immunosuppression. However, 
when re-challenged with SRBC on days 11 and 18, the mice demonstrated significantly enhanced
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-immune Status 21
delayed type hypersensitivity compared to nonconditioned and placebo mice. Ader, Kelly, Moynihan, 
Grota, and Cohen (1993) were also able to demonstrate conditioned enhancement of a specific 
antibody titer in experimentally conditioned mice.
O f interest is the implication for behavior modification and the immune system. Miller, 
Thomas, Pacheco, and Rollwagen (1993) found that rats subjected to stress by electric shock that 
were able to avoid shock by pressing a lever had higher NK activity and mitogen-stimulated 
proliferation of their splenocytes than did control rats or rats that were not able to avoid shock, 
implying that control o f the situation affected immune outcome. Laudenslager et al. (1983) 
suggested that control of stress is an important aspect of immune system modulation.
Studies o f  Stress and the Immune System in Humans 
Persons experiencing naturally occurring stress or laboratory-induced stress have 
demonstrated significant immunological changes. Selected studies will be reported dealing with 
laboratory-induced or scholastic examination-induced stress, psychological stress, and 
chemotherapy-associated stress. This will be followed by studies of behavioral interventions to 
modify stress-related immune changes.
Laboratory Induced or Scholastic Examination Stress
The effect of examination stress on selected immune functions of healthy students has 
been studied. One study included 23 undergraduate psychology students. Students were placed in 
two groups, with an experimental group taking examinations at two time periods, and a control 
group for which no examination was required. Anxiety/tension was assessed by self-report and 
with the STAI. Blood was drawn from experimental subjects 3 times; 6 weeks before the first
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examination, 1 day before the examination, and 12 to 14 days after the examination. Control 
subjects underwent psychological assessment and had one blood sample drawn at the same time 
as experimental subjects' second blood draw. Blood was tested for monocyte distribution, 
expression of IL-2 receptor, and mitogen stimulation. Results indicated that under acute 
examination stress, there was an increase in the number of monocytes and a reduction of the 
CD4:CD8 fractions. There were also reductions of cells expressing the IL-2 receptor and in the 
proliferative responses in IL-2 enriched culture medium. The third sample, obtained, nearly two 
weeks after the examination, indicated a decrease in mitogen and antigen response. The findings 
suggested that under acute examination stress, a decrease o f certain cellular immunological 
functions occurred (Halvorsen & Vassend, 1987).
Another study of the effect o f a naturally occurring stress on healthy people examined 75 
medical students experiencing examination stress. Baseline blood samples were drawn one month 
prior to, and a final sample drawn on the day of final examinations. Results showed a significant 
decrease in NK cell activity from the baseline to the second sample. In addition, persons who 
scored high on scales o f stressful life events and loneliness demonstrated lower levels o f NK cell 
activity. While plasma IgG and IgM and salivary IgA did not change, plasma IgA showed an 
increase from the first to the second sample. Decreased NK activity indicated immunosuppression 
associated with the mild stressor o f  examination, as well as with stressful life events and loneliness 
(Kiecolt-Glaser, Gamer, et al., 1984).
A very briefly reported study (Fittischen, Schultz, Schultz, Raedler, & von-Kerekjarto, 
1990) associated examination stress with a significant increase in the percentage of large
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immunocytes in the peripheral population. The significance of the findings was not discussed, 
except to imply that there was significance and that further study was warranted.
Bachen et al., (1992) studied the effect of acute laboratory-induced psychological stress 
on certain aspects of the immune system in 43 healthy young men, with 33 in the experimental and 
10 in the control groups. All subjects initially underwent immune assay, including T-mitogenic 
responses and circulating lymphocyte populations. Control subjects relaxed, while experimental 
subjects underwent a frustrating laboratory situation, following which the immune assay was 
repeated. Stressed subjects showed increases in heart rate and in systolic and diastolic blood 
pressure from baseline, as compared to controls, who did not show the increases. Stressed 
subjects also demonstrated a significant decrease in T-cell mitogenesis from baseline to post­
stressor measures, while controls showed an increase, thought by the researchers to be likely 
because their task was to relax during the time that stressed subjects underwent their frustrating 
task. Stressed subjects also showed a decline in the CD4:CD8 ratio, with an increase in the CD8 
cells and decrease in CD4 cells from baseline to post-stressor measurement, and an increase in 
circulating NK cells. These changes were not seen in controls, leading the authors to conclude 
that changes in the experimental subjects' immune function resulted from the acute mental 
stressor.
Psychological Stress
Depression, bereavement, and loneliness have also been associated with 
immunosuppression (Andreoli et al., 1993; Herbert & Cohen, 1993b; Irwin, Daniels, Bloom,
Smith, & Weiner, 1987b; Kiecolt-Glaser, Rickers et al.,1984), as has high state anxiety in
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stressed individuals (Fredrikson, et al., 1993; Halvorsen & Vassend, 1987; Linn et al., 1981). A 
longitudinal study of women with terminally ill spouses, that assessed them prior to and following 
the death of the spouse, and another study that assessed bereaved women who had lost a spouse 
to lung cancer within the previous one to four months showed that the bereaved women had a 
significant decrease in NK activity when compared to controls. Depressive symptoms, rather than 
the death of the spouse alone, were found to be associated with the immunosuppression (Irwin, 
Daniels, Bloom, Smith, & Weiner, 1987a & 1987b).
A study of non-psychotic psychiatric inpatients showed that patients who reported high 
loneliness levels exhibited higher levels of urinary cortisol and immune system suppression, 
demonstrated by significantly lower NK activity and less T-lymphocyte phytohemagglutinin 
response, than did persons reporting low loneliness (Kiecolt-Glaser, Rickers, et al., 1984).
The relationships among depression, age, and immunity were studied in a group of 53 
untreated adults presenting to a psychiatric clinic with a major depressive episode (MDE). Fifty- 
three healthy matched controls were included in the study. At the initial screening, a 
comprehensive psychosocial and diagnostic assessment was made on each, using standardized 
instruments. Blood was collected for assessment o f immune status, including cell counts, cell 
surface phenotyping, and mitogen stimulation. The only difference noted between the groups was 
a trend of decreased number of NK cells in the MDE group, as compared to the control group. 
However, in the MDE group, increasing age was significantly correlated with decreased numbers 
o f total lymphocytes and decreased mitogen response, while this was not noted in controls, 
leading the authors to suggest that age and clinical characteristics of depression may be
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independent factors to consider when studying major depression and psychoneuroimmunology 
(Andreoli et al., 1993).
Depression has also been associated with a decrease in cellular immunity to Varicella- 
Zoster vims (VZV). Irwin et al. (1998) evaluated a total of 53 subjects, examining the 
relationship between VZV-specific immunity and depression and age. The findings showed a 
marked decline in VZV-specific cellular immunity in the depressed group, as compared to the 
non-depressed group. In addition, an age-related decline in VZV-specific cellular immunity was 
found in non-depressed adults.
In a study of patients undergoing chemotherapy for breast cancer, Levy, Herberman, 
Lippman, and d'Angelo (1987) found that stressful factors, such as lack o f social support, 
depression, or fatigue, correlated with depression of NK cell activity, whereas chemotherapy, an 
expected immunosuppressant, did not show the same correlation. The authors, expressing their 
surprise at this finding, noted that due to the measurement interval, their assessment did not 
evaluate short-term or acute treatment-related effects on NK cells. They suggested that NK cell 
recovery may have occurred during the intervals between doses.
Linn et al. (1981) studied the association between immune functioning and levels o f  
anxiety in chronically ill patients who were undergoing the stressor o f a hospitalization. Subjects 
were assessed at time o f hospitalization and 75 were screened to be free o f autoimmune disease or 
cancer and included in the study. Anxiety was assessed using the Anxiety Factor of the Hopkins 
Symptoms Checklist. Humoral immunity was assessed using immunoglobulins IgG, IgA, and IgM. 
Cellular immunity was assessed using three skin tests, for in vivo testing, and three mitogens for in
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vitro testing. The researchers found that stressed patients exhibited decreased T-cell response to 
mitogens, suggesting an alteration in the in vitro assessment o f  cellular immunity. However these 
same patients showed more likelihood of multiple positive in vivo responses to skin tests. These 
mixed results have been found in other studies indicating that variables such as anxiety or stress 
may be immunosuppressive or immunoenhancing, depending on the tests being studied. The 
authors stated that the increased response to skin tests could indicate an increased susceptibility to 
disease. A study by Snyder, Roghmann, and Sigal (1993) examined the effects of stress and 
psychosocial factors on primary cellular immune responses in 89 healthy females. All subjects 
filled out questionnaires to assess stressful life events and psychosocial factors such as social 
support. Blood was drawn for baseline lymphocyte proliferation (LP) assessment, following which 
each subject was immunized with a subcutaneous injection o f  100 fig keyhole limpet hemocyanin 
(KLH), a novel antigen. Repeat assessments occurred at three and eight weeks following the first 
visit. Findings revealed a trend of decreased LP associated with increased "bad stress" and 
significantly decreased LP associated with increased level o f hassles at the three-week 
measurement when compared to the baseline measures. Subjects reporting "good stress" showed 
a trend of increased LP at the three-week measurement. At the eight-week measurement all 
subjects showed an enhanced LP effect. The conclusion drawn was that even minor life psycho­
logical stress can influence the immune system; the authors suggested that the findings may help 
explain individual responses to immunizations (Snyder et al., 1993).
Lymphocyte subpopulations and plasma catecholamine and cortisol levels in 15 normal 
subjects before and following physical and psychological stress were assessed by Landmann et al.
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(1984). Following physical stress, all circulating leukocyte subpopulations, but especially B and T 
cells, were increased, while following psychological stress, the numbers o f circulating B cells, 
monocytes, and NK cells increased. The authors interpreted these cell distribution patterns 
following stress as suggestive o f immunosuppression and thought them to be related to adrenalin 
production during stress.
A meta-analysis by Herbert and Cohen (1993b), studying the association between 
psychological depression and immunity, concluded that depression was significantly associated 
with decreased lymphocyte function (including mitogen stimulation with PHA, Con A, and 
pokeweed antigen), and decreased NK cell activity. Higher numbers o f circulating white blood 
cells (neutrophils and monocytes) were also found, with decreased numbers o f lymphocytes (NK, 
B, and T-cells) and decreased ratio o f  helper to suppressor T cells.
Conditioned Immune Changes in Persons Undergoing Chemotherapy
Recent human studies have revealed that an anticipatory immunosuppression occurs in 
some individuals undergoing chemotherapy. Bovbjerg et al. (1990) studied 20 patients who were 
receiving chemotherapy for ovarian cancer. Patients were to receive chemotherapy in the hospital 
every four weeks. After the patients had received at least three chemotherapy infusions, they were 
entered into the study. In the four-week interval prior to the next scheduled infusion, subjects 
were contacted and arrangements made for assessment to be done in the home setting, three to 
eight days before the next planned hospitalization. Assessment included psychological and 
behavioral questioning, using the STAI questionnaire and the VAS rating o f nausea and anxiety.
A blood sample was obtained by venipuncture for immune assessment, including functional assays
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of NK cell activity and proliferative responses to mitogens, as well as quantitative assays, 
including complete blood cell counts and subset numbers. The second set o f data was obtained in 
the hospital on the morning prior to chemotherapy infusion. Results showed that in the hospital 
setting, proliferative responses to mitogens were significantly lower than in the home setting. No 
significant differences were found in NK cell activity or in quantitative assay between home and 
hospital. These findings indicated that there was an anticipatory decrease in immune function, 
suspected to be a result of conditioning from repeated pairing o f immunosuppressive 
chemotherapy and immunosuppression. O f interest is the finding that subjects showing antici­
patory immunosuppression had higher levels of nausea in the hospital than those without 
anticipatory immunosuppression.
Fredrikson et al. (1993) conducted a second study o f conditioned immunosuppression 
resulting from chemotherapy. The primary aim of this study was to see if  patients undergoing a 
somewhat less aggressive chemotherapeutic regimen than that used in the 1990 Bovbjerg et al. 
study would also exhibit anticipatory immunosuppression. An additional point of the study was to 
examine whether anxiety was related to immunocompetence. The study included 27 patients with 
verified breast cancer who were to undergo chemotherapy with 6 courses o f CMF (Cyclophos­
phamide, Methotrexate, and 5-Fluorouracil). Each course was repeated every 28 days. Twenty- 
five healthy hospital staff females were included as controls. Blood for immune function 
assessment was obtained in the patients' homes two days before and then again immediately 
before their fourth or fifth course o f chemotherapy in the hospital outpatient chemotherapy 
department. Immunological assessment included identification o f lymphocyte subsets (CD3, CD4,
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CD8, CD 16, and CD20), spontaneous cytotoxicity o f lymphocytes, and mitogenic responses of 
lymphocytes (using Concanavalin A). Similar samples were obtained on controls. In addition, 
psychological assessment using the trait portion of the STAI was performed by giving the 
questionnaire to subjects when the first blood sample was obtained, to be collected two days later 
with the second blood sample. Overall findings revealed that patients had an increase in total 
granulocytes (109/liter) but a significant decrease in the percentage of monocytes and lymphocytes 
when in the out-patient hospital setting compared to the home setting. Patients with high anxiety 
demonstrated compromised NK cell activity and had reduced total numbers o f monocytes, as 
compared to patients with low anxiety. Controls did not demonstrate differences between home 
and hospital. Studies have shown that release of adrenalin (epinephrine) can mobilize granulocytes 
to move from storage tissues into the circulation, resulting in an increase o f  circulating 
granulocytes. The increase in the total number of granulocytes in peripheral blood of patients was 
thought by the researchers to be related to stress and release o f adrenalin. It was hypothesized 
that adrenalin-mediated changes, such as increase o f granulocytes, may be followed later by other 
immunosuppressive changes due to catecholamines (Fredrikson et al., 1993).
Behavioral Interventions to Alter Immune Status 
In 1993, Sabbioni noted that little study had been reported on interventions to modify 
stress-related neuroendocrine-immune changes. However, with the increasing interest in 
psychoneuroimmunology, there is greater interest in this area, and an increasing number of studies 
are being conducted and reported. Research studies that address selected behavioral methods to 
alter immunity are reviewed here.
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Relaxation Training and Imagery
Green, Green, and Santoro (1988) conducted a study in which 40 volunteers were 
randomly assigned to a waiting list control group, or to an experimental group in which the 
subjects practiced a relaxation technique daily for 3 weeks. The 24 subjects in the relaxation 
group were randomly assigned to practice 1 o f the 3 following relaxation techniques: a relaxation 
response while sitting up, a relaxation response while lying down, or guided visualization while 
lying down. Experimental subjects were directed to practice the relaxation technique daily for 20 
minutes while at home. They also received relaxation training on a weekly basis for three sessions. 
Blood and saliva samples were obtained prior to and immediately following relaxation practice on 
the experimental group at three intervals: the first day of the study, at day twenty-two after three 
weeks of practice, and, for the eleven subjects who remained in the study, at day forty-three.
Blood and saliva samples were obtained on the waiting list control group at three intervals; before 
and after relaxation training on day one, and three weeks following start o f  the study. Findings 
showed a significant increase from baseline in salivary IgA and in serum IgA, IgG, and IgM in 
subjects who practiced relaxation daily over a three-week period regardless o f technique used, 
leading the authors to suggest that relaxation could be a coping strategy that may positively affect 
some aspects o f the immune system.
A pilot study by Houldin et al. (1993) assessed relaxation training and immunological 
status o f persons suffering bereavement. Nine females whose spouses had recently died of cancer 
were recruited for the study. Each underwent a one-hour relaxation training program involving 
progressive muscle relaxation training and guided imagery on a weekly basis for four weeks. A
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standardized panel of psychological and immunological tests was used for assessment. Specific 
findings of the study were not reported, but findings were summarized to imply that a selective 
decrease in immune function, specifically IgG, IgA, and total lymphocytes was associated with 
increased levels o f psychological distress. In addition, a higher infection rate with herpes simplex 
type I antibody (70%) was reported in the research group compared with the normal population 
(50%), but after relaxation training there was a decrease in the rate o f infection (specific data 
were not given). The authors do note that there are limitations to the study, including the small 
sample size and lack of an experimental design, but suggest that relaxation showed a positive 
impact on immune function and the decreased rate of infection finding was a basis for further 
study.
Kiecolt-Glaser et al. (1986) assessed whether cellular immunity could be modulated in 34 
healthy medical student volunteers. Immune assessment occurred one month after one set of 
academic examinations, one month prior to, and the day of the next set o f  examinations. Psycho­
social assessment was performed, using self-report questionnaires. Half o f  the subjects were 
assigned to a control group that was offered the relaxation training the following month. The 
other half of the subjects were assigned to a professionally-led hypnosis/relaxation group that 
began with standard deepening exercises, followed by self-hypnosis, progressive relaxation, 
imagery exercise, and/or autogenic training. The end of the session included suggestions for 
relaxation during the day and enhanced study success. Students were encouraged to relax during 
the week. Immune assessment revealed that the percentage of helper/inducer cells and the 
helper/suppressor cell ratio showed significant decrease in all subjects for the examination sample
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compared to the baseline measurement. Overall, both control and experimental subjects showed 
lower than expected values even in the baseline samples, leading the authors to conclude that the 
low baseline values may be stress-related. After correcting for differences in baseline levels, an 
association was seen between frequent relaxation practice and increased helper/inducer per­
centages, but not with NK activity. The authors concluded that relaxation practice may be 
associated with enhancement o f some aspects o f cellular immune functions.
Zachariae et al. (1990) studied the effect of relaxation and guided imagery on cellular 
immune function in 10 healthy subjects. The aim of the study was to examine the effects o f a 
positive psychological experience on the immune systems of healthy volunteers. A baseline blood 
sample was obtained on the first day o f the study, after which each subject underwent a 45-minute 
session of guided imagery and relaxation; a second blood sample was then obtained. Subjects 
returned seven days later for a third blood sample and then underwent a 60-minute relaxation 
procedure, including visualization o f the immune system, cells, and cellular activity. A fourth 
blood sample was obtained following this 60-minute session. Subjects were asked to draw the 
mental images they experienced and were interviewed about the experience. This was followed 
one hour later by a fifth blood sample. Three days after the second session, a final blood sample 
was obtained, and each subject was interviewed to alleviate any concerns that may have occurred 
as a result of the study. The findings indicated no significant changes in total number of 
lymphocytes and NK cells, but a significant increase in NK cell function was seen following each 
guided imagery session compared to baseline.
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Relaxation training has also been studied in HIV-positive persons. Taylor (1995) studied 
10 HIV-positive males randomly assigned to a treatment or control group. Baseline and follow-up 
assessment on all subjects included State Trait Anxiety Inventory, Profile of Mood States, Self­
esteem Inventory, and T-cell count. Interventions for the treatment group included a combination 
o f progressive muscle relaxation, meditation, biofeedback, and hypnotic training involving 
visualization. Findings reported in the study included that analysis o f variance showed the 
treatment group had significantly more change in all measures from pre-treatment to post­
treatment compared to the control group, with decreased scores on both state anxiety (F = 15.25, 
p <.01), trait anxiety (F = 17.34, p <.01), profile of mood states and self-esteem inventory, and 
increased T-cell count (F = 12.65, p <.01). The authors recognized that the sample size was small, 
but reported that their findings support previous findings o f anxiety and distressed mood state in 
HIV-positive individuals.
Walker et al. (1999) conducted a clinical study specific to cancer patients undergoing 
chemotherapy. Ninety-six women, newly diagnosed with breast cancer, participated in the study. 
Half o f the subjects were randomized into a control group that underwent routine chemotherapy, 
while the other half underwent routine chemotherapy and relaxation training involving progressive 
muscle relaxation and guided imagery. Both psychological and immunological assessments were 
performed prior to initiation o f  chemotherapy and repeated during the course of treatment and 6 
weeks following completion. Analysis of findings indicated that women in the experimental group 
had less anxiety, enhanced lymphokine-activated killer (LAK) cell activity, higher numbers and 
percentage of activated T-cells and reduced blood levels o f tumor necrosis factor alpha (TNF)
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than the women in the control group. There was no evidence of a difference in the clinical or 
pathological response to chemotherapy between the groups, and the clinical significance of the 
immune changes was not clear (Walker et al., 1999).
Laughter
Laughter or humor as a coping strategy or a means to enhance health has been a topic of 
recent study. A study to assess the effect of humor on the salivary secretion of IgA was conducted 
with 10 upper-level psychology students. Subjects provided a salivary specimen prior to and 
following a humorous videotape, and prior to and following viewing of a didactic videotape. 
Subjects rated the videotapes on a 5-point scale (1 = not at all funny to 5 = very funny), and each 
subject was assessed using the Coping Humor Questionnaire. Findings revealed a significant 
increase in salivary concentration o f IgA after viewing the humorous videotape, although the 
increase was short-lived. Findings also suggested that persons who used humor as a coping 
mechanism had higher baseline salivary concentration o f IgA as compared to those who did not, 
leading the authors to suggest that use of humor could be incorporated as a coping strategy for 
health for some individuals (Dillon, et al., 1985-86).
In a study of the effects o f mirthful laughter on the immune and neuroendocrine systems 
performed on healthy males, ten experimental subjects were exposed to a humorous videotape for 
one hour, while ten controls were kept in a neutral environment. All underwent blood sample 
collection through indwelling venous cannulation at 10-minute intervals, providing a total of 12 
samples, including 3 before, six during, and 3 following the intervention time. Results indicated 
that, when compared to controls, subjects exposed to the humorous intervention demonstrated an
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increase in NK cell activity (Berk, Tan, Napier, & Eby, 1989), an increase in spontaneous 
lymphocyte blastogenesis (Berk et al., 1988), and a decrease in the stress-associated hormones 
cortisol, epinephrine, dopac, and growth hormone (Berk, Tan, Fry, et al., 1989).
Lambert and Lambert (1995) studied the effect o f humor on secretory immunoglobulin A 
(S-IgA) levels in fifth grade students. Students were randomly assigned to a group where they 
experienced an age-appropriate humor program or a group that participated in a non-humorous 
educational program. Concentrations o f S-IgA were significantly increased over baseline in the 
humor group and remained unchanged in the control group.
In discussing the biology o f humor, Fry (1994) noted that body systems that have been 
demonstrated by studies to be actively involved in humor are “... the muscular, the respiratory, the 
immune and endocrine systems, the cardiovascular, the central and autonomic nervous systems” 
(p. 114). He went on to note that there is increasing evidence that in most situations humor has a 
positive physiological effect and can be considered in general to be a positive contribution to 
maintenance of health.
Massage and Immunity
Back massage as a strategy for relaxation has been a topic o f  some nursing research. 
Duration of massage and variables studied vary from study to study, but nursing studies that used 
effleurage as the massage method reported that subjects expressed a subjective sensation of 
relaxation in addition to physiological or other changes (Bauer & Dracup, 1987; Corley, Ferriter, 
Zeh, & Gifford, 1995; Fakouri & Jones, 1987; Fraser & Kerr, 1993; Groer et al., 1994; 
Longworthy, 1982; Meek, 1993). O f the nursing studies specifically assessing back massage, only
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one included an assessment o f immune function. Groer et al. (1994) studied the effect o f 10- 
minute slow-stroke back massage on salivary IgA levels of well, elderly adults. All study subjects 
completed the STAI and gave an unstimulated 5-minute sample o f saliva. Following the sample 
collection and completion of the STAI, controls were positioned in Simms position in a bed for 10 
minutes, then had a second salivary sample collected and completed the STAI a second time. 
Experimental subjects were positioned in the same manner and given a 10-minute slow-stroke 
back massage, following which they provided a second salivary sample and completed the STAI. 
Data were analyzed using analysis of covariance (ANCOVA). Findings o f this study indicated that 
although anxiety levels decreased in both groups, massage did not significantly affect subjects’ 
anxiety levels. Both control and experimental groups showed some increased concentration and 
secretory rate of salivary IgA, with the greater increase in the experimental group. ANCOVA 
showed that the variance in the experimental group, with the salivary IgA rate change at a nearly 
significant level, was related to the back massage. The authors concluded that increased salivary 
IgA concentration may result from nursing back rub and suggested that further study was 
indicated.
Other disciplines have conducted studies that have included back massage as one of 
several relaxation strategies. One study assessed the effects o f relaxation on the immune system. 
Fifty college student volunteers were randomly assigned either to a control group, which involved 
touch control, or to one of four groups: guided visualization, back massage, lying quietly with 
eyes closed, or Benson's relaxation response. All subjects provided a saliva specimen prior to the 
intervention. Each intervention, including the touch-control, lasted 20 minutes, followed by a
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second saliva specimen being provided. Prior to the study, no significant difference in salivary IgA 
levels was found between the four treatment groups and the control group, but a significant 
difference was found following the intervention. Saliva assessment showed that subjects undergo­
ing relaxation response, visualization, or massage showed higher salivary IgA levels than did the 
touch control group, with massage subjects showing the highest levels o f any group. The authors 
suggested that since salivary IgA levels may indicate local resistance to upper respiratory 
infection, the regular practice of relaxation strategies to increase levels may be somewhat protec­
tive against upper respiratory infections (Green & Green, 1987).
Structured Psychological Support and the Immune System
Structured psychological support has been hypothesized as a behavioral strategy to 
positively affect health outcomes. Fawzy et al. (1990) studied the immediate and long-term effect 
on the immune system of structured psychological support, including stress management tech­
niques, health education, problem solving skills related to their diagnosis, and group psychological 
support, in patients recently diagnosed with malignant melanoma. The 35-member intervention 
group met weekly for 1 / i  hours over the course of 6 weeks. The control group received no 
intervention. Baseline assessment included both psychological assessment of affective state and 
coping, and serum immunological assessment, including NK cell numbers and activity, LGLs, the 
major T-cell subsets, and major T-cell subset activation markers. These assessments were repeat­
ed at six weeks, the end o f the intervention, and again at six months. Baseline comparisons 
showed no immunological function difference between the control and intervention groups. A 
significant difference between groups was found in CD57 LGLs after six weeks, with an increase
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in LGLs from baseline to six weeks in the intervention group. After six months, comparison of 
groups showed the intervention group demonstrating a larger increase in percent o f LGLs from 
baseline, an increase in NK cell percentage, and a slight but non-significant increase in NK cyto­
toxicity. T-cell subset measurement showed a small reduction in CD4 T-cell levels. Controls 
showed a similar increase in NK activity. The authors suggested that a short-term group 
psychiatric intervention was associated with longer-term changes of the NK cell system, demon­
strated primarily by an increase in the number of cells.
A somewhat similar study was conducted by Schedlowsi et al. (1994) in which 24 patients 
with cancer who had completed standard surgical treatment and were not undergoing 
chemotherapy or radiation therapy were enrolled either in an intervention group or a control 
group that would undergo the intervention at a later date. The experimental group participated in 
ten intervention sessions that occurred once a week for two hours. The intervention consisted of 
relaxation techniques o f  autogenic training and guided imagery performed at the beginning and 
end of each two-hour session, with education on health, stress and illness-related skill 
enhancement, and the “body-network” occurring between the two relaxation sessions (p. 340). 
Subjects were encouraged to practice the relaxation techniques at least twice a day. Blood 
samples were drawn before and immediately after the second and tenth sessions to assess plasma 
cortisol and white blood cell counts (WBC). The control group had blood samples drawn two 
days after the second and tenth intervention sessions participated in by the experimental group.
All subjects had the same psychological and physiological assessments, which looked at coping 
with chronic disease, plasma cortisol levels, and WBC. Results indicated no difference in coping
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strategies as measured, but there was a significant reduction in plasma cortisol in the intervention 
group at the second intervention, continuing over the nine-week period. There were no significant 
differences in WBC absolute numbers of leukocytes and monocytes between the groups, but there 
was an increase in lymphocyte numbers in the intervention group after the second intervention and 
continuing over the nine-week period. The researchers concluded that the results supported the 
hypothesis that a behavioral intervention could have positive effects on immune function in breast 
cancer patients who had undergone surgery.
Not all studies have found a positive relationship between support and immune function. 
Nicholas and Webster (1996) conducted a study of the effect o f a behavioral medicine program 
(a support group) on a variety o f psychological variables and immune function in persons with 
HIV. Forty-eight persons were enrolled in the program, which met weekly for ten weeks. Most 
(79.2%) of them were taking anti-HIV medication. CD4 counts and some other unnamed 
parameters were recorded pre- and post- intervention. However, the CD4 counts were measured 
by “self-report”. There was a significant relationship found between perceived health status and 
CD4 counts. However, CD4 counts declined during the intervention period, especially for persons 
with CD4 counts less than 200/mm3, indicating that the intervention resulted in no improvement 
on this parameter. It should be pointed out, however, that the subjects in this study were persons 
with expected immunosuppression both from the disease and also as a side effect o f some of the 
medications commonly used as treatment for HIV.
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Anxiety and Chemotherapy 
An estimated half of all new cases o f invasive cancer undergo chemotherapy (Otto, 1997). 
In the United States in 1999 there were an estimated 1,221,800 new cases of invasive cancer 
(Greenlee, Murray, Bolden, & Wingo, 1999). This would result in over 600,000 persons 
undergoing chemotherapy that year.
Anxiety in cancer patients undergoing chemotherapy is commonly reported in the 
oncology-related literature (Andrykowski, 1990; Bottomley, 1997; Eller, 1999; Fredrikson et al., 
1993; Jacobsen et al., 1993; Morrow et al., 1992; Rhodes, Watson, & Johnson, 1986; Sabo & 
Michael, 1996). Much of the interest in anxiety is related to findings that suggest that anxiety is 
related to an increased incidence of side effects such as anticipatory, as well as post-treatment, 
nausea and emesis (Jacobsen et al., 1993; Morrow, 1992; Rhodes et al., 1986) and anticipatory, 
or conditioned, immunosuppression (Bovbjerg et al., 1990; Fredrikson et al. 1993). A recent 
study by Newell, Swanson-Fisher, Girgis, & Ackland (1999) found that approximately 25% of the 
people in their study o f 201 persons with cancer had borderline or clinical levels of anxiety and 
depression. Depressive states were also found in about 40% of Danish patients prior to initiation 
of chemotherapy in a 1994 study (Middelboe, Ovesen, Mortensen, & Bech). Jacobson et al. 
(1993), studying anticipatory anxiety in women receiving chemotherapy for breast cancer, found 
that 91% of the women stated that they were anxious prior to the first treatment. This figure 
dropped to 64% reporting anxiety prior to the 2nd, 60% prior to the 3rd and 4th, and 57 % 
claiming anxiety prior to the 6th treatment, indicating that at least in this study some anxiety 
persisted throughout treatment.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-Immune Status 41
ANV as a Conditioned Response
Bovbjerg et al. (1990) suggested that since chemotherapy induces immune suppression as 
well as emesis, conditioned immunosuppression may develop, in addition to conditioned nausea. 
In recent years, anticipatory nausea and vomiting (ANV) has been widely studied (Andrykowski, 
1988).
The many side effects o f  chemotherapy range from uncomfortable physical symptoms, 
such as nausea and/or vomiting or stomatitis, to life-threatening effects, such as 
immunosuppression (Fischer, Knobf, & Durivage, 1993). Distress associated with chemotherapy 
treatment may affect the outcome of therapy and patient compliance or continuation with the 
regimen (Andrykowski, 1990; Burish & Carey, 1986; Challis & Stam, 1992; Holland et al., 1991; 
Jacobsen et al., 1993), with some patients considering the side effects to be worse than the 
treatment itself (Pickett, 1991) and some refusing chemotherapy (Fallowfield, 1992). As a result, 
nausea and vomiting associated with chemotherapy has been widely studied.
Although several models for development of ANV have been proposed, it is most 
commonly thought to occur as a result o f classic conditioning (Aapro, Kirchner, & Terrey, 1994; 
Bovbjerg et al, 1992; Burish & Carey, 1986; Challis & Stam, 1992; Ingle, Burish, & Wallston, 
1984; Morrow, 1992; Nerenz, Levendthal, Easterling, & Love, 1986). Chemotherapy treatment 
usually involves cycles o f treatment that are repeated over time periods ranging from several days 
to several weeks. The probability of developing anticipatory nausea increases with the number o f 
cycles received (Bovbjerg et al., 1992). ANV has been associated with emetigenicity or toxicity o f 
the treatment, number o f treatments (Aapro et al., 1994), age, and frequency of nausea and/or
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vomiting post-treatment (Cohen, Blanchard, Ruckdeschel, & Smolen, 1986). Morrow (1992), 
reviewing 4 studies involving a total o f 1,620 patients, concluded that the percentage o f patients 
reporting anticipatory side effects increased with the number o f chemotherapy cycles, and that 
after the fourth treatment, one third o f patients experienced anticipatory nausea and/or vomiting. 
Redd and Andrykowski (1982) reported that approximately 25% o f chemotherapy recipients 
develop ANV. A prospective longitudinal study by Challis and Stam (1992) found that o f those 
patients who developed ANV, all had developed ANV by the time o f their fifth treatment, with 
the average being after 3.4 treatments. Andrykowski and Redd (1987) found that 69.2% of 
patients who developed ANV had done so by the fifth cycle of chemotherapy, 88.5% by the sixth 
cycle, and 92.3% by the seventh cycle. By the eleventh cycle, all who were going to had 
developed ANV.
Reported incidence of ANV varies, depending on the type o f chemotherapy agent involved 
and the method of study. Bovbjerg et al. (1992) reported a rate o f ANV that ranged between 25% 
and 57% of patients receiving chemotherapy. Morrow (1992) reported that at least one in four 
patients receiving chemotherapy developed ANV. An analysis o f  17 studies involving 1,700 adult 
and 80 pediatric patients found that 32% of the adults and 29% of the pediatric patients reported 
ANV (Burish & Carey, 1986). A study o f 77 women receiving chemotherapy (methotrexate, 
fluorouracil, vincristine, and cyclophosphamide) revealed that 57% experienced ANV 
(Andrykowski et al., 1988), while a study o f patients receiving Cisplatin-based chemotherapy, 
well known for its emetic side effects, found that 65% of the patients reported anticipatory nausea 
in at least one situation (Coons, Leventhal, Nerenz, Love, & Larson, 1987). A study o f 149
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patients receiving chemotherapy revealed that 42% o f the patients reported pre-treatment nausea, 
and 27% of the patients reported anticipatory vomiting (Cohen et al., 1986). In a longitudinal 
study, Andrykowski and Redd (1987) found that 36.6% of patients studied developed ANV. A 
study of ninety-five outpatients receiving mild to moderate chemotherapy regimens that excluded 
drugs with high emetic properties revealed that 23% developed ANV (Watson, McCarron, & 
Law, 1992).
Research has indicated that the degree o f patient anxiety is positively related to occurrence 
of chemotherapy-related nausea and vomiting, although the specific nature o f the relationship 
remains unclear (Andrykowski & Redd, 1992; Jacobsen et al., 1993; Jacobsen & Redd, 1988; 
Morrow, 1992; Watson et al., 1992). Some studies have associated incidence o f ANV with in­
creased levels o f anxiety (Andrykowski, Redd, & Hatfield, 1985; Ingle et al., 1984; Nerenz et al., 
1986; Razavi et al., 1993), whereas Coons et al. (1987) did not find an association between 
anxiety and increased incidence of ANV. Andrykowski et al. (1988) reported that they did not 
find a direct association between anxiety and initial development o f ANV, although it appeared to 
be related to later development o f ANV. Contrary to the researchers' expectations, high state 
anxiety was associated with delayed onset o f ANV in one study conducted by Andrykowski & 
Redd (1987).
Andrykowski (1990) pointed out that a limitation in the study o f ANV was that state 
anxiety levels may increase as a result of ANV, rather than the other way around, and that there is 
no clear cause and effect relationship between anxiety and ANV. However, research does 
demonstrate a correlation between ANV and anxiety, although the relationship requires further
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study. To this end, Kvale et al. (1991) conducted a prospective study to assess autonomic reactiv­
ity, including heart rate and peripheral vascular changes, in addition to self-reported anxiety in 
patients undergoing chemotherapy. No difference in self-reported anxiety was found in groups 
with and without ANV, but a significant association was found between persons with increased 
autonomic reactivity and development o f ANV, leading the authors to suggest that autonomic 
reactivity was a more accurate marker for ANV susceptibility than self-reported anxiety. The 
authors also suggested that desensitization o f persons with increased autonomic reactivity prior to 
initiation of chemotherapy may decrease incidence of ANV.
Behavioral Studies to Modify Nausea and Vomiting 
ANV has shown to be resistant to drug intervention (Burish & Jenkins, 1992). Therefore, 
a number of behavioral interventions have been studied as strategies for decreasing or preventing 
ANV. The assumption is that behavioral interventions include a cognitive component that 
competes with stimuli associated with chemotherapy and thus interferes with development o f 
conditioned side effects (Vasterling et al., 1993).
Burish and Jenkins (1992) examined the effect o f relaxation training (RT) involving 
progressive muscle relaxation and guided relaxation imagery, versus biofeedback plus RT, versus 
biofeedback alone, versus a no-intervention control group, on nausea and vomiting associated 
with chemotherapy. Antiemetic medications were used as needed. The study showed RT, in 
conjunction with antiemetic medication, to be effective in reducing incidence o f nausea and pre­
venting exacerbation or development o f conditioned symptoms. Biofeedback was not found to 
have the same effect.
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Vasterling et al. (1993) studied use of relaxation training using progressive muscle 
relaxation or guided imagery distraction versus no intervention in chemotherapy recipients. They 
found that both relaxation and distraction groups reported a decreased incidence o f nausea prior 
to chemotherapy and displayed lower blood pressure measures, as compared to controls.
A prospective study by Razavi et al. (1993) examined stress prevention versus use of 
alprazolam in prevention o f adjustment disorders and anticipatory nausea secondary to 
chemotherapy. The study involved two groups using relaxation. In addition, the experimental 
group was given the anti-emetic alprazolam while the control group was given a placebo. Both 
groups were asked to practice progressive relaxation on a daily basis, and all were involved in a 
formal weekly or bimonthly counseling and support program. The results indicated that those 
using alprazolam experienced anticipatory nausea later than did the placebo control group. In both 
groups, the incidence o f nausea was nearly the same by the completion of the fourth treatment 
(26% and 25% respectively), indicating that in this situation, the medication was not more 
effective than relaxation alone in preventing anticipatory nausea.
A systematic desensitization strategy, using relaxation techniques in association with 
systematic desensitization, was shown to be effective in reducing the incidence and severity of 
ANV and post-chemotherapy vomiting in a group of patients (Morrow et al., 1992; Morrow & 
Morrell, 1982), while use o f hypnosis and imagery intervention was reported to result in decreases 
in anticipatory nausea in another chemotherapy study group (Redd, Andersen, & Minagawa,
1982). Research using guided imagery plus progressive muscle relaxation training (PMRT),
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initiated before the start of chemotherapy and during the first three treatments, resulted in prevention of 
conditioned nausea and was effective in decreasing severity and length of nausea following 
chemotherapy. In addition, relaxation training also reduced levels o f autonomic arousal, as assessed by 
blood pressure and pulse rates, during chemotherapy treatment (Burish et al., 1987).
A number o f studies have examined nausea and/or vomiting associated with chemotherapy 
in general, without specifying whether the symptoms were anticipatory. Lyles et al. (1982) found 
that relaxation training and guided imagery resulted in a significant reduction o f chemotherapy- 
related side effects such as anxiety, nausea, and physiological arousal in an experimental group, 
when compared to a group that engaged in conversation with therapists and with a control group. 
Another study, comparing use o f an antiemetic drug regimen and relaxation, found that while the 
drug regimen was more effective in preventing the peak phase of vomiting, the duration o f post­
chemotherapy vomiting was only half as long in the relaxation group, compared to the drug 
regimen group, suggesting that relaxation could be a useful strategy in decreasing duration of 
symptoms (Scott et al., 1986). Cotanch and Strom (1986) found that progressive muscle 
relaxation was effective in reducing anxiety, improving calorie intake, and decreasing severity of 
vomiting following chemotherapy.
Behavioral Interventions to Modify Anxiety 
A number of behavioral interventions have been proposed as helpful in modifying anxiety. 
Massage and progressive muscle relaxation are two that have been reported in the literature, and 
will be discussed briefly, omitting literature previously discussed when addressing immune 
function.
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Massage
Massage has long been considered a relaxation strategy to decrease anxiety and even pain. 
A meta-analysis by Labyak & Metzger (1997) o f nine studies that met the criteria of backrub 
length of at least three minutes, pre-and post vital signs, and statistical data analysis found the 
following: Ten-minute massages were associated with maximum reductions in heart and 
respiratory rate initially, with a gradual rise to pre-treatment level during the ten-minute post­
massage assessment period. Three-minute back massage was associated with the greatest 
reduction in both systolic and diastolic blood pressure immediately after the massage and a 
continued decrease for five minutes afterward. Interesting gender-related differences were 
reported in seven studies. Females demonstrated a rise in blood pressure during the first 3-5 
minutes of the back massage, followed by a decline in blood pressure during the 10-minute rest 
period. Males demonstrated a decline in blood pressure after 5 minutes o f massage and a 
continued reduction during the 10- minute rest period. Discussion suggested that massage is 
associated with decreased heart and respiratory rate for both male and females. The degree of 
decreased blood pressure seemed to be gender-related, with males showing greater overall 
decrease in systolic and diastolic pressure. The data indicated that “biological relaxation” 
demonstrated by decreased heart and respiratory rate is associated with effleurage back rubs o f at 
least three minutes.
Field, Grizzle, Scalfidi, and Schanberg (1996) conducted a study on 32 depressed 
adolescent mothers who were randomly assigned to a relaxation group or a relaxation group 
receiving massage. The massage group received ten 30-minute sessions o f massage over a five-
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week period, while the relaxation group received ten 30-minute periods o f relaxation that included 
yoga and progressive muscle relaxation. Study findings indicated that the massage group showed 
significant decrease in state anxiety, serum and salivary cortisol levels, and pulse rate, as 
compared with the relaxation alone group.
Following the study o f the effects of massage on depressed adolescent mothers, Field et al. 
(1998) studied effects o f massage on 23 children with asthma. In younger (age 4-8) children, 
massage was associated with decreased anxiety and salivary cortisol, improved attitude toward 
asthma, and improved peak air flow and other pulmonary functions such as forced vital capacity, 
forced expiratory volume, forced expiratory flow (FEF), and peak expiratory flow. In older (age 
9-14) children, massage was associated with lowered anxiety, improved attitude toward asthma, 
and improved forced expiratory flow.
The effects o f slow stroke back massage on 30 hospice clients was also studied. Clients 
were given a 3-minute back massage on two days. Vital signs were measured five minutes before 
the massage and again immediately before the massage. The client then got the 3-minute back 
massage, had vital signs measured immediately after the massage, and again five minutes later. 
Results from the study indicated that heart rates showed a pattern o f decrease following slow 
stroke back massage. Systolic and diastolic blood pressure also showed a pattern o f decrease.
Skin temperature showed a pattern o f increase. Statistically significant changes were 
demonstrated in all four o f the dependent variables. Clinically, however, the changes were 
considered modest by the authors, with a difference between the highest and lowest means o f 4.2 
beats per minute for heart rate, 9.17 mmHg for systolic blood pressure and 6.4 mmHg for
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-Immune Status 49
diastolic blood pressure, and 1.45 degrees Fahrenheit for skin temperature. The changes were 
interpreted as sufficient to indicate relaxation but not to a degree that they could put hospice 
patients in danger of hypotension, bradycardia, or hypothermia (Meek, 1993).
Ferrell-Torry and Glick (1993) conducted an exploratory study of the use of massage of 
30-minute duration administered on two consecutive evenings to nine cancer patients 
experiencing cancer pain. Assessment included Visual Analogue Scale (VAS) for self-report of 
pain and relaxation, STAI for anxiety, and heart rate, respiratory rate, and blood pressure, done 
just before, just after, and 10 minutes after massage. A significant decrease in anxiety levels, heart 
rate, respiratory rate, and blood pressure, and increased self-report of relaxation resulted.
A prospective study with repeated measures on the effectiveness of neuromuscular release 
massage therapy (NRMT) on five patients with chronic obstructive pulmonary disease (COPD) was 
conducted over a 24-week period to study the effect on pulmonary function, respiratory muscle 
strength, and quality of life. Subjects underwent weekly massage with pre and post-massage 
pulmonary function tests obtained. The authors reported that four of the five subjects had a mean 
increase in thoracic gas volume and forced vital capacity, although measures did not reach statistical 
significance, and statistically significant improvements in forced expiratory volume, peak flow, oxygen 
saturation, and forced vital capacity. An improvement in heart rate was also reported, and was 
determined by an initial decrease of a mean of 2.96 beats per minute from the end of treatment 
followed by an increase o f a mean of 2.85 beats per minute at the end of the entire intervention The 
study was limited by the small sample size, but did show statistically significant improvement of some 
functions after the NRMT intervention (Beeken, Parks, Cory, & Montopoli, 1998).
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Studies have also looked at other aspects o f massage. The effect o f a 1-minute back rub 
on venous oxygen saturation in 173 critically ill patients was studied by Tyler, Winslow, Clark, 
and White (1990). Massage of one minute duration was chosen to simulate clinical practice. Study 
findings indicated that heart rate initially increased and then gradually decreased somewhat, but 
remained significantly higher than baseline after four minutes. Sv02 decreased by 6% immediately 
after massage and gradually increased to baseline by four minutes. Discussion suggested that the 
small changes in the heart rate and Sv02 may have been due to tactile stimulation that triggered 
stimulation of the autonomic nervous system, but was a minor stimulus that was well tolerated by 
critically ill patients. However, individual assessment o f each patient’s ability to tolerate position 
changes in order to accommodate back rub was recommended.
Massage is commonly included as a non-pharmacological measure to reduce pain and 
enhance relaxation (Rhiner, Dean & Ducharme, 1996). Herr and Mobily (1992) found that simple 
massage and guided imagery were among five interventions receiving highest intervention content 
validity (ICV) scores on a 2-round Delphi study of interventions related to pain management. 
Massage was described as decreasing pain and producing relaxation, and simple guided imagery 
was described as a procedure to achieve relaxation and/or direct attention away from pain. 
Progressive Muscle Relaxation
Progressive muscle relaxation (PMR) is a commonly accepted relaxation strategy. It is 
taught in psychiatric nursing courses (Rawlings, Williams, & Beck, 1993; Stuart, & Sundeen,
1995; Wilson & Kneisle, 1992) and is suggested as a behavioral method o f promoting relaxation 
for persons with cancer (Bindemann, Soukop, & Kaye, 1991; Bridge, Benson, Pietroni, & Priest,
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1988; Seligman, 1996; Simms, 1987) and other persons undergoing stressful experiences (Carey 
& Burish, 1987; Mynchenberg & Dugan, 1995). A study conducted by Arakawa (1995) with 
eight Japanese patients undergoing chemotherapy found an average decrease of 2.5 in state- 
anxiety scores of persons in a treatment group using PMR, versus a control group. The author o f 
the study pointed out that the sample size was very small and further study is indicated. However, 
there seemed to be some positive effect o f PMR on the Japanese chemotherapy recipients that 
was worth further investigation. Other studies addressing PMR as an intervention for modulating 
stress have already been presented in this paper when discussing neuro-immune responses to 
stress and modification of side effects o f chemotherapy.
Stress and Health
What effects these stress-related changes have on the health o f individuals is not clear. 
There is evidence that relates psychosocially mediated immune alterations with susceptibility to 
disease and disease progression, specifically with infectious illness, cancer, and progression of 
HIV (Kiecolt-Glaser & Glaser, 1995). A clinical study by Cohen, Tyrrell, and Smith (1991) found 
that increased psychological stress was associated with increased rate of infection with the 
common cold. The study indicated that stress resulted in suppression o f some aspects o f the host 
resistance, possibly immune aspects, resulting in increased susceptibility to infection. The authors 
also noted that in some studies AIDS-infected individuals tended to differ in progression of 
disease based on support systems. A study by Kiecolt-Glaser, Marucha, Malarkey, Mercado, & 
Glaser (1995) evaluated wound healing in persons under chronic psychological stress. Results 
showed a significant slowing of wound healing in the stressed individuals as compared with
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controls. Alter reviewing multiple studies on infectious diseases Cohen and Herbert (1996) 
reported that there was an association between stressful life events and increased psychological 
stress and increased susceptibility to respiratory infections with colds and influenza, and infection 
with herpes vims. However, Cohen (1995) pointed out that despite studies showing evidence for 
an association between psychological stress and immune responses, the relationship to health is 
not clear.
There have been attempts to link stress with cancer. Some reasons for trying to link 
psychosocial factors and cancer are outlined by Bovbjerg (1991) in the three following 
hypotheses:
“(1) the outcome o f some cancers can be influenced by psychosocial factors,
(2) the activities o f the immune system can influence the outcome of some cancers, and
(3) at least one immune response (NK cell activity), thought to play a role in defense
against cancer, appears to be influenced by psychosocial factors” (p. 831).
Richardson, Landring, & Marks (1994) reviewed 11 key studies (involving 1149 patients)
of psychological factors in cancer survival. A number o f methodological problems were 
encountered, due to varying research designs and methods, and the conclusion from the review 
was that there was no clear relationship between psychological factors and cancer survival. 
However, the authors went on to say that the area has not yet been adequately studied. The 
relationship between stress and the development of breast cancer was explored by Bryla (1996) 
through a literature review. No relationship was found between stress levels and development of 
cancer, although studies revealed that stress was related to having breast cancer. Stress-reduction
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strategies were helpful in dealing with stress associated with the diagnosis o f cancer and 
improving quality o f life in those affected.
Anderson et al. (1998) recently studied the role o f stress and prognosis o f  cancer. The 
study involved 116 patients who had been surgically treated for invasive cancer o f the breast. 
Study findings revealed that increased stress level was significantly predictive o f decreased NK 
cell activity and T-cell responses, both of which are cellular immune responses that are important 
to cancer prognosis.
Cohen and Rabin (1998) pointed out that psychological stress can cause immune system 
changes of the type that can influence tumor growth and metastasis. There have been animal 
studies that support this concept. One study was performed on mice with Lewis lung carcinoma, 
in which the animals were subjected to different forms o f stress, such as spatial disorientation 
(induced by cage spinning), physical restraint, behavioral despair (induced by tail suspension), 
avoidable foot shock, and maternal deprivation. The results indicated that the psychological 
stressors of spatial disorientation, physical restraint, and behavioral despair significantly influenced 
tumor metastasis in mice (Giraldi et al., 1992). These researchers also studied the effect of 
experimental stress on tumor response to a cytotoxic antitumor drug. Laboratory mice with Lewis 
lung tumor were treated with cyclophosphamide, a commonly used anti-cancer drug and a drug 
very effective against Lewis lung tumor. Restraint stress, which alone does not affect mouse 
survival, was applied as an experimental stressor. Stressed mice were found to have significant 
changes in CD3+ and CD8+ T-lymphocyte numbers. The restraint stress eliminated increased 
survival time from cyclophosphamide treatment, with the stressed mice showing reduced tumor
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response to chemotherapy and dying at the same rate as untreated mice. The authors proposed 
that the antitumor effects o f cyclophosphamide may depend on a combination o f drug cytotoxicity 
and T-lymphocyte antitumor host response, and based on their study, that stress can reduce the 
therapeutic effect o f a cytotoxic drug (Zorzet, et al., 1998).
Another way to consider the relationships among stress, immunity and health outcomes is 
by looking at the Thl/Th2 balance. Cytokines fall into two main classes: the Thl class, which 
stimulates the development o f cellular, or cytotoxic, responses, and the Th2 class, which 
stimulates the development o f humoral, or antibody, responses (Vedhara, Fox, & Wang, 1999). 
Stress is associated with increased secretion o f glucocorticoids and catecholamines. 
Glucocorticoids and catecholamines stimulate IL-10, a Th2 cytokine, and suppress IL-12, a Thl 
cytokine, resulting in a suppression of Thl and shift toward Th2 function. “The change in 
Thl/Th2 balance may be involved in the stress-induced susceptibility to infectious, autoimmune, 
allergic, and neoplastic diseases” (Weizman & Bessler, 1999, p. 6). Production of TH2 cytokines, 
especially H-10, has been found to be elevated with a number o f human neoplasias, with a 
corresponding reduction of Thl cytokines in many of the same neoplasms. Type 1 cytokines have 
anti-tumor effect, while Type 2 cytokines have an opposite effect, down-modulating tumor 
specific immune responses. This suggests that tumor growth could be associated with 
immunological changes involving cytokines reflected in an altered Thl/Th2 balance (Clerici, 
Shearer, & Clerici, 1998)
Kuby (1997), discussing the effect o f the balance between the Thl and Th2 subsets on 
disease development and progression, gives the example o f  tuberculoid and lepromatous leprosy.
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Tuberculoid leprosy has a very slow progress and is characterized by a Thl-type cell-mediated 
response that develops to form granulomas and destruction of most o f the organisms. However, 
in lepromatous leprosy the cell-mediated response is depressed, and a Th2-type humoral response 
is stimulated with resultant humoral antibody formation. Hypergammaglobulenemia may occur, 
and organisms are disseminated and proliferate with extensive infection and damage.
Summary
Addressing anticipatory nausea and vomiting associated with chemotherapy, Burish and 
Carey (1986) suggested that research had been rather narrow in focusing on nausea and vomiting, 
and needed to broaden beyond that in studying aversive conditioning associated with 
chemotherapy. Using the paradigm established with study of ANV and the reported work on 
stress-related immunosuppression, this study addressed the potential o f an intervention to modify 
side effects of chemotherapy, specifically to decrease anxiety, nausea and emesis, and to modify 
the degree of immunosuppression associated with chemotherapy and thereby enhance immune 
function.
The relationship between psychological and physiological stress and modulation of the 
immune system is well supported in research-based literature. In addition, some immune changes, 
such as immunosuppression, can be conditioned. Immunosuppression is associated with a number 
o f cytotoxic chemotherapeutic agents, and Bovbjerg et al. (1990) suggested that 
immunosuppression may be conditioned as a response to chemotherapy.
The clinical significance o f stress-related immune changes is not clearly understood, but it 
is hypothesized to influence physical health. In a year-long prospective study o f the association
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between stress-related immune depression and health changes, Glaser et al. (1987) found an 
increase in the number of self-reported infectious illnesses associated with stress-related 
immunosuppression. The association between health and stress-related immune suppression is an 
area for further study.
Behavioral interventions have been shown to alter immune changes associated with stress. 
However, the way in which behavioral modification works on immune responses is not known 
(Roudebush & Bryant, 1991) and is another area for further research.
Literature review revealed some studies addressing anticipatory neuro-immune response 
before a stressor and other studies addressing neuroendocrine-immune responses following a 
stressor. However, there are few studies addressing whether intervention can modify the neuro- 
immune response. Prior to 1999, no prospective clinical studies were found that examined the 
effect o f a relaxation intervention on neuro-immune responses of persons undergoing a psycho 
biological stressor. This research was intended to add to the body of nursing knowledge and to 
help fill a gap in the scientific literature.
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Chapter in  
Methods and Procedures 
Overview
The research hypotheses were studied by evaluating whether a relaxation intervention, 
slow-stroke back massage and progressive muscle relaxation, performed prior to initiation of and 
during a chemotherapy regimen, influenced neuro-immune status changes in individuals 
undergoing chemotherapy treatment. This chapter addresses the research design, sample 
identification, setting, intervention, measurements and instruments, procedure for data collection, 
ethical considerations, and data management.
An overview of the methodology is shown in Figure 3, and will be briefly described. 
Individuals who fit the sample criteria were enrolled into the study and assigned to a control 
group or an experimental group. Both groups underwent four doses o f chemotherapy treatment, 
with a three-week interval between treatments. In addition to the chemotherapy, experimental 
subjects underwent a relaxation intervention which included a slow-stroke back massage before 
each dose of chemotherapy and daily practice of progressive muscle relaxation. Three neuro- 
immune assessments, including a panel o f immune function tests, serum catecholamines, and 
assessment of state and trait anxiety, were conducted on all subjects. The first was a baseline 
assessment done prior to the first dose o f chemotherapy. The second assessment was done after 
two doses (cycles) o f chemotherapy and just before the third dose. At this point evaluation of 
nausea and vomiting, using the Morrow Assessment o f Nausea and Emesis (MANE) was added
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to the assessment. The third and final assessment was done just before the fourth and final dose of 
chemotherapy. At this point subject participation in the study was completed.
Research Design
This study used a quasi-experimental design with an untreated control group, an 
experimental group, and repeated measures with pre-test and post-tests. A non-probability 
convenience sample was solicited from patients sequentially identified with breast cancer and 
scheduled to undergo an Adriamycin/Cyclophosphamide (AC) chemotherapy regimen in the 
outpatient department o f a large university medical center. The study fit the model o f a 
longitudinal study with a pre-test post-test control group design (Bums & Grove, 1997).
Sample Identification
For this pilot study, a sample size of 20 was sought initially, with 10 planned for the 
experimental and 10 for the control group. An over sampling o f 20% was expected to be included 
to assure an adequate sample size in the event o f subject attrition (Polit & Hungler, 1991). 
However, due to unforseen complications, this sample size was not feasible. The sample was 
made up of patients diagnosed with breast cancer and scheduled to undergo a chemotherapeutic 
regimen involving a combination o f Adriamycin 60 mg/m2 and Cyclophosphamide, 600 mg/m2 
administered intravenously (IV) every 21 days in an outpatient department. Inclusion criteria for 
the study were as follows. Individuals would:
1. be female
2. have a confirmed diagnosis of breast cancer
3. be at least 18 years o f age
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4. be able to speak, read, and write English
5. be slated to receive intravenous AC chemotherapy on an outpatient basis\
Exclusion criteria for the study were as follows:
1. any previous history of cancer, or cancer at another site
2. receiving radiation treatment at time of breast cancer diagnosis
3. history of prior radiation or chemotherapy
4. smokers
5. any underlying immunosuppressive health problem
6. medical contraindication for back massage
7. already involved in systematic relaxation practice
8. receiving biological modifiers (such as granulocyte-cell stimulating factor) at time of 
chemotherapy institution
9. involvement in any other research protocol other than one of the medical center 
chemotherapy protocols
The sample consisted o f females because that is the most common group identified with 
breast cancer. Since this was a pilot study with a small sample, including a single gender 
eliminated one uncontrolled variable.
Setting
The research was conducted at a large medical center with an active oncology out-patient 
clinic in the Faculty Medical Offices (FMO). Once identified, subjects were met by the researcher 
in the clinic to discuss the study, obtain a written consent and answer questions that might arise.
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Baseline physiological assessment, including blood pressure and heart rate assessment, and 
administration o f the STAI-Y were done in the oncology outpatient clinic. Interventions for the 
experimental group were performed in one of the examination rooms in the oncology clinic. 
Environmental distractions were minimized, and the setting was controlled for temperature, noise, 
and privacy as much as possible. A quiet and pleasant setting away from the clinic had been set up 
for experimental subjects to get the massage, but when it came to the actual process, subjects 
preferred to stay in the clinic area for convenience and so they would not lose their parking 
spaces. This had advantages and disadvantages. The unique site planned for the massage would 
have been more pleasant and probably more relaxing in itself. However, the process of getting 
there and then back to the clinic and then looking for a parking space in a crowded parking lot 
would have been an additional stressor. In addition, as the chemotherapy occurred in the clinic 
setting, it was possible that the massage in the clinic setting provided a better association between 
relaxation and the chemotherapy treatment.
Blood samples were drawn for analysis in the outpatient clinical laboratory by qualified 
individuals or, if the subject had a central venous access port for chemotherapy, by a qualified 
registered nurse in the clinic setting. Because venipuncture is often an unpleasant experience for 
persons, and especially for chemotherapy patients if veins are damaged, blood samples were 
obtained at the time of blood collection for routine tests or at the time o f intravenous cannulation 
for chemotherapy, in order to minimize additional venipuncture.
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Relaxation Intervention 
The independent variable for the experimental group was a relaxation intervention 
including slow-stroke back massage and progressive muscle relaxation. Slow-stroke back 
massage was performed according to specific criteria, based on the technique developed by 
Jensen-Nelson in 1948 and modified and described by Groer et al. (1994). The technique used 
follows (with the modification that talcum powder was used instead of warm lotion if requested 
by the subject, to minimize any soiling o f patient clothing. If the subject preferred to keep clothing 
on, which was most commonly requested for comfort of the subjects, no substance was used on 
the hands, but the massage was otherwise performed according to the technique described).
"After warmed lotion was distributed over the back, three slow effleurage circles were 
made, beginning near the vertebrae and moving across the trapezius, infraspinatus, and 
pectoralis major muscle group. The circles continued down the lateral portion of these 
muscles and back toward the vertebral column. Then three circles were made in the 
opposite direction over the lower portion of the trapezius, infraspinatus, and upper portion 
of the latisimus dorsi muscles. Reversing direction again, three circles were made between 
the areas of thoracic vertebrae 12 and the iliac crest over the midsection o f the latisimus 
dorsi. The massager then made three slow strokes up and down the perivertebral region of 
the participant's back. Lotion was added to the nurse's hands as needed, but touch was 
maintained throughout the procedure. The pattern was repeated for a timed 10-minute 
period." (Groer et al., 1994, p. 5).
Progressive muscle relaxation (PMR) guidance was provided with the use o f an audio tape 
developed specifically for the study. For development of the audiotape, literature on PMR
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technique was reviewed (Mynchenberg & Dugan, 1995; Rawlins et al., 1993; Sabo & Michael, 
1996; Stuart & Sundeen, 1995; Wilson & Kneisle, 1992), and a 30-minute PMR script was 
developed (see Appendix A for script). The script was reviewed by three psychiatric nursing 
faculty who assessed it to be appropriate. The script was read by the researcher and recorded in a 
professional sound studio. Instructions for the PMR included suggestions that the subject feel 
relaxed during chemotherapy treatments. Once recorded, soothing archived music, with no 
copyright constraints, was added in the studio. The completed PMR tape was listened to by three 
psychiatric nursing faculty and deemed to be relaxing and appropriate for PMR in terms of 
technique and sound. Tapes were duplicated, and all experimental subjects were provided with a 
PMR tape and small tape player and were encouraged to practice at home at least once daily. 
Subjects were asked to note the number o f days and times per day they practiced PMR on an 
index card provided for documentation.
Measurements and Instruments 
The purpose o f the research was to study the effect o f a relaxation intervention on anxiety, 
nausea and vomiting, and immune functions o f persons undergoing AC chemotherapy for breast 
cancer. These drugs have identified side effects that could influence the study. Toxic side effects 
o f both Cyclophosphamide and Adriamycin include leukopenia and nausea and vomiting (Carter, 
Bakowski, & Hellmann, 1987; Fischer et al., 1993). Adriamycin is also associated with alopecia, 
which many patients find very stressful (Fischer et al., 1993). For the purpose o f this study, 
hematologic and gastrointestinal side effects, specifically those involved with immunosuppression
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and nausea and vomiting, were noted. Dependent variables that were studied and recorded were 
anxiety, immune function, and nausea and vomiting.
Anxiety
Anxiety assessment included blood pressure and heart rate, the serum catecholamines 
epinephrine and norepinephrine, and state and trait anxiety.
Blood pressure and heart rate on all experimental subjects were collected before and after 
massage as an indicator o f physiologic arousal. Blood pressure has been shown to be affected by 
stressful situations (Sparacino, 1982), with increase in systolic and diastolic blood pressure 
associated with increase in psychological stress (Halvorsen & Vassend, 1987). Cardiovascular 
changes, including as a minimum heart rate and blood pressure assessment, are indicators of 
intensity and duration o f stress, and also are related to the degree of immune change (Kiecolt- 
Glaser, et al., 1992). Because of the stress associated with diagnosis and treatment, autonomic 
physiologic assessment, including heart rate and blood pressure, is important when assessing 
chemotherapy and cancer (Nicholas & Hollandsworth, 1986). Initially blood pressure and heart 
rate information was also to be obtained from the clinic records on all subjects immediately before 
chemotherapy infusion and during treatment. However, this information was not consistently 
obtained by clinic staff, so the data were incomplete.
Serum catecholamine levels were measured to assess physiologic response to a stressor. 
Epinephrine and norepinephrine are secreted in response to a stressor (Rabin, 1999; Robinson, 
1990). Catecholamine levels may be measured in plasma, urine, and to various degrees, saliva. An 
increase in urine catecholamine levels has been found as a body response to stress (Kathol, Anton,
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Noyes, & Gehris, 1989; Lundberg, 1976). However, for adequate assessment, a 24-hour urine 
specimen collection is needed and may prove impractical for outpatient collection. In addition, a 
24-hour urine specimen is cumulative, reflecting stress over a period o f time, and so would not 
reflect the stress of the moment when subjects were in the clinic setting. Therefore, urine 
collection for catecholamine levels was not considered appropriate for this study. Assessment for 
catecholamine levels in saliva has also been suggested as a means for physiologic assessment, but 
a study assessing catecholamine response to stress in saliva versus serum found that saliva levels 
were not indicative of a stress response, and serum catecholamine levels were o f most value 
(Schwab, Heubel, & Bartels, 1992). Serum assessment was used for this study as the measure 
with the greatest accuracy (Frankenhaeuser, 1971; Schwab et al., 1992). Specimens were 
collected and transported to the main hospital clinical laboratory according to laboratory protocol. 
There they were processed according to protocol and sent to an accredited outside laboratory for 
catecholamine assessment.
State and trait anxiety were assessed before chemotherapy was instituted, just before the 
third dose, and just before the fourth dose, using the State-Trait Anxiety Inventory, Form Y 
(STAI-Y) developed by Spielberger (1983) and purchased for use. This tool was designed to 
assess the current anxiety status of an individual, state anxiety, and how characteristically anxious 
an individual was, trait anxiety. The instrument has been widely used, including in studies of 
chemotherapy-related anxiety and stress effects on the immune system. Because anxiety states are 
transient, test-retest correlations for reliability are not as meaningful as the alpha coefficient for 
internal consistency. The STAI-Y has an across-studies reported alpha reliability coefficient o f .92
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for state anxiety and .90 for trait anxiety. Concurrent validity was established through a variety of 
means. Use on contrasted groups revealed significantly higher scores for trait anxiety in 
neuropsychiatric patients as compared to normal subjects, and higher scores of state-anxiety in 
military recruits undergoing a stressful training program, as compared to similar age students who 
were not in a stressful situation. Correlation of the trait anxiety scale with other measures of trait 
anxiety, specifically the DP AT Anxiety Scale, the Taylor Manifest Anxiety Scale (TMAS), and the 
Zuckerman Affect Adjective Checklist (AACL), showed high correlations with the IP AT and the 
TMAS, ranging from .85 to .73, but a moderate correlation with the AACL, suggesting that the 
AACL is less useful for measurement of trait anxiety. Correlations o f the STAI with other, similar 
instruments demonstrated divergent and convergent validity (Spielberger, 1983). Okun, Stein, 
Bauman and Silver (1996) analyzed three commonly used psychiatric scales, the Psychiatric 
Symptom Index, CES-Depression Scale, and State-Trait Anxiety Scale, from the perspective of 
DSM-IV. Their analysis supports that all three scales are appropriate measures for anxiety and 
depression.
Other measures considered for this study included use o f the Profile o f Mood States 
(POMS), which assesses seven mood states, including anxiety. However, this instrument is de­
signed to measure the current mood state as opposed to trait and current state of anxiety, as does 
the STAI. There is controversy whether anxious mood and state differ in significance for research. 
When comparing use o f both instruments in the study o f ANV, one researcher reported "It 
appears that anxiety when measured as a constellation o f symptoms (such as is done on the SCL- 
90 and the STAI) is related to the development of ANV, while anxiety measured as a mood
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(POMS) is not." (Morrow, 1992, p. S54). The Symptom Check List - 90 (SCL-90) was also 
considered, since anxiety is one component of the instrument; however, it is a long instrument of 
90 questions, including several dimensions of which anxiety is only one, and had no obvious 
advantage over the STAI.
An advantage of the STAI was that both state and trait anxiety were addressed. 
Andrykowski (1990) had observed that a weakness in previous research was that only state 
anxiety had been assessed. In this study both state and trait anxiety were assessed, both prior to 
and following chemotherapy.
Anticipatory Nausea and Vomiting
Assessment of nausea and vomiting was performed using the Morrow Assessment of 
Nausea and Emesis (MANE) instrument, developed to assess for anticipatory nausea and/or 
vomiting (Morrow, 1984). This is currently the most widely used instrument for assessment of 
chemotherapy-associated nausea and vomiting addressing both anticipatory and post-treatment 
occurrence.
Initially the MANE author (Morrow, 1984), using 20 subjects tested 4 times, established 
test-retest reliability coefficients ranging from r = .72 to r = .96. Construct validity, using 
convergent and divergent measures, was also studied. The MANE was found to correlate more 
highly with measures associated with nausea and vomiting than with measures o f other side 
effects o f chemotherapy. A nonsignificant correlation was found between patients' self-report of 
other chemotherapy side-effects and results of the MANE, showing divergent validity. A study by 
Camrike et al. (1988) o f 35 outpatients receiving chemotherapy established moderate reliability
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and validity of the MANE. Test-retest reliability was established for each of the 17 items, using 
Pearson product moment correlations for all duration variables and Spearman rho correlations for 
all other variables. Test-retest reliability ranged from r = .35 (p = .04) to r = .70 (p = .001) for all 
non-duration variables. Duration variables ranged from r = -.01 (p = NS) for anticipatory emesis 
to r = .78 (p = .001) for anticipatory nausea.
Recently, the MANE was revised into two forms. The second form is now called the 
Morrow Assessment o f Nausea and Emesis Follow-up (MANE-FU) and includes the original 17- 
item instrument that assesses for nausea and vomiting in general and also includes items on ANV. 
This form is used for assessment o f both ANV and nausea and vomiting that occurs following 
chemotherapy, but is designed for assessment of one treatment at a time so was not appropriate 
for this study, which used the original MANE instrument.
The MANE was first administered to all subjects after they had undergone two cycles of 
chemotherapy, and a second time at the fourth and final infusion of chemotherapy.
Immune Status
Tests to assess cellular, humoral, and functional immune status were selected to assess 
neuro-immune response to a stressor. Blood samples were drawn, and tests were performed under 
a blanket order from the institution's chief oncologist. Immune function tests included Total 
Complement; Semm Immunoglobulin; Flow Cytometry Phenotyping o f CD3+ T-Lymphocytes 
percent and absolute numbers, CD20+ B-Lymphocytes percent and absolute numbers, CD3+25+ 
IL-2 Activated T-Lymphocytes percent and absolute numbers, CD3-CD16+56+ NK Cells percent 
and absolute numbers, Mitogen Stimulation Assay with PHA, Natural Killer Cell Assay including
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-immune Status 69
Effectors, Target, 40:1,20:1, 10:1,5:1 and Lytic units, and Cytokines IL-2, IL-4, IL-6, IL-10, 
IL-12, and INFy.
Immune globulins, found in the serum, are the effector molecules of the humoral immune 
system and function as antibodies. Human immunoglobulins fall into five classes: IgG, IgA, IgM, 
IgE and IgD (Kuby, 1997; Vedhara et al., 1999). Immune globulins are an important part of the 
defense system against infectious agents (Rabin, 1999). IgG comprises about 80% o f the total 
serum immunoglobulin. It coats microorganisms so that neutrophils and macrophages can 
recognize and destroy them (Kuby, 1997; Vedhara et al., 1999). IgG is also effective in 
neutralizing some bacterial toxins (Rabin, 1999). IgA, which comprises 10-15% o f serum 
immunoglobulin, is the most common immunoglobulin in external secretions, and functions on 
mucous membrane surfaces to protect against pathogenic organisms (Jemmott & McClellend, 
1989; Kuby, 1997; Vedhara et al., 1999) IgM, which comprises about 5-10% of the total serum 
immunoglobulin, is the first immunoglobulin class produced in response to an antigen (Kuby, 
1997). Its function includes triggering o f complement-mediated lysis and formation o f antibody- 
antigen complexes (Kuby, 1997; Vedhara et al., 1999). IgE antibodies, found in small amounts in 
serum, are responsible for triggering release o f histamines, which result in hypersensitivity 
reactions producing symptoms such as allergic reactions, asthma, hay fever, and anaphylactic 
shock (Kuby, 1997; Rabin, 1999; Vedhara et al., 1999). Little is known about the function of 
IgD, the final class of immunoglobulin, but it is thought to function in the activation o f B cells 
(Kuby, 1997).
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Measurement o f immunoglobulins has limitations, because antigen specificity means that 
only certain antibodies will respond to an antigen (Vedhara et al., 1999). However, evaluation o f 
serum immunoglobulin can provide some insight into the functioning o f the humoral, or Th2, 
aspect of the immune system.
Complement, a major effector o f the humoral branch o f  the immune system, consists o f  
proteins that function to amplify the antigen-antibody response (Janeway & Travers, 1997; Kuby, 
1997). Complement activation may result in lysis, phagocytosis, and chemotaxis (Rabin, 1999). 
Complement measurement is also an indication of humoral, or Th2, immune system function.
Flow cytometry can be helpful in evaluating numbers and percentages of peripheral blood 
leukocyte subpopulations. In this research study, the percent and absolute numbers of T- 
lymphocytes, B-lymphocytes, activated T-lymphocytes, and NK cells were assayed. Lymphocyte 
subsets are commonly assessed in psychoneuroimmunology research (Vedhara et al., 1999). 
Findings such as those cited by Rabin (1999), who discussed multiple studies of immune 
alterations that occur in association with stress, and findings such as those of Dhabhar, Miller, 
McEwen, and Spencer, (1995) who found that laboratory induced stress resulted in changes in the 
numbers and percentages o f leukocyte populations in peripheral blood of laboratory rats, support 
the enumeration of lymphocytes. Stress-induced changes in rat studies found greater decrease in 
numbers and percentages o f B cells, NK cells and monocytes than in T cells (Dhabhar et al.,
1995). Therefore, there is an advantage to cell counts based on research findings. However, 
limitations to cell counts include that cell numbers do not always correlate with cell function, and 
cell numbers fluctuate according to a number of factors, so changes may be due to physiologic 
effects and not stress-related (Vedhara et al., 1999).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-immune Status 71
T- and B-lymphocytes are concentrated predominantly in the spleen and lymph nodes, 
with only 2% contained in blood. However, because of ease o f access, blood is the most 
frequently used source for the study o f  lymphocytes in humans (Westerman & Pabst, 1992). This 
study used blood samples for assessment.
Cytotoxicity is an important function of the immune system to remove foreign cells, such 
as tumorigenic cells or infected cells (Vedhara et al, 1999). Cytotoxicity can occur both with T 
cells and with NK cells. NK cells are an important early response to infection, and also show non­
specific tumor cell killing functions (Kuby, 1997). A limitation in much o f the research is that 
many studies use whole peripheral blood mononulcear cells (PBMC) as effectors, but NK cells 
make up only a small part of these cells. Thus cytotoxicity occurring in studies using whole 
PBMC as effectors may be due to effects of other cytotoxic cells as well as from NK cells 
(Vedhara et al, 1999). To eliminate this problem, the cells used in this study were purified NK 
cells, using the combined marker o f CD 16+ and CD56+, which is specific for NK cells. This 
eliminated other cell subsets that are capable of cytotoxic activity. NK cytotoxicity assay is helpful 
in evaluating the ability to mount a response to non-self cells and is a part of the cellular, or Thl, 
arm o f the immune system.
Lymphocyte proliferation in response to mitogen stimulation is also a part of cellular 
immunity. Typically lymphocytes are stimulated with a mitogen such as PHA or CON A, resulting 
in cell activation and proliferation. The mitogen PHA stimulates mainly T cells. Proliferation 
responses to mitogens can inform researchers about the general responsiveness of lymphocytes,
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and if  more than one mitogen is used, may show differences in general responsiveness (Vedhara et 
al, 1999).
Assessment o f cytokine levels can be helpful in evaluating functional abnormalities in the 
immune system (Vedhara et al, 1999). Cytokines are soluble polypeptide proteins that signal 
messages to generate and augment immune responses (Weizman & Bessler, 1999). Cytokines are 
key to activating B cells, cytotoxic T cells, and other cells responsible for the immune response 
(Kuby, 1997). Although there are many cytokines now known, and more being discovered, some 
that fit in the Th I and Th2 groups were o f major interest for this study. The Thl response 
involves cytokines IL-2, IL-12, EL-15, and IFNg, and mainly regulates cellular immunity. The Th2 
response includes cytokines IL-4, IL-5, IL-6, IL-10, and EL-13, and mainly regulates humoral 
immunity (Clerici et al., 1998; Weizman & Bessler, 1999). Activation of the Thl response results 
in cytokine production which activates T cytotoxic cells and macrophages. Activation of the Th2 
response results in activation o f B cells (Kuby, 1997). The Thl or Th2 responses have opposing 
action, so activation o f one will inhibit the other (Rabin, 1999; Vedhara et al., 1999), which has 
significance when one looks at the Thl :Th2 balance.
This study included measurement o f the Thl cytokines IL-2 , IL-12, and IFNg and the 
TH2 cytokines IL-4, IL-6, and IL-10. Although there are good reasons for wishing to measure 
cytokine levels, it is problematic in that cytokine levels are difficult to measure in healthy 
individuals and, according to Vedhara et al. (1999), may be most useful studied in diseased 
populations. Persons who are undergoing chemotherapy likely fit into that population so despite 
the limitations it was decided to include cytokines in the immune function measures. Immune
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function tests were performed in accredited laboratories according to standard protocol. For some 
tests, where there may be variability in measurements, samples were stored and all run at the same 
time to decrease chance of procedure related variability.
Procedure and Steps of Data Collection 
Following approval by the Loma Linda University Medical Center Cancer Board, the 
University of San Diego Committee on the Protection of Human Subjects (see Appendix B for 
approval), and the Loma Linda University Medical Center Internal Review Board (see Appendix 
C for approval), oncology physicians and nurses in the approved outpatient oncology clinic were 
informed of the study, given criteria for patient inclusion and exclusion, and asked to support the 
study by identifying potential subjects.
Enrolling Subjects Into Study 
Potential subjects were identified by an oncology physician or nurse and queried as to 
willingness to participate. If the person was willing to participate in the study, the researcher was 
paged. The researcher immediately called the site where the potential subject was and asked the 
nurse or physician some preliminary questions about whether the individual met criteria for 
inclusion in the study. If the initial criteria were met, a time was arranged for a meeting with the 
potential subject in the clinic, usually within a few minutes of the call. The timing of the researcher 
response was important because an agreement with the oncology department was that the study 
would not interfere with patient treatment, and chemotherapy was usually started on the same day 
o f the clinic appointment.
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At the meeting with the researcher, subjects were given full information about the study, 
including the purpose of the study and what participation would involve. All subjects were given 
the same information at time of consent. The researcher consciously avoided including any 
statements that might bias a subject about the efficacy of the relaxation intervention. An informed 
consent (see Appendix D) was presented at the meeting, any questions answered, and subjects 
told that there would be no additional cost to them or change in their planned treatment regimen 
as a result o f participation. Subjects were advised that they could remove themselves from the 
study at any time without penalty, and the name of an impartial contact person was provided in 
case of problems. Confidentiality of data was discussed, and a telephone number for the 
researcher was provided in the event that any further questions should arise. A signature was 
obtained from those agreeing to participate. Signatures were also obtained from a witness and 
from the researcher. Copies o f the signed informed consent and the California Experimental 
Subjects’ Bill of Rights (see Appendix E) were given to each subject in a folder that also 
contained copies of all data collection instruments that would be used. At the time o f the 
explanation, subjects were informed that they would draw a slip o f paper from a container for 
assignment either to Group A, the control group, or to Group B, the experimental group. During 
informed consent the researcher specifically avoided making statements that might bias the 
subjects to think that the experimental intervention would benefit their cancer outcome. Subjects 
were presented with a small box with the slips o f paper as an attempt for random assignment to 
one of the two groups. At this point, however, the plan for randomization broke down. Some 
subjects said that the physician had told them that they could be “in the massage study,”
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interpreting this to mean that they would get the massage. Two stated that they would happily 
agree to be in the study but only if they could be in the massage group, as that is what their 
physician told them. Others quite obviously looked into the box and choose Group B, the 
experimental group. Only one person followed the procedure and drew randomly from the box. 
For this reason the study design changed from a random to a convenience sample, so that the first 
seven persons who actually were able to complete the study were experimental subjects. After 
data collection was completed on the first seven subjects, the researcher informed potential 
subjects that the experimental group was filled and specifically asked the next seven persons who 
agreed to be in the study if they would be in Group A, the control group. O f persons who met the 
initial criteria, two refused when they found that they would be in the control group, and all of the 
five who did agree expressed a strong desire to be in the experimental group. The researcher 
expressed appreciation and offered that if  their chemotherapy protocol included treatment (i.e. 
Taxol) beyond the four AC doses during which data collection occurred, they would be offered 
massage before each treatment for the remaining protocol. In addition, control subjects were told 
that at the completion of the data collection they would receive the PMR audio tape and tape 
player in the event they would like to practice PMR.
Subject Assessments
All subjects underwent the same neuro-immune assessments. The first was a baseline 
assessment. This was followed by two more assessments; the second after two cycles of 
chemotherapy and just before the third dose, and the third assessment after three cycles of 
chemotherapy and just before the fourth and final dose.
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Baseline Assessment
A time for baseline assessment was arranged at the initial meeting, before chemotherapy 
was started. Usually the assessment was on the same day as the initial meeting because 
chemotherapy was going to be instituted that day.
Blood pressure and heart rate were collected from the clinic record. The STAI-Y form, 
including both state and trait anxiety assessments, was given to the subject with the request that 
they complete it at that time.
A 25-ml. blood sample was obtained for stress hormone and immune function assessment. 
Because the contact with the subject was just before institution of the first chemotherapy 
treatment, the blood sample was collected when intravenous access was established for drug 
infusion. The blood sample was drawn in the out-patient clinic by a qualified registered nurse and 
did not require any additional venipuncture. Specimens were drawn in appropriate tubes (a 10-ml 
plain red-top and a 5-ml plain green-top tube for the immunology research lab, a 5-ml green tiger- 
top for catecholamines and a 5-ml red tiger-top for complement and immunoglobulins), labeled, 
and transported by the researcher to the appropriate laboratories according to protocol.
Chart review was performed by the researcher to obtain relevant demographic data, 
including tumor site, stage and grade, hormone receptor status, medication history, CBC and 
differential, weight, and serum albumin level (see Appendix B for data collection). As needed, 
further information, such as any major change in dietary intake, sleep, or unexpected stress, was 
solicited from the subjects. Although it would have been ideal to plan neuro-immune assessment 
at the same time of day for each subject and at a specific time in the menstrual cycle to decrease
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hormonal or circadian effects on the immune or catecholamine tests, this was not realistic, as the 
timing o f specimens was dependent on timing of the chemotherapy regimen. Subjects were asked 
to abstain from caffeinated food or drink on the day of, and not engage in heavy exercise on the 
day prior to collection o f blood samples, as these could affect catecholamine excretion (Lundberg, 
1976) and immune function (Kiecolt-Glaser, 1988; Kiecolt-Glaser et al., 1992). Subjects were not 
expected to fast prior to collection of blood samples.
Experimental Group
A preliminary schedule o f times for massage was discussed with each subject. During the 
first year of the study, subjects came to the clinic the day before chemotherapy was scheduled to 
have blood work and for an appointment with the oncologist. At that time it was established if 
they would have chemotherapy the following day, based on their blood profile. The researcher 
came to the clinic at the time o f the oncologist appointment and met with the subject and the 
oncology nurses, and the time was confirmed that chemotherapy would be given the next day. A 
telephone and pager number was provided to the subject, with the request to call the researcher in 
the event of any variation from the schedule. In addition the receptionist was asked to page the 
researcher when the patient arrived. When the experimental subjects came in for chemotherapy, 
they were met in the clinic by the researcher, and the massages were given. This schedule 
changed, however, and during the second year of data collection subjects had their blood work 
done, an appointment with the oncologist, and if their blood counts were high enough, 
chemotherapy all on the same day. This schedule was then adapted to by the researcher.
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Before the first chemotherapy cycle and just before each o f the subsequent cycles o f 
infusions, experimental subjects were given a 10-minute slow-stroke back massage. A room with 
an examination table, chairs, and privacy curtains was used. Initial blood pressure and heart rate 
were measured using equipment provided in the clinic. Subjects were offered an open-backed 
gown to wear, or if they chose, kept on their own clothes (usually a soft tee-type cotton shirt over 
a supportive brassiere). Most subjects had undergone a surgical procedure, such as biopsy, 
lumpectomy, or mastectomy, and found that keeping on their brassiere and clothing was most 
comfortable. Because of the surgical intervention, subjects were given the option of lying supine 
on the examination table, lying on their side, or sitting on a chair leaning over a pillow on the 
height adjusted examination table. Four subjects chose the supine position and three chose to sit 
leaning over a pillow for the massage. Slow-stroke massage was then performed for 10 full 
minutes by the researcher according to the specified criteria. Following the massage, subjects 
were asked to rate the experience on a simple scale of 1 to 4, with 1 = not at all relaxing, 2 = 
somewhat relaxing, 3 = quite relaxing, and 4 = very relaxing. Four categories were included on 
the scale to eliminate a tendency to simply choose the middle rating. The researcher showed a 
large card with the scale defined and asked the subject how they would rate their experience. 
Responses were recorded on the subject's data sheet and used in conjunction with heart rate and 
blood pressure values following the massage as a general indication of relaxation. The subject was 
covered with a bath blanket and another blood pressure and heart rate measurement obtained. The 
oncology nurses were then told that the subject was ready for chemotherapy and the subject was 
permitted to get up and leave at their discretion or when called by the nurse.
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Upon enrollment in the study, each experimental subject was given a small portable 
cassette machine with earphones and a tape of instructions for PMR and asked to practice PMR at 
least once a day. Subjects were advised that no penalty would be associated with number o f times 
of practice, but that they were asked to report the number o f times PMR was practiced. An index 
card with the subject's research identification number was provided to each subject, to be kept 
with the PMR tape for the purpose of recording the number o f times PMR was practiced.
Subjects were asked to bring the card with them when they had their next appointment, and a new 
card was provided. If the card was forgotten, a stamped and addressed envelope was provided for 
mailing of the card. Duplicate cards were provided in case o f loss. Subjects were asked to limit 
their relaxation practice to PMR for the duration of their participation in the study, or to let the 
researcher know of any other relaxation strategy they were using. No subjects reported use of 
additional relaxation strategies.
The second assessment was done just before the third chemotherapy infusion. Blood was 
obtained either with routine blood test or when venous access was established for chemotherapy. 
The STAI-Y was obtained, and in addition the subject was given the MANE questionnaire to 
complete. Cards recording PMR practice were collected.
The third and final assessment was the same as the second and was done just before the 
fourth and final chemotherapy infusion of AC.
Control Group
The control group received chemotherapy according to the usual treatment regimen. The 
researcher was advised that blood pressure and heart rate was recorded before and during
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chemotherapy treatment. These data were obtained and recorded from the clinic records on all 
subjects when available. However, they were not consistently recorded, and because of multiple 
missing data were not included in data analysis
Control subjects had baseline assessment performed in the same manner as experimental 
subjects. For the second and third assessment, the STAI-Y and MANE were given to the subject 
prior to their clinic appointment, and the subject was requested to fill out the STAI-Y and the 
MANE in the clinic on the day o f chemotherapy and place it in a provided addressed envelope. If 
subjects forgot the questionnaires the researcher met very briefly with them to provide copies and 
provide an addressed envelope. Blood samples were obtained either with the routine blood work 
or when intravenous access was established for chemotherapy. The researcher made arrangements 
ahead o f time for the blood draw and also was available to collect and transport specimens 
immediately.
Completion of Participation
After the final assessment, all subjects were advised that their participation in the study 
was completed. They were asked if  they had any questions about the study and, if  so, these were 
addressed. They were thanked for their participation and again offered a summary o f the findings 
once the study was completed
Ethical Considerations 
An ethical consideration was the cost of study versus potential benefit. Even at decreased 
costs for a research study, the cost o f  blood analysis alone for catecholamines and immune studies 
was significant. The cost was covered by the researcher, so no additional cost was experienced by
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subjects in the study. The potential benefit was that if interventions could be found that decrease 
the side effects of anxiety, nausea and vomiting, and immunosuppression associated with 
chemotherapy, this may have a significant impact on the health o f individuals undergoing 
chemotherapy. An incidental potential benefit was that the effect o f AC combination 
chemotherapy on immune function has been reported for a number o f immune functions but not 
for the combination o f tests used in this study, so there will be information available on the effect 
of AC chemotherapy that may be helpful for future treatment planning.
Maintaining the confidentiality o f participants while also relaying results o f the immune 
studies to their physicians was not a significant problem, as data were handled according to 
existing methods of laboratory reporting. Confidentiality of persons in the study was maintained 
by recording data on number-identified forms. The cross-reference and any identifiable 
information was kept in a locked file in the office of the researcher. Neuro-immune studies were 
collected according to patient name and hospital identification number and were reported to 
primary physicians in that manner. If a subject had asked about the results, she would have been 
referred to her primary physician. The same information was recorded without name on a number 
identified form.
There were no anticipated risks associated with this study. Potential risk to participants 
due to data collection via venipuncture was not significant because specimens were obtained with 
routine venipuncture. The psychological risk was unknown. It was possible that persons newly 
diagnosed with cancer could be further stressed by participation in the research study. It is also 
possible that some could find participation a positive experience. All experimental subjects
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volunteered that the PMR tape was very relaxing and that the massage was relaxing. Control 
subjects expressed no negative feedback. The fact that all persons asked to participate in the study 
expressed strong desire to be in the experimental group, despite being advised that the effect of 
the intervention was unknown, posed a potentially ethical concern about “denying” a person 
participation in something that they thought might be beneficial. In further study o f this nature it 
may be important to consider having control subjects in a delayed entry status so they would 
anticipate having the intervention at a later time when it would not affect data collection.
Data Management
A system of coding data, using pre-categorization for the demographic data on the 
questionnaire was established prior to data collection. Upon completion of data collection, data 
were cleaned and coded. Missing data were handled by assignment of an unused number (Polit & 
Hungler, 1991).
A statistician was consulted prior to data collection and for data interpretation. Data were 
analyzed statistically to assess for differences within groups and differences between groups. 
Within-group differences to be studied included differences between immune function tests, 
anxiety measures, and serum catecholamine levels from beginning, second, and final analysis. 
Analysis also included correlation studies of the dependent variables immunosuppression, ANV, 
and anxiety. Subjects acted as their own controls.
Not all sample sets were complete. Heart rate and blood pressure obtained before and 
during chemotherapy were initially planned for inclusion, but these were not obtained consistently 
in the clinic, and because of the amount of missing data could not be included in analysis.
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Beginning and ending blood samples were drawn on all but one experimental subject, who was 
transferred to another facility before the final assessment. However the middle assessment was 
missed on a number of subjects due to problems with obtaining blood either in the laboratory or in 
the clinic, or in three cases, because o f  subject refusal; one refused because she had her blood 
drawn in the emergency room and didn’t want any more drawn, one because she was considering 
dropping out of the study although she decided to stay in, and the third because she was not 
feeling well and said that she was afraid that any additional blood draw would make her feel 
weaker. In addition, some values were missing because o f laboratory error in processing the 
specimens.
There was also considerable variation among experimental subjects in practice o f PMR. 
Subject use of PMR was categorized into three groups. Final evaluation revealed that two of the 
experimental subjects did not practice PMR at all after the first two or three times and were 
categorized in a no practice (no PMR) group. Two subjects practiced PMR 10-50% of the time 
and were categorized as moderate use (moderate PMR), and three o f the subjects practiced PMR 
50% of the time or more and were categorized as high use (high PMR).
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Chapter IV 
Findings
The following research hypotheses and goals were addressed. A brief summary of the 
findings is reported with each.
Hypothesis 1: Relaxation intervention, in the form of slow-stroke back massage and 
progressive muscle relaxation, would reduce the degree o f anxiety in clients receiving 
chemotherapy, as compared to those who did not experience the relaxation intervention. This 
hypothesis was partially supported by one measurement: State anxiety was significantly lower at 
measure 2 for the experimental group (t = 3.20, p = 0.02).
Hypothesis 2: Relaxation intervention, in the form of slow-stroke back massage and 
progressive muscle relaxation, would reduce the degree of anticipatory nausea and vomiting 
(ANV) in clients receiving chemotherapy, as compared to those who did not experience the 
relaxation intervention. This hypothesis was not supported, and no significant difference in 
anticipatory nausea and vomiting was found between groups.
Hypothesis 3: Relaxation intervention, in the form o f slow-stroke back massage and 
progressive muscle relaxation, would reduce the degree o f immunosuppression in clients receiving 
chemotherapy, as compared to those who did not experience the relaxation intervention. This 
hypothesis was not supported by the limited amount o f usable data generated by the research.
Because of the lack o f information on bio-behavioral intervention and chemotherapy, 
additional goals of this pilot study were to expand on the available information o f the effect of 
Adriamycin/Cytoxan (AC) chemotherapy on the immune system and to develop a plan for a
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further intervention study of persons undergoing chemotherapy. The goals of this pilot study were 
met. Clinical and immunological information was gained on what to expect with A/C 
chemotherapy, providing a basis on which to plan a further study.
Sample Description
A quasi-experimental design was used with a convenience sample of women diagnosed 
with breast cancer and scheduled to undergo chemotherapy, assigned either to a control or an 
experimental group. The final sample included twelve subjects: five in the control group and seven 
in the experimental group. Six o f the experimental group subjects completed the study, and a 
seventh subject completed all but the final evaluation and then was lost because o f transfer to 
another facility for stem cell transplant therapy.
All subjects were female with a confirmed diagnosis o f  breast cancer and were scheduled 
to receive four cycles of chemotherapy with Adriamycin 60 mg/m2 and Cyclophosphamide 600 
mg/m2 (AC) administered intravenously every 21 days. The subjects were between the ages of 33 
and 58, with a mean age of 46.9.
Baseline neuroimmune assessment was performed prior to the first dose of chemotherapy. 
A second assessment was performed after two cycles and just before the third cycle. A third and 
final assessment was done after three cycles and just before the fourth (final) cycle. Subjects in the 
control group received AC chemotherapy according to usual regimen. Subjects in the 
experimental group also received chemotherapy according to usual regimen, and, in addition, 
received a 10-minute slow stroke back massage just before each chemotherapy treatment and 
were asked to practice guided PMR on a daily basis.
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Presentation of Findings
Data were analyzed using descriptive statistics, correlational statistics with stepwise 
multiple regression and pair-wise deletion, and Analysis of Covariance (ANCOVA). An alpha 
level o f 0.05 was used to indicate statistical significance.
For each group, t-tests were performed on variables to assess for significant difference 
between the control and experimental groups. In addition, ANCOVA was performed on all of the 
assessment measurements to explore whether the experimental group and control group differed 
to a greater degree than one would expect by chance. ANCOVA was also used because of the lack of 
random assignment of subjects (Munro & Page, 1993). A Pearson correlation matrix using step-wise 
regression with paired deletions was also performed, but this was really a theoretical exercise since the 
number of subjects was below what would be needed for significance.
The sample size in this pilot study was small, requiring cautious interpretation o f study 
findings. However, when considering the clinical nature of the study and the tests involved, 
important information was gained that will help in planning for future study.
Findings are presented according to each hypothesis category o f  anxiety, ANV, and 
immune function. These are followed by a discussion of the findings, and then the goals of the 
study are addressed with a plan for further study.
Anxiety
Measurements for anxiety included state and trait anxiety inventories (STAI) and the 
catecholamines epinephrine and norepinephrine. Blood pressure and heart rate were not analyzed
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statistically because of missing data. Basic descriptive statistics with t-tests o f mean differences 
are shown in Table I.
There was one statistically significant finding with the anxiety data. The state anxiety mean 
was significantly lower in the experimental group at Measure #2 when compared to the control 
group (t = -3.20, p=0.02). At baseline and end measures the groups had no statistically significant 
difference.
Table 1
Descriptive Analysis of Anxiety Measures
Test and Sample # Mean SD Mean for Mean for
(Reference Ranee) o f All All Control Experimental t-score d
Epinephrine (<60 pg/mL)
Measure #1 (baseline) 14.200 15.598 12.750 (n=4) 15.167 (n=6) 0.227 0.826
Measure #2 17.667 17.614 28.333 (n=3) 7.000 (n=3) 1.773 0.151
Measure #3 12.556 9.735 12.750 (n=4) 12.400 (n=5) 0.050 0.961
Norepinephrine (120-680 pg/mL)
Measure #1 (baseline) 536.900 329.494 687.250 (n=4) 436.667 (n=6) 1.207 0.260
Measure #2 523.833 261.796 671.667 (n=3) 376.000 (n=3) 1.574 0.190
Measure #3 442.333 198.144 561.250 (n=4) 347.200 (n=5) 1.832 0.110
State Anxiety Score (20-80)
Measure #1 (baseline) 45.833 13.960 43.200 (n=5) 47.714 (n=7) 0.534 0.600
Measure #2 42.850 12.389 51.000 (n=4) 32.000 (n=3) 3.200 0.02*
Measure #3 37.182 11.898 37.000 (n=5) 37.333 (n=6) 0.043 0.960
Trait Anxiety Score (20-80)
Measure #1 (baseline) 39.083 13.104 36.400 (n=5) 41.000 (n=7) 0.581 0.570
Measure #2 35.286 9.232 39.250 (n=4) 30.000 (n=3) 1.417 0.210
Measure #3 38.545 8.937 38.000 (n=5) 39.000 (n=6) 0.175 0.860
^significance at <.05
Although the state means were slightly higher for the experimental group at baseline and higher 
for the control group at Measure #2, Measure #3 means were similar in both groups.
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Trait means were higher at baseline in the experimental group and higher at measure #2 for the 
control group, but these are not supported statistically.
Table 2
Analysis of Covariance for Anxiety Measures
Tests o f Between-Subjects
Test and assessment Mean for Mean for Effects
Time Controls Exp. Grp F Sie
Epinephrine (<60 pg/mL)
Measure #1 baseline) Not calculated (<l/t pairwise deletion)
Measure #2 13.397 (n=3) 13.953 (n=3) not calculated
Measure #3 13.667 (n=3) 13.750 (n=4) 0.003 0.959
Norepinephrine (120-680 pg/mL)
Measure #1 (baseline) 555.500 (n=3) 230.000 (n=4)
Measure #2 800.500 (n=2) 374.000 (n=3) 0.123 0.759
Measure #3 549.000 (n=3) 282.000 (n=4) 5.453 0.080
State Anxiety Score (20-80)
Measure #1 (baseline) 44.250 (n=5) 34.500 (n=6)
Measure #2 51.000 (n=3) 33.000 (n=4) 11.594 0.027*
Measure #3 33.500 (n=5) 32.000 (n=6) 0.008 0.930
Trait Anxiety Score (20-80)
Measure #1 (baseline) 39.250 (n=5) 32.000 (n=6)
Measure #2 39.250 (n=3) 31.500 (n=4) 0.077 0.795
Measure #3 37.500 (n=5) 30.000 (n=6) 0.031 0.865
^significance at <.05
With ANCOVA (see Table 2), state anxiety scores were also found to be significantly 
lower at the middle assessment, Measure #2, in the experimental group (F = 11.59, p = .027) as 
compared to the control group. No difference was found between the groups at the final measure.
Examination of the norepinephrine means, shown in Table 1, suggests that the control 
group had higher norepinephrine means at all assessments, and particularly at the middle
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assessment. However because o f the small sample size and variation within groups, no statistical 
significance was found. When groups were adjusted with ANCOVA for baseline differences the 
differences flatten out and show no significant difference between groups at midpoint (F = .123, 
p = 0.759), but they do show a possible trend towards a significant difference at end measure, 
with the experimental group having a lower mean than the control group (F = 5.453, p = 0.08),
(see Table 2). These data have to be regarded with caution because of the limited sample size. 
Although the numbers were small, a Pearson Product Moment Correlation Coefficient was run to 
find if there was any correlation between norepinephrine level and anxiety score. The Pearson 
correlation matrix showed insignificant association between norepinephrine level and state anxiety 
(r = -0.27) and Trait anxiety (r = -0.22). No significant differences or trends were found with the 
trait anxiety or epinephrine measurements on either t-test or ANCOVA.
Although the sample size was too small to expect any statistically significant findings, the 
researcher was interested to see if  there were any changes that, with a larger sample, might 
indicate differences associated with amount of PMR use. Anxiety measures were depicted 
graphically according to whether the subject was in the control or experimental group, and 
according to amount o f PMR practice. These data will be discussed only in terms of the pattern 
seen on the graphic depiction and are not considered statistically significant. However, they may 
be useful when planning further study. When PMR practice and state anxiety scores were 
evaluated, as graphically depicted in Figure 4, a pattern was seen indicating a greater degree of 
drop in state anxiety scores in persons who had moderate to high PMR use as compared to 
controls. Interestingly the experimental group who did not practice PMR showed the lowest end
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No use No use Moderate use High use
Control group Experimental groups aooorcfing to
progressive muscle relaxation use
Figure 4. State anxiety scores at three different intervals 
according to group and amount of PMR practice.
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measurement score. This may be because of personality characteristics that may have contributed 
to their not following the PMR regimen, and it would be of interest for further study. When 
looking at trait anxiety score means and PMR use (see Figure 5), trait score means showed an 
increase from baseline in the control group and also in the experimental group with high PMR 
use, although the experimental group had lower baseline and ending trait score mean with a drop 
at Measure #2 compared to the control group. In the experimental groups with no PMR use and 
moderate PMR use, the trait score dropped from baseline to end measurement, with the moderate 
PMR use group showing a further drop at Measure #2.
Overall, the experimental groups had lower end point trait and state score means than did 
the control group. The experimental group that did not practice PMR started out with the lowest 
trait anxiety score mean. It would be interesting to study whether this is associated with 
personality factors that reflect a more relaxed attitude in general on stress measurement 
instruments.
Analysis of norepinephrine level means and groups according to use o f PMR, shown in 
Figure 6, showed an interesting pattern. Control subjects and experimental subjects who did not 
use PMR showed an increase from baseline in Norepinephrine level means, while experimental 
subjects who used moderate to high practice o f PMR showed a decrease from baseline in 
Norepinephrine level means. The high use PMR group had a drop from baseline to measure two, 
and then went up for the third measure. The high use PMR group started out with the highest 
baseline and remained higher than the other groups through all measures. A larger sample size 
might reveal different results and would be of interest to study further, and to evaluate whether
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progressire rrusde relaxation use
Figure 5. Trait anxiety scores at three different intervals
according to group and amount of PMR practice.
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Figure 6. Norepinephrine levels at three different intervals
according to group and amount o f PMR practice.
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there are personality factors that are associated both with anxiety level and high use of a strategy 
such as PMR. While the findings must be regarded cautiously, they do raise the possibility that 
there may be differences found based on amount o f PMR use and anxiety measures and would be 
o f interest for further study.
Anticipatory Nausea and Vomiting
Occurrence o f nausea and vomiting was assessed using the MANE instrument. The 
MANE was administered at the second and third measurement during the chemotherapy regimen, 
because the instrument was designed to evaluate chemotherapy associated nausea and emesis. 
Each MANE instrument assessed for nausea and/or emesis occurring after the previous 
chemotherapy cycle and also prior to the cycle the subject was undergoing.
Table 3
Number of Subjects Who Reported Nausea and/or Emesis on MANE
Group Before cycle 3 After cycle 3 Before cycle 4
Experimental Group (n=6) 1 out of 6 5 out of 6 0 out of 6
Control Group (n=5) 2 out of 5 4 out of 5 1 out o f 5
Difference between groups 
using Chi Square Analysis
X2=0.75, df = 1, 
p = 0.39
X2=0.02, d f=  1, 
p = 0.89
X2= 1.32, df=  1, 
p = 0.25
Analysis of the MANE results obtained showed no significant difference between groups 
in terms of anticipatory or post-chemotherapy nausea and vomiting (see Table 4).This is not to 
say that nausea and/or emesis did not occur in the subjects. The AC regimen is known to be 
emetogenic, and rigorous management with pre- and post-chemotherapy medication was included
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-Immune Status 95
in the patient treatment regimen. Nausea and/or emesis occurred most commonly after 
chemotherapy in all o f the study subjects, although there were some reports o f ANV primarily in 
the control group. The number in each group was small, and even though there might be a 
difference anticipated when looking at the raw data, it was not sufficient for statistical 
significance.
Immune Function
Immune function was assessed with tests in six major categories, some of which had 
multiple measures. Immune function tests included Total Complement, Serum Immunoglobulins, 
Flow Cytometry Phenotyping that included CD45-F/CD12-PE lymphocyte purity, CD3+ T- 
lymphocytes (percent and absolute numbers), CD20+ B-lymphocytes (percent and absolute 
numbers), CD3+25+IL-2 Activated T lymphocytes (percent and absolute numbers), CD3- 
CD16+56+ NK Cells (percent and absolute numbers), Mitogen Stimulation Assay with PHA at 
three concentrations, Natural Killer Cell Assay including Effector cells, Target cells, cell death at 
40:1, 20:1, 10:1, 5:1 and Lytic units, and the Cytokines IL-2, IL-4, IL-6, IL-10, IL-12, and INFy.
Initially, the results of all of these immune function test results were analyzed. However further 
evaluation revealed that three of five control subjects (60%) and two out of seven experiment subjects 
(28%) required Neupogen, a granulocyte cell-stimulating factor(G-CSF), for neutropenia. Chi-Square 
analysis was done to evaluate if there was any significant difference in the requirement for Neupogen 
use between groups. No significant difference was found (X2 = 1.185, d f = 1, p = .276). However, 
because of the immune system stimulation effect that G-CSF has, results obtained on subjects who 
required Neupogen were unusable in this study. The results on subjects who did not require G-CSF
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were analyzed using descriptive statistics simply to see if any trends might emerge despite the very 
small sample size (see Appendix G for descriptive statistics). There were few statistically significant 
differences in immune tests found between the control and experimental groups, and those that were 
found must be viewed with great caution because of the very small sample size, particularly for the 
control group at measure #2 which included a sample size of one.
Evaluation of immunoglobulins showed that at the final measure, measure #3, the mean for 
IgM was higher for the experimental group (179.50 mg/dl) compared with the control group (89.45 
mg/dl) and approached significance (t = -2.557, p = .063). No other differences were seen with the 
immunoglobulins. Total Complement could not be evaluated because of missing data.
Evaluation o f Lymphocyte sub-sets showed a possible trend of T Lymphocyte CD3+ 
percent being higher in the control group at Baseline (t = 2.315, p = 0.69), but this pattern was 
not reflected in the T Lymphocyte CD3+ absolute numbers, where no significant difference was 
found between groups. The IL-2 Activated Lymphocyte percent was significantly higher in the 
single control subject at Measure #2, with a mean of 53% as compared to 16.6% for the three 
experimental subjects (t = 12.503, p = .006*). IL-2 Activated Lymphocyte absolute numbers 
looked slightly higher in the single control subject at Measure #2 as compared with the 
experimental subjects, with means o f 0.580 and 0.203, respectively, but the difference was not 
statistically significant (t = 3.225, p = .084). No significant difference was seen between the 
groups with B Lymphocyte CD20 cells or NK Cells.
No statistically significant difference was found in the NK Assays of percent cell death. 
The means for the control group and experimental group at baseline measure were 7.7% and
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29.6%, respectively (t = -1.335, p = .089), and on other assays some means seemed to be higher 
in the experimental group than in the control group, but no statistically significant differences 
were found. At Measure #2 a significant difference was seen in Target Cells, with the single 
individual in the control group having a significantly higher level than the three individuals in the 
experimental group (t = 12.950, p = .006*). Because this involved a sample o f one in the control 
group, the meaning is questionable.
The final category o f tests evaluated involved selected cytokines. The cytokine IFN 
gamma was evaluated, but the results were reported as zero in all o f the subjects, so no statistical 
evaluation was performed for this test. The cytokine IL-10 was also evaluated, but the test was 
repeated when results appeared suspicious, and when they again appeared suspicious, the kit 
manufacturer was contacted. It was discovered that the kit was contaminated, so the information 
was unusable, and there was no remaining sample for repeating the test. IL-2 was assessed on all 
subjects. Only one sample out of the 30 IL-2 samples processed resulted in any level of IL-2 being 
detected. This one positive sample gave a reading of 11.4 pg/ml, very much out o f the expected 
range (the usual reference range for IL-2 is 0 -1.6 pg/ml) and it was concluded that this finding 
was not valid. The researcher thus concluded that there were no IL-2 levels detected in the 
control or experimental subjects.
There were no significant differences found between groups with IL-4 and EL-12.
However, at Measure #2 the single individual in the control group had a higher IL-6 mean (4.32 
pg/ml) than the experimental group mean (1.77 pg/ml), and this was statistically significant (t =
11.602, p = .007). No conclusion can be drawn from this finding because o f the limited sample 
size.
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Discussion of Findings
Although statistically significant findings were limited, there are some interesting patterns 
to be seen in this pilot study that would suggest further study. The findings give direction and 
raise questions that are important for future research in this area.
Anxiety
Anxiety is commonly associated with chemotherapy. In 1999, over 600,000 persons were 
estimated to have undergone chemotherapy in the U.S.A., so there is the potential for a large 
number o f individuals to be affected. Ninety-one percent o f the women studied by Jacobson, 
Bovbjerg, and Redd (1993), stated that they were anxious prior to their first chemotherapy 
treatment. This figure dropped to 64% reporting anxiety prior to the 2nd, 60% prior to the 3rd 
and 4th, and 57 % reporting anxiety prior to the 6th treatment. Other studies have reported 
anxiety and depressive states ranging from 25% to 40%. Based on data of this nature, this study 
was undertaken with the understanding that the process o f  undergoing chemotherapy is a stressor 
that results in anxiety as one o f the responses.
If one looks at only the means in this study, without statistical analysis, all subjects show a 
pattern o f lower end measure means than baseline means for epinephrine, norepinephrine levels, 
state anxiety, and trait anxiety scores. That is to be expected because at the beginning all subjects 
were facing the unknown o f chemotherapy, and at the end measurement they were at the end of 
the treatment. Means for norepinephrine appear lower in all measures for the experimental group, 
despite one experimental subject having the highest recorded baseline norepinephrine level of all 
subjects.
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A curious pattern seems to appear in the middle measure for the anxiety measurements. In 
the experimental group, a drop from baseline to Measure #2, the middle measurement, is seen 
with epinephrine and both state and trait anxiety levels means. At the third and final measure, the 
means go up from Measure #2, but remain below baseline for epinephrine and state and trait 
anxiety, and drop further from baseline for epinephrine. This pattern is different in the control 
group, where means for epinephrine, state anxiety, and trait anxiety go up from baseline at 
measure #2, while norepinephrine drops very slightly. At the final measure, control means for 
epinephrine are the same as at baseline, means for norepinephrine and state anxiety are lower than 
baseline, and trait anxiety is slightly higher than at baseline. None of these are statistically 
significant, due to the small sample size and the standard deviation in each group, but there is a 
pattern that is a positive indicator for further study with a larger population
With ANCOVA, norepinephrine levels show a trend toward being significantly lower in 
the experimental group as compared to the control group at the final measure. A greater decrease 
in levels in experimental subjects who practiced PMR can be seen when looking at groups 
according to PMR use. Norepinephrine levels drop in the experimental groups that had moderate 
PMR use and very slightly in the high PMR use group, while levels go up in the control group and 
also go up slightly in the no PMR use experimental group.
The state anxiety score is significantly lower at the second measure in the experimental 
group as compared to controls. Trait score means also appear lower at the second assessmentin 
the experimental group, compared with the control group, although the difference is not 
statistically significant. It would seem logical that persons with higher state or trait anxiety scores
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would have higher epinephrine levels. However, this pattern did not emerge in the means shown 
in Table 2, and at least at baseline the experimental group showed lower epinephrine levels and 
higher state and trait anxiety levels than did the controls.
Although interpretation of this requires a larger sample and further study, this pattern and 
subjective statements by subjects in the experimental group suggest that the most important 
difference between groups might be at the mid-point rather than at the beginning and at the end 
points of chemotherapy. It is possible that at baseline all subjects have similar anxiety levels 
because all are going to undergo chemotherapy and the process is an “unknown”. At the final 
measure all subjects have completed three cycles of chemotherapy and are anticipating the final 
cycle and the end to the chemotherapy regimen. At this point all subjects, both experimental and 
control, expressed relief that the process was nearly over. At Measure #2, however, the subjects 
had undergone two cycles o f chemotherapy and were anticipating a third. It is possible that at this 
point the experimental subjects experienced a reduction in anxiety, whereas the control subjects 
may have either experienced no decrease or even an increase. This pattern seems to emerge in the 
means shown in Table 1, and is validated by the subjective comments o f subjects.
Interestingly, the experimental group actually had slightly higher state and trait means at 
baseline than the control group. This may be because one subject in the experimental group had a 
very high state score at baseline, the highest score possible, and a high score at Measure #2. The 
subject was diagnosed with depression after three cycles of chemotherapy and started on 
treatment for depression at that time. At the fourth (final) cycle, and at the final data point, the 
diagnosis of depression and subsequent treatment was relayed to the researcher, but because the
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subject had completed the study, she was kept in with the rationale that she may very well reflect 
what one would encounter in clinical practice if  enough patients were enrolled in a study.
When the PMR aspect is included, there is a downward directional trend to Measure #2 
and then an increase at Measure #3 in both state and trait anxiety scores in the experimental 
group, regardless of how much PMR was practiced. The state anxiety scores dropped very 
slightly, in the control group, as compared to a larger drop in the experimental groups, and the 
trait score goes up. Variation in trait scores is not expected since trait anxiety level is expected to 
remain stable over time. As previously discussed, Taylor (1995) reported changes in trait anxiety 
following an intervention in HIV- positive individuals. It may be possible that life-changing 
events, such as diagnosis with cancer, result in a period when trait anxiety is not static, and this 
would be useful to study further in persons with cancer.
An interesting finding with the very small group involved was that the experimental group 
that did not practice PMR started out with the lowest trait anxiety score mean and showed the 
lowest end measurement on state and trait score means. This may because of personality 
characteristics that may have contributed to their not following the PMR regimen. It would be 
interesting to study whether this difference is associated with personality factors that reflect a 
more relaxed attitude in general on stress measurement instruments. Subjects who practiced high 
PMR use have higher norepinephrine level means both at baseline and end measurement, although 
they show a slight drop in norepinephrine compared to the increase in norepinephrine in the 
control group and the no PMR use group. The question arises whether the persons who practiced 
high PMR use may have had a more anxious personality than those who practiced moderate use.
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It would be interesting to study any correlation o f a relaxation intervention and anxiety indicators 
including use of an anxiety inventory, serum catecholamines to assess for acute stress, and also 
cortisol levels to include stress o f a more chronic nature.
Control subjects and experimental subjects who did not use PMR show an increase from 
baseline in norepinephrine level means, while experimental subjects who used moderate to high 
practice of PMR show a decrease from baseline. This raises the question o f whether systematic 
use of PMR may result in modulation of stress hormone production for some persons, and would 
be of interest for further study.
The conceptual framework used for this research was the SC A framework, which includes 
the concepts of a stressor with resulting coping and adaptation. The intervention in the research 
was aimed at assisting the individual in the intervention group with both psychological and 
physiological coping with the stressor of the cancer treatment process, seeking a resultant 
adaptation showing lower catecholamine levels and state and trait anxiety score than the non­
intervention group. It appears that the experimental group at mid-point had lower indicators of 
anxiety than did the control group, and it is possible that the intervention played a part in this 
psycho-physiological adaptation response to the stressor. This is consistent with previously 
reported research, which shows a decrease in anxiety scores associated with some types of 
relaxation intervention, such as that reported by Walker et al. (1999) who found that women who 
were receiving chemotherapy for breast cancer and were in a group that practiced relaxation 
training involving progressive muscle relaxation and guided imagery had less anxiety than women 
in a control group.
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Nausea & Emesis
No significant difference in nausea and emesis was found between the control and 
experimental group. There are three likely reasons for this finding. First, patient report of 
anticipatory side effects increases with the number o f cycles received. The regimen used in this 
study was a combination o f AC, which required only four cycles. No studies reporting ANV 
specific to the combination o f AC were found reported in the literature. It may be that the 
duration of the therapy is too short for ANV to occur, and had the regimen required further cycles 
more ANV might have been reported. Second, the treatment regimen for all subjects included 
rigorous management o f nausea and vomiting associated with the chemotherapy, and this could 
likely decrease report o f and incidence of ANV. Third, the sample size is small; a larger sample 
would have been very helpful in giving a better picture o f any association of ANV with AC 
chemotherapy.
For the purpose o f further research, the aspect o f anticipatory nausea and emesis, as 
measured by MANE, may not be a high priority for inclusion in a study, if chemotherapy o f short 
duration is used and if rigorous anti-emetic management is a part of the treatment regimen. Of 
more significance would be use o f an instrument evaluating the amount o f distress associated with 
the symptom of chemotherapy-associated nausea. It is recommended that use o f a symptom- 
distress scale designed for chemotherapy recipients be included in further research o f this nature. 
Immunity
A major confounding variable in this study was that a number of subjects required the G- 
CSF Neupogen when their granulocyte counts dropped. On the surface it appears that Neupogen
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-Immune Status 104
was used in more of the control subjects than in the experimental group. Two of the seven 
experimental subjects (28%) were treated with Neupogen, while three of the five control subjects 
(60%) required the treatment. Although Chi-square analysis showed no significant difference, it 
would be of interest in a larger study of this nature to see if  there were any difference between 
groups in the number of persons who required G-CSF. Use of G-CSF with chemotherapy is 
reported in the literature, but none was found that projects the percentage of persons undergoing 
AC chemotherapy or for that matter, any of the major chemotherapy regimens, who would be 
expected to require G-CSF. This complicates planning immune function studies in further similar 
research of persons undergoing chemotherapy, because the effect of the G-CSF renders the 
results unusable with results from persons who did not require G-CSF. It may be o f more benefit 
to eliminate immune function tests and instead focus on the clinical criteria for G-CSF need.
No differences were seen between groups for IgG and IgA. At Measure #3 the end 
measure, the experimental group had a significantly higher IgM than the control group. What this 
means is unclear and it would be helpful to evaluate with a larger sample.
No meaningful significant differences were found with cell subsets, mitogen stimulation, or 
NK activity. It was anticipated that if changes were to be seen, they would be associated with NK 
function. This is because decreased NK function has been found to correlate with a number of 
psychological factors such as elevated stress level (Anderson et al., 1998), loneliness (Kiecolt- 
Glaser et al., 1984), bereavement (Irwin et al, 1987a), depression (Andreoli et al., 1993), and lack 
o f social support, depression, or fatigue (Levy et al., 1987). Certain life events, such as 
examination stress, have also been associated with decreased NK activity (Kiecolt-Glaser et al.,
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1984). However, in contrast, Bachen et al. (1992) found in a group of healthy subjects exposed to 
an acute laboratory stress situation that there was an increase in the number of circulating NK 
cells. Levy et al. (1987), studying patients undergoing chemotherapy for breast cancer, found that 
decreases in NK activity was correlated with factors such as depression or lack o f support, but 
not with the actual chemotherapy. It is hypothesized that certain relaxation interventions can 
enhance NK activity in persons who are experiencing stressful situations. Zachariae et al. (1990) 
found a significant increase in NK cell function after guided imagery practice in a healthy group of 
subjects. However, Kiecolt-Glaser et al. (1984) did not find that duration of relaxation practice, 
comprising self-hypnosis, progressive relaxation, imagery exercise, and/or autogenic training, 
affected NK activity in a study of healthy individuals. This study found no differences between 
groups in terms of NK numbers or activity in the small number o f subjects with results that could 
be analyzed.
Lymphocyte response from mitogen stimulation is a  way o f assessing the functional aspect 
o f the immune system. Mitogen stimulation with PHA alone would not be used again in further 
study unless a very good reason became apparent. Using mitogen stimulation with only PHA 
limits one to evaluating T-lymphocyte but not B-lymphocyte activity. The limited findings and 
difficulty in getting the test performed consistently in this setting does not justify the cost at this 
time.
Increases in cytokine activity can help the researcher understand the type o f immune 
response being mobilized and what cells are probably most active (Vedhara et al., 1999).
Cytokines may be responsible for activation of the cellular or humoral aspects o f the immunity.
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Only a limited number of cytokines can be detected in plasma of healthy individuals, and 
according to Vedhara et al. (1999), their measurement is generally more useful in diseased 
populations. In this study, IL-2 (a Thl cytokine) levels were found at higher than reference range 
levels in the control group but not in the experimental group. Investigation of this finding revealed 
that only
one sample of the thirty analyzed showed any result, and there was strong evidence that the 
finding was due to error, so the results were considered negative and were not analyzed.
At Measure #2 the individual in the control group had a significantly higher EL-6 level (a 
Th2 Cytokine) than did those in the experimental group (t = 11.602, p = .007). This could be a 
random event and really cannot be interpreted based on the sample size. If indeed it is a valid 
finding, it may reflect an up-regulation of the Th2 cytokine arm at this measurement. Up- 
regulation of one has a suppressive effect on the other. One would expect to see a suppression of 
Thl cytokines if  there is an up-regulation of Th2 cytokines and vise-versa. In this study, one 
would expect to see up-regulation o f Th2 cytokines (e.g. IL-4 and IL-6) if  there is an down- 
regulation of the Thl cytokines ( e.g. IL-12). There seems to be a pattern o f lower IL-12 means in 
the experimental group at Measurement #2 and baseline, but these do not approach statistical 
significance, and a larger sample is needed to evaluate the findings. It would be o f interest in 
further study to evaluate the cytokines IL-4, EL-6, EL-10, and IL-12 to see if  any significant trend 
is seen in persons undergoing chemotherapy.
There are some difficulties with evaluating the cytokine findings in this study because of 
some of the unknown information. First, it is difficult to know if  the lack o f results for IFN
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gamma and IL-2 are actual or instead because o f sample decay during storage, even though the 
samples were maintained frozen at the appropriate temperature. It is likely that the findings reflect 
real results, but a larger sample would have helped clarify this. Second, it is most likely that the 
single IL-2 finding was due to a contaminant. However there is a very small chance that it was a 
real result. The IL-10 results were lost because of a manufacturer kit problem and would have 
been helpful in looking at the larger picture of TH1 :TH2 balance had they been available. Six 
cytokines had been chosen to represent both Thl and Th2 immune function. Only three o f these 
showed growth, although the two that showed no growth could also be considered valid. The Thl 
cytokines, particularly 11-2, occur in very small amounts and are difficult to measure in plasma, 
particularly in healthy hosts. Persons undergoing chemotherapy are not usually considered healthy 
hosts, and it may be that chemotherapy affects detection of the cytokines used in this study. That 
information was not found reported in the literature about AC therapy. Theoretically one would 
like to study cytokines that would permit assessment o f the Thl :Th2 balance. However, 
measurement of cytokines in plasma is difficult for a number of reasons. The amounts present for 
measurement are very small, and also it is uncertain how much of the cytokine is free and how 
much is receptor-bound. In considering further study, a design would probably not include 
cytokines IL-2 or IFN gamma because the expected level is zero in the non-diseased host. Use of 
a new method that involves assessing the messenger RNA for the cytokine would be explored 
instead. Third, G-CSF is a powerful cytokine and use in subjects would alter cytokine results.
There may be other significant reasons for the limited statistically significant findings. 
These could possibly be related to the cytotoxicity o f the chemotherapy agents. Despite careful
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searching, no literature was found reporting the effects o f the AC combination chemotherapy on 
the immune function tests used in this study. There was literature discussing one or the other of 
the drugs, or other combinations o f the drugs, but there appears to be a dearth of information 
specifically about AC. This complicated the process of choosing which immune function tests to 
use in the study.
One key aspect missing in this study was the subjective aspect of how persons undergoing 
chemotherapy felt about the process. Although there was no formal process for addressing the 
subjective aspect, there was an informal recording of some of the information. Six o f seven 
experimental subjects volunteered that participation in the study, including the massage and 
interaction with the researcher, seemed to make the whole experience less negative. Four subjects 
used the words “I don’t dread coming in for chemo” or “I don’t dread coming in for chemo so 
much” in their volunteered statements. One subject stated that she “almost looked forward to 
coming in” when discussing coming in for chemotherapy treatment, and went on to say that it 
gave her an opportunity to talk to someone who would listen. None of the control subjects gave 
any positive expression about the chemotherapy duration until the end, when they made 
statements about being glad that it was over.
A curious subjective observation, made over time by the researcher, was that at the second 
assessment, most subjects seemed to express more negative feelings than at other times regarding 
the chemotherapy process and how they were feeling and coping with the side effects and changes 
associated with the treatment. Subjects appeared more relaxed and even happy at the final 
assessment because, as they expressed it, they knew it was the last AC treatment, and they could
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look forward to relief from some of the negative side effects associated with their therapy. This 
might explain why there seemed to be an increase at the second assessment in both state and trait 
anxiety scores in the control subjects. However, this trend o f  increased state and trait anxiety 
scores was not reflected in the experimental subjects, although because the researcher was more 
involved with them (giving the massage), they expressed more to the researcher about then- 
negative feelings at the second assessment than did the control group. Further study would well 
include the subjective aspects o f  patient expressions. Some o f  these aspects might be addressed by 
using a quality of life inventory and a symptom distress scale, both quantitative, but patients 
should also be given the opportunity to express what they perceive as important subjective 
aspects.
Proposed Plan for Further Study
Based on the findings in this pilot study, a proposed plan for further study would include 
some changes. The design proposed would include a prospective two-group experimental 
intervention design. The intervention would include PMR and either a teaching support 
interaction or massage prior to each chemotherapy cycle. Assessments would include STAI-Y for 
anxiety as well as the stress hormones epinephrine and norepinephrine to assess for acute stress 
and cortisol to assess for chronic stress. Instead of MANE, a Symptoms Distress Inventory 
specific to cancer patients would be used, along with a Coping Inventory to assess how 
individuals were reacting to and coping with the chemotherapy. Very limited immune function 
tests would be proposed, but clinical information including use o f  G-CSF would be collected. 
Possibly tests to assess for NK numbers & function several months after chemotherapy
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completion would be done. Tests reflecting the Thl :Th2 balance would be strongly considered; 
including possibly the cytokines IL-2, IL-4, IL-6, and IL-10, because these could be frozen and 
stored for processing at the end o f the data collection and subjects requiring G-CSF could be 
removed from the data set. However, another strategy that would be explored would be tests to 
measure cytokine RNA messenger instead. The sample size would be increased, and although it 
would increase variability, it might include more than one specific type of chemotherapy, using 
categories of chemotherapy with similar side effects.
The overall goal o f  a future study would be to examine whether a nursing intervention 
could modify side effects o f  the psycho-biological stressor, chemotherapy, and enhance individual 
coping and adaptation in persons who require the treatment.
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Chapter V
Summary, Conclusions, and Recommendations 
With the bi-directional interplay among the endocrine, neurological, psychological, and 
immune systems, it is clear that stressors can have psycho-biological responses that affect all o f 
these systems. Chemotherapy, which large numbers o f persons undergo, can be considered both a 
physiological and a psychological stressor. Chemotherapy has known side effects that may 
adversely affect the outcome or the process o f treatment. Anxiety, nausea, emesis, and 
immunosuppression are commonly associated with chemotherapy. Anxiety can be associated with 
a number of negative side-effects, including nausea and emesis, anticipatory nausea, and even 
anticipatory immunosuppression. Some psychological stressors such as anxiety can result in 
down-regulation of certain immune functions. Many types o f chemotherapy are also directly 
associated with immunosuppression. Some interventions have been found to modify stress-related 
immune modulation. This has led to questions about whether an intervention designed for 
relaxation could modify the stress response to chemotherapy resulting in a reduction in degree of 
side effects.
Summary of Study Findings 
In this study, the experimental group demonstrated significantly less state anxiety at mid­
measure than did the control group and showed a trend of lower norepinephrine level at the end 
measure. The findings tend to support the research hypothesis that a nursing relaxation 
intervention would result in lower anxiety in the research group as compared to controls in this 
study group.
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The findings on nausea and emesis did not support the research hypothesis; no difference 
was found between groups. This really was also true o f the immune test findings, because 
although there were statistically significant differences or trends with four measures, these are 
meaningless because of the small sample size.
The goal of obtaining information of the effect o f Adriamycin/Cytoxan chemotherapy on 
the immune system was met in this pilot study. It became apparent that this regimen has a 
profound effect on immune function, requiring, in a number o f  cases, treatment with G-CSF in 
order to continue chemotherapy. Although the immunosuppressive effects of this regimen are 
known and expected, literature on the specific effects o f AC chemotherapy on the immune 
function tests used in this research, and the expected incidence o f G-CSF requirement, were not 
found in literature searches. This pilot study has provided a basis for omitting these tests in further 
planned study of this nature. The results o f immune function tests for persons who received G- 
CSF may be evaluated at a later date and compared with those who did not receive G-CSF to see 
if that information might be useful to oncology clinicians since nothing of that nature was found in 
the current medical or cancer literature. A plan for further study did emerge with a number of 
changes from the pilot study.
Methodological Limitations
There were a number o f methodological limitations involved in the study. Some of these 
reflected the nature of clinical research where there are variables in terms of timing, blood cell 
counts, and other uncontrollable factors.
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States of health differ between participants and could account for differences seen in the 
study. There may have been unidentified underlying health problems that could have influenced 
the study. Variations o f hormone and immune levels may occur based on individual differences, 
circadian rhythms, and circumstances of daily life (e.g., no sleep).
Stressors, both positive and negative, are a part o f life and cannot be eliminated. When 
studying a specific stressor, such as the chemotherapy experience, it is impossible to separate 
stress reactions associated with the chemotherapy completely from stress reactions associated 
with other stressors occurring at the same time. Subjects in both the experimental and control 
groups of the study had significant stressors in their lives. One subject had just started a job after a 
period of unemployment. She had minimal health insurance and had to work during the whole 
course of chemotherapy. Her work was based on commission, and she had no savings to fall back 
on. Her elderly father who lived some distance from her was very ill, and her mother was unable 
to manage adequately, so they relied on the subject for help. Another subject not only had a 
disabled child who required major surgery during the chemotherapy regimen, but also discovered 
that her father had a rather large bowel cancer and required treatment. Another had, in addition to 
several other children, a severely mentally handicapped child who required considerable and 
constant care. Although not all had stressors to the same extent, all o f the subjects reported 
feelings of stress related to the diagnosis, the treatment, and side effects such as the loss o f hair, 
and concern about the outcome, in addition to concerns about keeping up with normal daily 
activities.
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Another potential limitation was that individuals differ in response to interventions such as 
massage or progressive muscle relaxation. If changes occur, one cannot assume that the change is 
due to intervention alone. In addition, while subjects were asked to practice PMR while at home, 
there was no way to assure that subjects would not only do so, but would also report their activity 
accurately. It was important to the study that the practice of PMR not be an additional negative 
stressor to the subjects. Two subjects did not practice it after the first few times. One o f them 
volunteered to drop out o f the study but then elected to stay in. Another subject did not bring in 
the cards noting practice, even when reminded by telephone. She changed the subject consistently 
when asked about how often she was able to practice, even when assured that there was no 
negative aspect with number o f  times practiced, and it was only an attempt to see if  there was any 
relationship with number of practices and any outcomes. O f the subjects who filled out the cards 
and returned them, the times o f  practice ranged from daily to sporadically.
Self-reported subjective phenomena such as anxiety and nausea may be difficult to 
discriminate between (Andrykowski, 1990), and they may influence how subjects responded to 
the STAI and the MANE. In addition, venipuncture (e.g., for blood samples) may increase 
aversiveness and anxiety (Andrykowski, 1990) of subjects and may be reflected in self-reporting 
of anxiety.
An unforseen limitation involved the types of chemotherapy regimens offered patients.
The study was developed initially, in conjunction with the chief o f Oncology, to include patients 
scheduled for CMF (Cyclophosphamide, Methotrexate, and 5-FU) chemotherapy. It was 
anticipated that between six and eight patients per month would be treated with this combination
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and so would be available as a potential subject pool. After all the appropriate approvals had been 
obtained, the researcher met with the contact physician in the Oncology department to proceed 
with data collection, and at that time found out that there had been some major changes in the 
department, among them that there was a new chief o f the department and, the oncology center 
had joined a national cancer study. The drug protocols now anticipated include a number of 
combinations to meet the national study requirements, none of which included CMF therapy. The 
researcher then met with the new chief of the Oncology department and redesigned the study to 
use patients with breast cancer who were in a protocol that required four doses of AC 
chemotherapy. Some o f these patients would go on to get additional drugs (e.g., Taxotere or 
Tamoxifen), but all would initially get AC for four doses. The study proposal and consent forms 
were rewritten and re-submitted to appropriate review committees, and once approval was 
obtained again, data collection began. Patients with breast cancer who were treated at the 
Oncology department were randomly assigned to one o f several national chemotherapy protocols, 
only one of which involved AC alone. This resulted in the number of potential subjects dropping 
from an anticipated six to eight per month with the originally designed study using CMF to an 
anticipated zero to two per month. During one period, there were none that met the criteria for 
nine months. This was an unforseen, uncontrollable, and rather frustrating aspect that limited the 
number of potential subjects available.
The change in study design affected assessment o f conditioned nausea and vomiting. If a 
person is to develop ANV, it usually occurs after five to eight treatments. However, with the 
change to AC chemotherapy, only four doses were required, making it far less likely that patients
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would develop ANV. Another very positive aspect that affects ANV is that now rigorous anti­
emetic medication management is used to prevent and manage nausea and emesis, so the problem 
is not as extensive as it once was.
Another limitation had to do with timing of clinic visits. At the beginning of the study 
patients would come to the clinic for routine blood work and to see the physician. Their 
chemotherapy would then be given the following day. This gave two opportunities for the 
researcher to establish contact with subjects in the clinic setting. After the first year this changed 
so that the patient would get the blood work, see the physician, and receive chemotherapy on the 
same day if the blood counts were satisfactory. The researcher then made arrangements to come 
to the clinic when a subject was scheduled to come in. In addition, a note to page the researcher 
was attached to clinic records, and either the receptionist at the front desk or an oncology nurse 
received the message and request to page. Initially subjects were also asked to call if any changes 
in their schedule occurred. However, because chemotherapy was dependent on blood counts, 
subjects did not know if there would be a change in dose schedule until the time of the visit. It 
became apparent that asking subjects to contact the researcher was a negative stressor. Therefore, 
the researcher took responsibility for assuring follow-up when the subjects came to the clinic. For 
the most part this worked well. However, there were several occurrences where the researcher 
had personally come to the clinic when a subject was scheduled and spoken with staff and left 
written request to be contacted when the subject actually came in, but because of an extremely 
busy flow of patients, the contact did not occur. Twice the researcher was paged only after 
chemotherapy was actually started, so the data collection point was lost. This was understandable
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though, because the clinic was very busy and crowded, and staff were under a great deal of 
pressure to prepare chemotherapy drugs and administer them under time, space, and distraction 
constraints. Their first concern was for care and safety of the patient, but it did affect data 
collection.
The process o f blood collection for specimens in the outpatient laboratory setting was also 
challenging. Patients who did not have a central venous access device (e.g., a port-a-cath) had 
blood drawn in one o f two laboratories in the clinic. Detailed arrangements were made with both 
laboratories. A small bag containing appropriate collection tubes and instructions was provided, 
and personal contact was made just before the subject was to come in for blood draw. Subjects 
were called the day before to find out when they were planning to come in, and a note requesting 
that the researcher be paged and the time the patient was coming in was placed with their name at 
the desk where they would check in for blood-draw. The researcher tried to come to the 
laboratory when the patient was scheduled to come in, but this was not always possible because 
the clinic site was at another part of the university campus from the researcher’s work site, and 
often patients would be quite late for appointments, necessitating long waits for them to arrive. 
Blood collection went flawlessly in one o f the laboratories, but was problematic in the other. On 
one occasion, a subject in the study reminded the person drawing blood that the research 
specimen was to be drawn, and was assured that it had been obtained. However it had not, and 
follow-up revealed that the venipuncutrist was simply trying to placate the subject. On two other 
occasions, the request to page the researcher was not followed. There was a “double-check” on 
this problem by having the clinic staff page the researcher before chemotherapy was instituted, so
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that if a specimen was missed in the clinical laboratory, it could be drawn when venous access 
was established for chemotherapy, and on one occasion the specimen was obtained at that time. 
The only drawback to this was that the oncology nurses could not wait more than a few minutes 
for the researcher to arrive because of back-up of patients waiting for chemotherapy, and on more 
than one occasion started chemotherapy without paging the researcher. The agreement was that 
the study would not interfere with normal chemotherapy administration, so this was 
understandable. However, these occurrences resulted in missed measures, which complicated the 
initial problem of having a small sample size.
Another complication occurred in the main laboratory that processed the specimens. All 
specimens were transported according to the required protocol, in correct tubes, labeled, and with 
the corresponding order slip and also instructions about the study and to call the researcher if 
there were any questions. About 20% of the specimens taken to one o f the laboratories were 
mishandled once there, resulting in missing data. A great deal o f attention was paid to this 
problem once it was identified, but the outcome was that a lot o f data were missing from 
specimens processed by this laboratory. All of the specimens that were taken to the second 
laboratory, an approved designated research laboratory for immune studies, were processed 
properly. There the only problem was with timing of specimens for mitogen response. If the 
specimens were submitted on a Wednesday or a Thursday, they could not always be processed 
because that laboratory was a  research laboratory with staff who were not routinely scheduled to 
work on the weekend, and these specimens required handling at 48 and 72 hours. If there was a 
diagnostic patient test in process that required management over the weekend staff were
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scheduled to be in the laboratory and processed the research mitogen response tests along with 
the diagnostic patient tests. Thus some of the mitogens were missing from samples submitted to 
this laboratory.
Occasionally an unavoidable problem occurred when there was not enough blood sample 
to complete the panel o f tests. There were a few tests reported as “not enough cells for 
processing”.
Midway through the data collection, there was a change in the amount of blood required 
by the laboratory for catecholamine processing, going from a requirement of 5 ml to 10 ml. This 
information was not relayed to the researcher, despite a written request with each sample to call a 
telephone or pager number in case o f questions, and was discovered only when some specimens 
were simply reported as “not processed.” Once the requirement was noted by the researcher, the 
additional amount of blood was collected. Initially a total o f  25 ml o f blood was obtained, with a 
10-ml tube and three 5-ml tubes used. When the requirement was raised to 30 ml, it required 
twolO-ml tubes and two 5-ml tubes. Even though it was explained as “two tablespoons of blood” 
the sight o f the tubes had an initial negative psychological impact on the subjects. Earlier subjects 
did not comment very much on the 25 ml draw, simply making a few jokes about the amount of 
blood drawing in general. However, when the change was made, subjects focused on the two 
large tubes and expressed some concern about the amount o f blood loss they were experiencing. 
They were reassured that the amount, in addition to their clinical needs, was within established 
guidelines of safety according to the protection of human subjects committee. Two subjects,
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however, refused to participate in the study when they saw the collection tubes set out for the 
blood sample.
There was also considerable variation among experimental subjects in practice o f PMR. 
One participant openly stated, at the second assessment, that she was unable to fit the PMR 
practice into her day. She had already been started in the experimental group and was kept in the 
study. One participant simply refused to provide the card enumerating the number of practices, 
and with careful and diplomatic questioning, it became apparent that she was not doing the PMR. 
Final evaluation revealed that two of the experimental subjects did not practice PMR at all after 
the first two or three times and fit a category of no practice (no PMR).Two subjects practiced 
PMR between 10-50% o f  the time and were considered in a category of moderate use (moderate 
PMR), and three of the subjects practiced PMR at least 50% of the time and up to about 90% of 
the time and fit a category o f high use (high PMR). Assessment measures were run in the form of 
a descriptive graph to show if  there was any trend o f difference in test results among subjects 
practicing PMR at different degrees. In general, those who did not practice PMR were more 
similar to the control group than to those who made moderate to high use o f PMR. The numbers 
involved were too small to be of statistical significance, but they were displayed in descriptive 
graphs showing the differences between the control group and the experimental group broken into 
three categories according to how much PMR was practiced.
A final limitation was related to the need for use of a granulocyte colony stimulating factor 
(G-CSF) in subjects whose blood counts dropped dangerously. G-CSF directly affects the 
immune system since it is a cytokine that stimulates production of granulocytes. Two of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Relaxation and Neuro-Immune Status 121 
experimental subjects (28.5%) and three of the control subjects (60%) required use of G-CSF 
when their granulocyte counts dropped. In the past these subjects would have required blood 
transfusion, but development of G-CSF has been o f real benefit to these subjects, and the 
researcher was aware that some subjects might require it. Use of G-CSF was recorded in data 
collection. It was unknown at the start how this would affect the study results, because the effect 
o f G-CSF on immune function tests in research of this nature had not yet been reported, and there 
was no way of anticipating who would require G-CSF.
Recommendations For Nursing Practice
These findings have implications for nurses who are evaluating and designing management 
strategies for clients who are facing a stressor such as chemotherapy. In this very small 
population, state anxiety was lower at one measurement during the process o f chemotherapy in 
the group that underwent relaxation intervention. If the findings can be validated in further study, 
it may have significant implications for treatment o f cancer patients. Relaxation interventions can 
be inexpensive and can be used widely and independently. If the findings can be generalized to a 
larger population with further study, relaxation interventions could be planned into the treatment 
regimen of chemotherapy clients. Promoting these strategies could not only enhance response to 
therapy but also improve quality of life in patients requiring chemotherapy.
Taking care o f the person as a whole is a common concern of nurses in this era o f health 
management and increasing technology. This requires individualized assessment and planning of 
interventions that meet the person’s needs. Relaxation interventions are one way o f addressing the 
individuals needs in response to stressors, with the goal o f  helping them adapt in both
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psychological and physiological ways that promote health. This is also a timely topic with the 
current increased awareness and interest in complementary therapies. With studies that are 
supportive of such therapies, some health maintenance organizations (HMOs) are now 
reimbursing for selected relaxation interventions for patients undergoing chemotherapy because 
the outcome seems to be to the advantage of both the patient and the HMO. This is a time when 
nursing validation o f the effectiveness o f these therapies could affect payment for them. 
Recommendations for Nursing Education
This pilot study indicates that relaxation might result from a nursing intervention. 
However, extensive review o f the literature to support the study revealed that few nurses are 
involved in or publishing in the area o f neuro-immunology. A recommendation for nursing 
education is to place more emphasis on physiological and research aspects in the curriculum to 
provide a basis or interest in psycho-biological intervention research. Nursing education could 
address the aspect o f psychoneuroimmunology in terms of how body systems interact and respond 
to psychological and biological stressors. At this time, most new nursing physiology texts address 
this aspect briefly, but it is not a strong component in nursing education. In addition, more 
credibility could be given to relaxation interventions in nursing curricula. It is not infrequent to 
hear persons who have recently been hospitalized complain that they never received a back 
massage. Relaxation interventions such as back massage have given way to use of analgesics and 
the nursing complaint that there is no time for interventions like massage. Nurses need to be 
educated about the underlying physiological and psychological benefit that can result with these 
simple and relatively inexpensive interventions. They need to learn which interventions are best
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suited for various situations, and how to evaluate outcomes for these interventions so that their 
use can be justified as a necessary part of nursing care.
Recommendations for Further Research
Additional research is needed to explore further whether nursing intervention such as 
specific relaxation strategies can result in modification o f side effects associated with psycho- 
biological stressors such as chemotherapy. Ideally a much larger sample size should be used. 
Studies of this nature tend to have small sample sizes because of the very high cost involved with 
the laboratory tests. This contributes to lack of “statistical significance”. However, if upon 
replication one consistently gets the same pattern, the “statistical significance” per se may not be 
the critical factor. Similar findings over time and repeated studies could indicate significance even 
if the individual study does not show statistical significance.
Another aspect that would be very helpful for future research would be to study what 
changes are associated with specific interventions, and also whether the degree of use o f the 
interventions makes a difference. Further research could study whether there was a difference in 
findings based on how often subjects practiced PMR. Additionally, research is needed on personality 
types and who is most likely to benefit from certain types of intervention. This pilot study raises the 
question of whether personality factors were associated with persons who did not practice PMR, 
compared with persons who had moderate or high use of PMR, and it leads to the question of whether 
personality aspects are correlated with anxiety levels and stress hormone levels.
Further research also needs to evaluate the effect o f G-CSF on immune measures in 
persons undergoing chemotherapy. The effect of G-CSF on research o f this nature has yet to be
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reported and may be an area for collaborative research. Another potential area for collaborative 
research is in defining clearly the immunological changes that occur with Adriamycin and Cytoxan 
chemotherapy. Although parts of this information are available in various sources, none was 
found that described the effects of this combination.
There is also a need for a qualitative aspect to this type o f study. In the experimental 
group, five stated that they did not “dread” coming to the clinic for their treatments and one 
stated that she “almost looked forward to chemotherapy” because of the intervention and 
resultant interaction with the researcher. This information was unsolicited and offered voluntarily 
by the subjects. None of the control group offered similar comments. It would be helpful to 
include a qualitative aspect in future research to enrich and possibly explain in another way the 
empirical findings.
Conclusion
Chemotherapy is widely used and has significant side effects. It is anticipated that further 
study may result in methods of management that can modify the degree o f the side effects and 
enhance patient quality of life and response to therapy. Although the findings o f this study have 
been limited there seems to be evidence that further study is warranted, and the data collected will 
be useful in designing further study. Despite the challenges inherent in clinical research, it is 
important that further clinical studies be undertaken.
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Appendix A
SCRIPT, PROGRESSIVE MUSCLE RELAXATION AUDIOTAPE
The purpose of this progressive muscle relaxation exercise is to help you relax as you undergo 
chemotherapy. Sit or lie down in a comfortable position in a  quiet place. Make sure that your 
body feels comfortable. Let any stresses and anxieties go for the next few minutes. As your 
muscles relax, let your mind relax as well. As you practice relaxing, breathe in and out slowly, 
deeply, and easily. Concentrate on how your muscles feel when they are relaxed.
Let your eyes close and take a deep breath in, counting to five 
1,2,3,4,5
now breath out slowly 









Slowly clench your left hand
tighter - and hold it(l2345) - think of what the tension feels like 
and relax - feel the difference
Clench your right fist - hold it -1,2,3,4,5 - 
Relax your fist, notice the difference
Extend your fingers o f both hands as far as you can - 1,2,3,4,5 
and relax
Stretch your fingers again - 1,2,3,4,5
and relax them, feel the difference 
notice how relaxed your hands feel
Now tighten the muscles in your arms 
hold them tense - 1,2,3,4,5 
and let your arms relax 
Tighten the muscles in your arms again 
hold them tense 
and let your arms relax 
feel the difference and enjoy the contrast
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Shrug your shoulder muscles and make them tense 
tense them
and let them relax completely 
Pull your shoulders up and back - 1,2,3,4,5 
now relax
Push your shoulders forward, keep them tense 1,2,3,4,5 
and relax
feel the difference when you relax 
Shrug your shoulders again and tense them 
hold i t  and relax
concentrate on how relaxed your shoulder muscles feel
Now tense the muscles of your forehead
frown and feel the tension as you frown, tense - 1,2,3,4,5 
and relax your forehead 
Frown again, keep it tense 
and relax
feel the difference when you are relaxed 
Raise your eyebrows and hold it - 1,2,3,4,5 
now relax 
Do it again, raise them 
and relax
Tense the muscles around your eyes
squeeze your eyes shut - 1,2,3,4,5 
and let them relax 
Squeeze your eyes shut again 
hold it 
and relax
Concentrate on how those muscles feel when they are relaxed
Pinch your lips together and tense the muscles of your cheeks and lips 
hold them tense - 1,2,3,4,5 
and relax, feel the difference 
Open your mouth as wide as you can - 1,2,3,4,5 
and let your mouth relax 
Bring your tongue up to the top of your mouth 
keep it tense, hold it - 1,2,3,4,5 
let it relax 
Now tighten your jaw muscles
hold it tight, tight - 1,2,3,4,5 
and relax
enjoy the feeling of your jaw being relaxed 
Concentrate on how relaxed your face feels
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Now take in a deep slow breath, breath in as deep as you can 
feel how your chest muscles stretch 
hold it - 1,2,3,4,5 
and breathe out as much you can, 
relax
Breathe in deeply again, deeper 
and out 
relax
Tighten the muscles in your back as much as you can 
tighten your muscles - 1,2,3,4,5 
and relax
feel the difference as you relax
tighten your back muscles again 
hold it 
and relax
enjoy the feeling o f  being relaxed
Now tighten the muscles o f your stomach
push your stomach out as much as you can - 1,2,3,4,5 
and relax
tighten your stomach muscles again 
push it out 
and relax
Pull your stomach in as far as you can 
hold it - 1,2,3,4,5 
and relax
pull in your stomach muscles again 
and relax
Notice how relaxed your stomach feels
Now tighten the muscles o f  your buttocks 
tighten them - 1,2,3,4,5 
feel the tension 
and relax
tighten your buttocks muscles again 
tighter and hold it 
now relax
Tighten the muscles o f your left thigh 
and lift your legs up slightly 
hold your let up and feel your muscles tight - 1,2,3,4,5 
and relax as you breathe slowly and easily
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Now tense your right thigh
lift your right leg up slightly 
and hold it
feel how tense your muscles feel 
and relax
feel the difference
Now push your left leg down as hard as you can
feel the muscles in your legs tighten -1,2,3,4,5 
hold it 
and relax 
Push your right leg down 
tense your muscles 
and relax
notice how your legs feel relaxed
Bend both your ankles and point your toes as far as you can
hold it and feel the tension in your calf muscles - 1,2,3,4,5 
relax your muscles 
do it again, and point your toes 
relax
and feel your calf muscles relaxed
Now pull your toes up as far as you can 
hold it - 1,2,3,4,5
and relax. Feel the difference in your muscles as you relax 
Tense your toes again - Stretch them up as far as you can
press your toes against the top of your shoes - 1,2,3,4,5 
now relax them
Press your toes down against your shoes them down as far as you can 
press and hold -1,2,3,4,5 
and relax 
again press your toes down 
and relax them
feel how relaxed your toes feel
Now breathe easily and deeply several times 
in
and out
and concentrate on how relaxed your muscles feel
feel your toes relaxed 
feel your ankles relaxed
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feel your calves relaxed 
feel your thighs relaxed 
feel your buttocks relaxed 
feel your stomach relaxed 
feel your shoulders relaxed 
feel your arms relaxed 
feel your hands relaxed 
feel your fingers relaxed 
feel your neck relaxed 
feel your face relaxed
Breathe in deeply and feel your breathing muscles expand 
breathe out and feel them relax
Do it again and notice the feeling of your muscles relaxed
Let yourself stay as you are for a few moments and enjoy the feeling of being relaxed. Breathe 
easily, and deeply. Think of how you will relax your muscles when you receive your 
chemotherapy.
When you are ready move your focus back to your day and what you will be doing next. Get up 
when you feel like it.
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Appendix C 
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Offict of Spoiuond gjuanh Lama Linda, California 9Z3SQ
(909) 324-4531
January 8. 1996 FAX: f 9 0 9 1  ‘i 7 a ~ t i a 1
Patricia EC. Taytor Potbier. RN. MS 




The application for a study entitled “The Effect of a Nursing Relaxation Intervention on Neuro-Immune Responses of 
Persons Undergoing Chemotherapy’* was reviewed administratively on behalf o f the Insdmdonal Review Board of Loma 
Linda University on January S, 1996.
The actions o f the review are as follows:
* The subjects are at minimum risk.
* The protocol is approved from January 8,1996 to January 7.1997.
* Approval is based on condition that exclusion criteria in the protocol assure that no individual will have mote
than a total of450m l of blood drawn for any purpose within an eight-week period.
The enclosed consent form has been validated with the IRB approval stamp. This now becomes your official consent 
form for the dates specified and should be used as a ouster copy for enrolling subjects.
If there are modifications to the proposed research protocol or problems arising from the study, please notify the Board in 
writing. If you have any questions, please feel free to contact us.
You are required to provide a progress report on this study in one year indicating the number o f subjects enrolled.





4 s s r s /m r .iu Y  .tn m m s r  h e m th  sc ien c es m siW JU W
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Appendix D
INFORMED CONSENT FOR PARTICIPATION IN A CLINICAL RESEARCH 
STUDY ON THE EFFECT OF A NURSING RELAXATION INTERVENTION ON 
NERUO-IMMUNE RESPONSES OF PERSONS UNDERGOING CHEMOTHERAPY
I have been invited to participate in a research study. Before I give my consent, I will read the following 
and ask whatever questions I may have.
PURPOSE OF THE STUDY
The purpose of this study is to examine the effects of relaxation, including slow-stroke back massage and 
progressive muscle relaxation, on the immune system of persons who are undergoing chemotherapy. The 
immune system is made up of cells which function to protect the body against problems like infection. Certain 
drugs used for chemotherapy may affect cells involved in the immune system. The immune system may be 
sensitive to stressful situations. Some people might feel chemotherapy is stressful because of the side effects 
that may accompany it. This study will try to find out whether a change in immune function occurs along with 
chemotherapy. It will also study what effect relaxation has on some people who are having chemotherapy.
This will be done by examining the immune status before starting chemotherapy and again after three 
doses of chemotherapy. Half of the people will be in a part of the study that includes back massage and 
progressive muscle relaxation along with the usual chemotherapy program. The other half will be in a part of 
the study that involves the usual chemotherapy program alone. After three treatments with chemotherapy, the 
immune function will be studied to see if there is any difference between people who had the relaxation with 
chemotherapy and those who had the usual chemotherapy program.
I have been told that nothing in this study will in any way affect or modify the medication and treatment 
prescribed by my physician.
PROCEDURE
I understand that if I participate in this study I will be randomly assigned, by my drawing a slip of 
paper out of a box, to a Group A that gets standard care and treatment or to a Group B that gets standard care 
and treatment plus relaxation training.
I understand that I will be asked to have an assessment done before starting chemotherapy. This will 
involve filling out a form asking questions about feelings of anxiety, and having about two tablespoons more 
of blood drawn with my regular blood tests. My blood pressure and heart rate will also be measured. 
Information about my general health status, medications I need to take, and the kind of cancer will be taken 
from my medical record. At the first three chemotherapy treatments I will be asked to answer questions about 
my diet.
If I am in Group A, I will have my chemotherapy according to a usual schedule. If I am in Group B,
I will also have my chemotherapy according to usual schedule. In addition, I will also have a slow-stroke back 
massage just before four chemotherapy treatments. I will also be given an audio tape of instructions on 
progressive muscle relaxation and asked to practice the procedure for 30 minutes at least once a day
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INFORMED CONSENT FOR PARTICIPATION IN A CLINICAL RESEARCH STUDY ON THE EFFECT OF A 
NURSING RELAXATION INTERVENTION ON NEURO-IMMUNE RESPONSES OF PERSONS UNDERGOING 
CHEMOTHERAPY
After the second chemotherapy treatment, and just before the third treatment, I will have about two 
tablespoons of blood drawn with my regular blood tests. My blood pressure and heart rate will be measured. 
I will fill out a form asking about feelings of anxiety. I will also be asked to fill out a form that asks questions 
about nausea and vomiting associated with chemotherapy treatment.
Just before the fourth chemotherapy treatment, I will have about two tablespoons of blood drawn 
along with my regular blood tests. I will fill out a form asking questions about anxiety. While I am having the 
chemotherapy treatment, I will also fill out a final form asking questions about nausea and vomiting. After fhnr 
I will be finished with participation in the study.
TIME
Because this research involves my participation during 4 courses of chemotherapy, I understand that 
it will take about 12 weeks from start to finish. Filling out the form asking questions about anxious feelings 
will take about 20 minutes. Filling out the form asking questions about nausea and vomiting will take about 
10 minutes. The dietary questionnaire will take about 10 minutes. If I am in the group that uses the relaxation, 
I will get a 10-minute back massage before my chemotherapy treatment. I will also be asked to spend 30 
minutes a day listening to a tape.
RISKS
I have been told that no aspect of this study will change in any way the treatment ordered by my 
physician. The Institutional Review Board, a committee that carefully reviews all research done at Loma Linda 
University, has determined that participating in this study exposes me to minimal risk for participating in the 
study. I understand that the possible risk to me is minor pain and bruising at the site of the needle insertion for 
drawing a blood sample.
BENEFITS OF THE RESEARCH
I have been told that I may not directly benefit from this study. However, it is hoped that the results 
of the research will help in planning cares that may help persons undergoing chemotherapy in the future. 
Results of blood studies will be sent to my physician.
PARTICIPANTS RIGHTS
My participation in this study is completely voluntary. I understand that I may withdraw at any time 
without any penalty. I have been told that my decision of whether to participate or not, or a decision to 
withdraw from the study will not affect my treatment now or in the future. I understand that there is no 
agreement, either written or verbal, beyond that expressed in this consent form.
CONFIDENTIALITY
I understand that my confidentiality will be protected and that information that is identifiable will be 
kept in a locked file cabinet in the researcher’s office. I have been told that any published document that results 
from this study will not reveal my identity. I have been told that the Department ofHealth and Human Services 
or their designated representative may inspect the records relating to my participation in this study.
COST
There will be no additional cost to me as a result of participation in this study. There will be no 
reimbursement to me for participating in this study.
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INFORMED CONSENT FOR PARTICIPATION IN A CLINICAL RESEARCH STUDY ON THE EFFECT OF A NURSING 
RRIAXATION INTERVENTION ON NEURO-IMMUNE RESPONSES OF PERSONS UNDERGOING CHEMOTHERAPY
CONTACT PERSON
If at any time I wish to contact an impartial third party not associated with this study or with my 
medical care, I may contact Jean Frankhanel, Patient Representative, at Loma Linda University Medical 
Center, Loma Linda, California 92350, telephone (909) 824-4648, for assistance.
INFORMED CONSENT STATEMENT
“I  have read the contents o f  the consent form  and have listened to the verbal explanation given 
by the investigator, Patricia Pothier, RN, MS, a  doctoral candidate a t the Philip Y. Hahn School o f  
Nursing, University o f  San Diego. M y questions concerning this study have been answered to my 
satisfaction. I  hereby give my voluntary consent to participate in this study. Signing this consent form  
does not waive my rights, nor does it release the investigators, institution, o r sponsors from  their 
responsibilities.
I  may call Patricia Pothier, RN, during routine office hours a t (909) 824-4360, Ext. 45480, or  
leave a  message at that number on an answering machine. I  can also page her by calling (909)
824-0800, Pager Number 5023.
J have been given a  copy o f  this consent form. I  have received a  copy o f  the California 
Experimental Subject's Bill o f  Rights an d  have had these rights explained to  me. "
Signature Date
Witness
"I have reviewed the contents o f  the consent form  and the California Experimental S ubject’s Bill 
o f  Rights with the person signing above. I  have explained the potential risks an d  benefits o f  the study."
S ignature of Investigator Date
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Appendix E
CALIFORNIA EXPERIMENTAL SUBJECT'S BILL OF RIGHTS
You have been asked to participate as a subject in an experimental dinical procedure. Before you deride whether 
you want to participate in the experimental procedure, you have a right to:
1. Be informed of the nature and purpose of the experiment;
2. Be given an explanation of the procedures to be followed in the medical experiment, and any drug or device 
to be utilized;
3. Be given a description of any attendant discomforts and risks reasonably to be expected from your partici­
pation in the experiment;
4. Be given an explanation of any benefits reasonably to be expected from your participation in the experiment;
5. Be given a disdosure of any appropriate alternative procedures, drugs, or devices that might be advanta­
geous to you and their relative risks and benefits;
6. Be informed of the avenues of medical treatment, if any, available to you after the experimental procedure if 
complications should arise;
7. Be given an opportunity to ask any questions concerning the medical experiment or the procedures involved;
8. Be instructed that consent to partidpate in the experimental procedure may be withdrawn at any time and 
that you may discontinue partidpation in the medical experiment without prejudice;
9. Be given a copy of this form and the signed and dated written consent form; and
10. Be given the opportunity to dedde to consent or not to  consent to the medical experiment without the 
intervention of any element of force, fraud, deceit, duress, coerdon, or undue influence on your decision.
I have carefully read the information contained above in the 'California Experimental Subject’s  Bill of Rights* and I 
understand fully my rights as a potential subject in a medical experiment involving people a s  subjects.
Date Patient
Time Parent/Legal Guardian
If signed by other than the patient, indicate relationship:
Relationship Witness
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1. Research ID # ____________




4. Research Status (Control = I, Experimental = 2 )____
Health History (Yes = 1, NO = 2)
5 . __ HTN
6 . __ Diabetes
7 . __ Other major health problem (specify)___________________
Medication currently taking (Yes = 1, NO = 2)
8 . __ Medication for HTN (specify__________   )
9 . ___Hypoglycemic agent
10 . __ Cardiac medication (specify________________________)





Surgical Intervention before chemotherapy (YES = 1, NO = 2)
12 .  Lumpectomy
13 .  Simple mastectomy
14 .  Modified radical mastectomy
15 . Chemotherapy before surgery
Nutritional analysis
16. Weight in lbs. before chemotherapy_____
17. Weight in lbs. before dose 3______
18. Weight in lbs. before dose 4______
19. Serum albumin before chemotherapy_______
20. Serum albumin before dose 3 _______
21. Serum albumin before dose 4 _______
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Days between chemotherapy doses
22. # days between dose I and dose 3




26. State Score prior to dose 3 _____
27. Trait Score prior to dose 3 _____
28. State Score prior to dose 4 ____
29. Trait Score prior to dose 4 _____
MANE (YES = 1, NO = 2)
30. Nausea prior to dose 3 ______
3 1. Nausea/vomiting post dose 3 ___













Total Complement draws 1,2,  & 3
42. at baseline________
43. prior to 3rd dose________
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65. T- Lymphocytes C D 3+_____
66. B- Lymphocytes CD 20+_____
CD3-F/CD25-PE
67. T-Lymphocytes CD 3+______
68. IL-2 Activated T Lymphocytes CD3+25+____
CD3-F/CD16,56-PE
69. T-Lymphocytes C D 3+_____
70. NK Cells CD3-CD16+56+_______
71. CD3 Average______




73. T Lymphocytes C D 3+______
74. B Lymphocytes CD 20+______
CD3-F/CD25-PE
75. T-Lymphocytes C D 3+______
76. IL-2 Activated T Lymphocytes CD3+25+____
CD3-F/CD16,56-PE
77. T-Lymphocytes C D 3+______
78. NK Cells CD3-CD16+56+______
79. CD3 Average________
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81. T Lymphocytes CD3+______
82. B Lymphocytes CD20+______
CD3-F/CD25-PE
83. T-Lymphocytes CD3+______
84. IL-2 Activated T Lymphocytes CD3+25+______
CD3-F/CD16,56-PE
85. T-Lymphocytes CD3+_______
86. NK Cells CD3-CD16+56+______
87. CD3 Average_______
Mitogen Stimulation Assay (whole blood): Baseline
88. PHA 12.5 ug/mL________
89. PHA 3.125 ug/mL_______
90. PHA 1.56 ug/mL________
Mitogen Stimulation Assay (whole blood): prior to 3rd dose
91. PHA 12.5 ug/mL________
92. PHA 3.125 ug/mL_______
93. PHA 1.56 ug/mL________
Mitogen Stimulation Assay (whole blood): prior to 4th dose
94. PHA 12.5 ug/mL______
95. PHA 3.125 ug/mL______
96. PHA 1.56 ug/mL_______
NK Cells
97. NK baseline
98. NK prior to 3rd dose
99. NK prior to 4th dose
(Leave space here for additional NK data
Massage (0 = none, 1 = not relaxing, 2= somewhat relaxing, 3= quite relaxing, 4=very relaxing) 
110.______
Progressive Muscle Relaxation (0 = none, 1 = occasionally, 2 = about Vz the days, 3 = usually, 4 
= almost every day)
1 1 1 .________
COMMENTS: (What did client say about response to therapy? How did client respond to 
appointments? Any verbalized stressors?)
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Appendix G
Descriptive Statistics for Immune Function Tests for Subjects Not Requiring GCSF
Test & # Mean for Stand. Mean for Stand.
Mean
(Ref. Raneel Control Dev. Experimental Dev.______ Diff. t-value p
Ig G  (694-1618 mg/di)
Baseline #1 (n=2) 1053.000 176.605 (n=3) 1343.333 326.2412 -290.333 -1.113 .347
Measure #2 (ip-1 ) 984.000 (n=3) 1046.666 47.25 -62.666 -1.144 .370
Measure #3 (n=2) 1090.000 0.000 (n=4) 1129.250 330.487 -39.250 -0.154 .882
IgA (68-378 mg/dl)
Baseline #1 (n=2) 188.500 47.37 (n=3) 354.333 235.602 -156.833 -0.884 .442
Measure #2 (n=0) not able to calculate because of missing data
Measure #3 (n=2) 195.000 50.911 (n=4) 313.7500 218.374 -118.750 -0.719 .512
IgM (60-263 mg/dl)
Baseline #1 (n=2 102.250 32.173 (n=3) 232.000 73.082 -129.750 -2.740 .107
Measure #2 (n=0) not able to calculate due to missing data
Measure #3 (n=2) 89.450 40.375 (n=4) 179.500 40.763 -90.050 -2.557 .063
T Lymphocyte CD3+ % (61-87%)
Baseline #1 (n=2) 82.500 3.535 (n=5) 73.200 5.069 9.300 2.315 .069
Measure #2 (n=l) 93.00 (n=3) 77.333 14.153 15.666 0.959 .439
Measure #3 (n=2) 95.000 2.828 (n=4) 81.500 8.062 13.500 2.188 .094
T Lymphocyte CD3+ # (1.642-2.342 b/L)
Baseline #1 (n=2) 1.515 0.134 (n=5) 1.776 2.067 -0.261 -0.169 .873
Measure #2 (n=l) 1.030 (n=3) 1.006 0.456 2.333 0.044 .969
Measure #3 (n=2) 1.155 0.346 (n=4) 1.027 0.341 0.127 0.430 .690
B Lymphocyte CD20+ % (2-19 %)
Baseline #1 (n=2) 14.500 0.707 (n=5) 14.000 4.301 0.500 0.155 .883
Measure #2 (n=l) 0.000 0 (n=3) 10.666 16.743 -10.666 -0.552 .637
Measure #3 (n=2) 0.000 0 (n=4) 0.750 0.957 -0.750 -1.044 .355
B Lymphocyte CD20+ # (0.027-0.458 b/L)
Baseline #1 (n=2) 0.270 5.657 (n=5) 0.342 0.440 -7.200 -0.218 .836
Measure #2 (n=l) 0.000 0 (n=3) 0.200 0.329 -0.200 -0.526 .651
Measure #3 (n=2) 0.000 0.000 (n=4) 1.250 1.893 -1.250 -0.880 .428
IL-2 Activated Lymph’s % (15-39%)
Baseline #1 (n-2) 31.000 8.384 (n=5) 17.200 5.357 13.800 1.733 .477
Measure #2 (n=l) 53.00 (n=3) 16.666 2.516 36.333 12.503 .006*
Measure #3 (n=2) 28.500 14.849 (n=4) 22.000 5.887 6.500 0.833 .452
IL-2 Activated Lymph’s # (0.072-2.287 b/L)
Baseline #1 (n=2) 0.555 0.267 (n=5) 0.472 0.646 7.800 0.158 .881
Measure #2 (n-1) 0.580 (n=3) 0.203 0.101 0.376 3.225 .084
Measure #3 (n=2) 0.315 7.778 (n=4) 0.275 8.888 4.000 0.536 .621
♦(significance = .05)
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T est& # Mean for Stand. Mean for Stand. Mean
(Ref. Ranee) Control Dev. Experimental Dev. DifF. t-value p
NK Cells CDI6+CD56+ %  (0-24 %)
Baseline #1 (n=2) 3.500 2.121 (n=5) 3.000 6.284 -9.500 -1.992 .103
Measure #2 (n-1) 6.000 (n=3) 12.000 0.000 -6.000 - -
Measure #3 (n=2) 6.000 1.414 (n=4) 16.250 6.500 -10.250 -2.086 .105
NK Cells CD 16+CD56+ # (0.000-0.646 b/L)
Baseline #1 (n=2) 7.500 4.950 (n=5) 0.228 0.166 -0.153 -1.215 .279
Measure #2 (n=l) 7.000 (n=3) 0.146 6.658 -7.660 -0.997 .424
Measure #3 (n=2) 7.000 4.243 (n=4) 0.190 8.206 -0.120 -1.868 .135
Target Cells
Baseline #1 (ip-2) 1.120 2.828 (n=5) 2.552 2.060 -1.432 -0.929 .396
Measure #2 (n-D 4.8700 (n=3) 1.336 0.263 3.533 12.950 .006*
Measure #3 (n=2) 1.260 0.226 (n=4) 3.317 4.012 -2.Q57 -0.683 .532
Effector Cells
Baseline #1 (ip-2) 25.215 13.230 (n=5) 13.924 15.398 1.291 0.900 .409
Measure #2 (n=l) 30.130 (n=3) 29.163 8.234 0.966 0.100 .929
Measure #3 (n=2) 38.880 11.469 (n=4) 24.487 26.345 14.392 0.706 .519
NK Assay 40:1 % death
Baseline #1 (n=2) 14.095 3.627 (n=5) 35.378 27.623 -21.283 -1.027 .351
Measure f-2 (n-1) 10.930 (n=3) 16.436 2.822 -5.506 -1.690 .233
Measure #3 (n=2) 14.560 0.707 (n=4) 23.582 20.618 -9.022 -0.583 .591
NK Assay 20:1 % death
Baseline #1 (n=2) 7.710 1.569 (n=5) 29.562 21.865 -21.852 -1.335 .089
Measure #2 (n-1) 6.430 (n=3) 9.373 2.716 -2.943 -0.938 .447
Measure #3 (n=2) 8.645 0.629 (n=4) 14.482 13.461 -5.837 -0.578 .594
NK Assay 10:1
Baseline #1 (n=2) 5.115 0.318 (n=5) 14.804 11.460 -9.689 -1.130 .310
Measure #2 (n=l) 2.710 (n=3) 5.906 1.699 -3.196 -1.629 .245
Measure #3 (n=2) 3.645 0.487 (n=4) 7.595 5.059 -3.950 -1.039 .357
NK Assay 5:1
Baseline #1 (n=2) 3.175 1.888 (n=5) 7.556 6.427 -4.381 -0.901 .409
Measure #2 (n=l) 0.000 (n=3) 3.816 1.301 -3.816 -2.540 .126
Measure #3 (n=2) 2.765 0.756 (n=4) 3.337 2.583 -0.572 -0.291 .785
(♦significance = p <.05)
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Baseline #1 (n=2) 15.000 4.242 (n=5) 78.400 98.647 -63.400 -0.859 .430
Measure #2 (n=l) 1.000 (n=3) 18.000 5.196 -17.000 -2.833 .105
Measure #3 (n=2) 13.500 2.121 (n=4) 30.250 34.101 -16.750 -0.654 .549
PHA 12.5 (49,393-21,015 cpm)
Baseline #1 (n=2) 507.350 109.389 (n=4) 464.500 460.498 42.850 0.123 .908
Measure #2 (n=l) 306.600 (n=3) 455.033 500.092 -148.433 -0.257 .821
Measure #3 (n=2) 273.700 148.351 (n=4) 690.950 573.286 -417.250 -0.960 .392
PHA 3.125 (31,140-11,850 cpm)
Baseline #1 (n=2) 242.850 165.816 (n=4) 190.700 233.384 52.150 0.276 .796
Measure #2 (n=I) 27.900 (n=3) 349.000 414.621 -321.100 -0.671 .571
Measure #3 (n=2) 141.400 119.783 (n=4) 249.600 184.172 -108.200 -0.733 .504
PHA 1.56 (15,310-696 cpm)
Baseline #1 (n=2) 176.450 178.403 (n=4) 46.925 52.108 129.525 1.006 .487
Measure #2 (n=l) 13.500 (n=3) 171.566 220.172 -158.066 -0.622 .598
Measure #3 (n=2) 66.150 45.891 (n=4) 133.675 89.663 -67.525 -0.963 .390
Hi-4 (normal 0.6-450 pg/ml)
Baseline #1 (n=2) 0.5200' 0.141 (n=5) 1.034 1.134 -0.514 -0.604 .572
Measure #2 (n=l) 0.840 (n=3) 0.846 0.341 -6.666 -0.017 .988
Measure #3 (n=2) 0.445 0.134 (n=4) 0.560 0.171 -0.115 -0.815 .461
Hi-6 (0.6-450 pg/ml)
Baseline # I (n=I) 4.800 (n=5) 3.870 4.852 0.930 0.175 .870
Measure #2 (n=l) 4.320 (n=3) 1.773 0.190 2.546 11.602 .007*
Measure #3 (n=2) 2.435 1.690 (n=4) 6.967 9.264 -4.532 -0.649 .552
EL-12 (normal: 0 pg/mL)
Baseline #1 (n=2) 1.065 1.506 (n=5) 0.964 1.761 0.101 0.070 .947
Measure #2 (n=l) 0.000 (n=3) 1.667 2.887 -1.666 -0.500 .667
Measure #3 (n=2) 0.000 0.000 (n=4) 2.100 2.545 -2.100 -1.100 .333
(^significance = p <.05)
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